ID	Description	GeneRatio	BgRatio	RichFactor	FoldEnrichment	zScore	pvalue	p.adjust	qvalue	geneID	Count
GO:0033059	cellular pigmentation	4/89	64/21288	0.0625	14.9494382022472	7.2414849383665	0.000149746861372239	0.220876620524053	0.21374394107448	BACE2/VPS33A/AP1S1/BBS5	4
GO:0003183	mitral valve morphogenesis	2/89	12/21288	0.166666666666667	39.8651685393258	8.72570916579028	0.00111002790339173	0.420670504391807	0.407085961787896	DCHS1/BMPR1A	2
GO:0003174	mitral valve development	2/89	13/21288	0.153846153846154	36.7986171132239	8.36561142415776	0.00130828762124649	0.420670504391807	0.407085961787896	DCHS1/BMPR1A	2
GO:0034058	endosomal vesicle fusion	2/89	13/21288	0.153846153846154	36.7986171132239	8.36561142415776	0.00130828762124649	0.420670504391807	0.407085961787896	VPS8/VPS33A	2
GO:0043473	pigmentation	4/89	117/21288	0.0341880341880342	8.1774704696053	5.04415246492023	0.0014768541682729	0.420670504391807	0.407085961787896	BACE2/VPS33A/AP1S1/BBS5	4
GO:0035542	regulation of SNARE complex assembly	2/89	15/21288	0.133333333333333	31.8921348314607	7.75485580957012	0.00175160576538182	0.420670504391807	0.407085961787896	VPS8/VPS33A	2
GO:2001212	regulation of vasculogenesis	2/89	16/21288	0.125	29.8988764044944	7.49257903459931	0.00199640239372383	0.420670504391807	0.407085961787896	EMP2/RRAS	2
GO:0035864	response to potassium ion	2/89	20/21288	0.1	23.9191011235955	6.64421685813395	0.00312682220575632	0.476065444783812	0.460692055755111	CACNA1H/KCNC1	2
GO:0042985	negative regulation of amyloid precursor protein biosynthetic process	2/89	21/21288	0.0952380952380952	22.7800963081862	6.47009822058702	0.00344659686879578	0.476065444783812	0.460692055755111	BACE2/ITM2C	2
GO:0032400	melanosome localization	2/89	24/21288	0.0833333333333333	19.9325842696629	6.01294987619347	0.00449311270735299	0.476065444783812	0.460692055755111	VPS33A/BBS5	2
GO:0035493	SNARE complex assembly	2/89	24/21288	0.0833333333333333	19.9325842696629	6.01294987619347	0.00449311270735299	0.476065444783812	0.460692055755111	VPS8/VPS33A	2
GO:0051875	pigment granule localization	2/89	25/21288	0.08	19.1352808988764	5.87863596779435	0.00487060117768594	0.476065444783812	0.460692055755111	VPS33A/BBS5	2
GO:0006378	mRNA polyadenylation	2/89	26/21288	0.0769230769230769	18.3993085566119	5.75189769490112	0.0052622094412468	0.476065444783812	0.460692055755111	CLP1/APP	2
GO:0010561	negative regulation of glycoprotein biosynthetic process	2/89	26/21288	0.0769230769230769	18.3993085566119	5.75189769490112	0.0052622094412468	0.476065444783812	0.460692055755111	BACE2/ITM2C	2
GO:0003181	atrioventricular valve morphogenesis	2/89	27/21288	0.0740740740740741	17.7178526841448	5.63203154040756	0.00566781555450693	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:0003272	endocardial cushion formation	2/89	28/21288	0.0714285714285714	17.0850722311396	5.51842249069533	0.00608729832675261	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:0042983	amyloid precursor protein biosynthetic process	2/89	28/21288	0.0714285714285714	17.0850722311396	5.51842249069533	0.00608729832675261	0.476065444783812	0.460692055755111	BACE2/ITM2C	2
GO:0042984	regulation of amyloid precursor protein biosynthetic process	2/89	28/21288	0.0714285714285714	17.0850722311396	5.51842249069533	0.00608729832675261	0.476065444783812	0.460692055755111	BACE2/ITM2C	2
GO:1903019	negative regulation of glycoprotein metabolic process	2/89	29/21288	0.0689655172413793	16.4959318093762	5.41053020063897	0.00652053731603732	0.476065444783812	0.460692055755111	BACE2/ITM2C	2
GO:0003171	atrioventricular valve development	2/89	30/21288	0.0666666666666667	15.9460674157303	5.30787771462612	0.00696741282515437	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:1902751	positive regulation of cell cycle G2/M phase transition	2/89	32/21288	0.0625	14.9494382022472	5.11664730470095	0.0079015983137325	0.476065444783812	0.460692055755111	ATAD5/APP	2
GO:0060914	heart formation	2/89	34/21288	0.0588235294117647	14.0700594844679	4.94186901890413	0.00888891195784108	0.476065444783812	0.460692055755111	BMPR1A/EMP2	2
GO:0035751	regulation of lysosomal lumen pH	2/89	35/21288	0.0571428571428571	13.6680577849117	4.8599128654513	0.00940220039449904	0.476065444783812	0.460692055755111	VPS33A/ATP6V0A1	2
GO:0031123	RNA 3'-end processing	3/89	110/21288	0.0272727272727273	6.52339121552605	3.76317332380409	0.0110507290382697	0.476065444783812	0.460692055755111	INTS2/CLP1/APP	3
GO:0032438	melanosome organization	2/89	40/21288	0.05	11.9595505617978	4.49529562296148	0.0121603676470245	0.476065444783812	0.460692055755111	BACE2/AP1S1	2
GO:0071711	basement membrane organization	2/89	40/21288	0.05	11.9595505617978	4.49529562296148	0.0121603676470245	0.476065444783812	0.460692055755111	NID2/PHLDB1	2
GO:0048753	pigment granule organization	2/89	41/21288	0.048780487804878	11.667854206632	4.43011231746427	0.0127495538823015	0.476065444783812	0.460692055755111	BACE2/AP1S1	2
GO:0003203	endocardial cushion morphogenesis	2/89	42/21288	0.0476190476190476	11.3900481540931	4.36715054221448	0.0133509969216446	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:0001662	behavioral fear response	2/89	44/21288	0.0454545454545455	10.8723186925434	4.24738769376301	0.0145902126104663	0.476065444783812	0.460692055755111	USP46/GNG7	2
GO:0045740	positive regulation of DNA replication	2/89	44/21288	0.0454545454545455	10.8723186925434	4.24738769376301	0.0145902126104663	0.476065444783812	0.460692055755111	FAF1/ATAD5	2
GO:2000406	positive regulation of T cell migration	2/89	44/21288	0.0454545454545455	10.8723186925434	4.24738769376301	0.0145902126104663	0.476065444783812	0.460692055755111	ABL2/APP	2
GO:0002209	behavioral defense response	2/89	45/21288	0.0444444444444444	10.6307116104869	4.19035923836758	0.0152277665812078	0.476065444783812	0.460692055755111	USP46/GNG7	2
GO:0051648	vesicle localization	4/89	228/21288	0.0175438596491228	4.19633353045535	3.14401693553264	0.0154099442781738	0.476065444783812	0.460692055755111	VPS33A/EXOC7/CCDC186/BBS5	4
GO:0010463	mesenchymal cell proliferation	2/89	46/21288	0.0434782608695652	10.399609184172	4.13509561864772	0.0158771399910854	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:0010811	positive regulation of cell-substrate adhesion	3/89	128/21288	0.0234375	5.6060393258427	3.38664239511498	0.0165686782715733	0.476065444783812	0.460692055755111	SPOCK2/EMP2/RRAS	3
GO:1901989	positive regulation of cell cycle phase transition	3/89	131/21288	0.0229007633587786	5.47765674586157	3.33084135841597	0.0176133374233818	0.476065444783812	0.460692055755111	ATAD5/DLGAP5/APP	3
GO:1902749	regulation of cell cycle G2/M phase transition	3/89	132/21288	0.0227272727272727	5.43615934627171	3.31262190971793	0.0179695661825474	0.476065444783812	0.460692055755111	FOXO4/ATAD5/APP	3
GO:0060485	mesenchyme development	5/89	367/21288	0.0136239782016349	3.25873312310565	2.82814243970069	0.018931325649102	0.476065444783812	0.460692055755111	TCF21/DCHS1/BMPR1A/PHLDB1/EMP2	5
GO:0010171	body morphogenesis	2/89	52/21288	0.0384615384615385	9.19965427830596	3.83579510929604	0.0200156082640877	0.476065444783812	0.460692055755111	PHLDB1/RRAS	2
GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	2/89	53/21288	0.0377358490566038	9.02607589569642	3.79061441903738	0.0207447415778498	0.476065444783812	0.460692055755111	ATAD5/USP28	2
GO:0003197	endocardial cushion development	2/89	54/21288	0.037037037037037	8.85892634207241	3.74661215483283	0.0214848519724545	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:0042596	fear response	2/89	54/21288	0.037037037037037	8.85892634207241	3.74661215483283	0.0214848519724545	0.476065444783812	0.460692055755111	USP46/GNG7	2
GO:2000403	positive regulation of lymphocyte migration	2/89	55/21288	0.0363636363636364	8.69785495403473	3.70373524664365	0.0222358371171354	0.476065444783812	0.460692055755111	ABL2/APP	2
GO:0010559	regulation of glycoprotein biosynthetic process	2/89	56/21288	0.0357142857142857	8.54253611556982	3.66193393631753	0.0229975953279028	0.476065444783812	0.460692055755111	BACE2/ITM2C	2
GO:0030198	extracellular matrix organization	5/89	387/21288	0.0129198966408269	3.0903231425834	2.68893265065666	0.0231821031300856	0.476065444783812	0.460692055755111	NID2/SPOCK2/TPSAB1/PHLDB1/APP	5
GO:0043062	extracellular structure organization	5/89	388/21288	0.0128865979381443	3.08235839221592	2.6822097892852	0.0234095814670143	0.476065444783812	0.460692055755111	NID2/SPOCK2/TPSAB1/PHLDB1/APP	5
GO:0045229	external encapsulating structure organization	5/89	390/21288	0.0128205128205128	3.06655142610199	2.66882873035098	0.0238688784424937	0.476065444783812	0.460692055755111	NID2/SPOCK2/TPSAB1/PHLDB1/APP	5
GO:0001954	positive regulation of cell-matrix adhesion	2/89	58/21288	0.0344827586206897	8.24796590468811	3.58137409045044	0.0245530274245256	0.476065444783812	0.460692055755111	EMP2/RRAS	2
GO:0072132	mesenchyme morphogenesis	2/89	59/21288	0.0338983050847458	8.10816987240526	3.54253036391778	0.0253465011447005	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:2000404	regulation of T cell migration	2/89	60/21288	0.0333333333333333	7.97303370786517	3.5045914434994	0.0261503475926501	0.476065444783812	0.460692055755111	ABL2/APP	2
GO:0016050	vesicle organization	5/89	400/21288	0.0125	2.98988764044944	2.60318280410585	0.026252923181703	0.476065444783812	0.460692055755111	VPS8/BACE2/VPS33A/AP1S1/ATP6V0A1	5
GO:0031124	mRNA 3'-end processing	2/89	62/21288	0.032258064516129	7.71583907212758	3.43128341887485	0.0277887652876212	0.476065444783812	0.460692055755111	CLP1/APP	2
GO:1903018	regulation of glycoprotein metabolic process	2/89	62/21288	0.032258064516129	7.71583907212758	3.43128341887485	0.0277887652876212	0.476065444783812	0.460692055755111	BACE2/ITM2C	2
GO:0003179	heart valve morphogenesis	2/89	63/21288	0.0317460317460317	7.59336543606206	3.39584702724211	0.0286231414039102	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:0003007	heart morphogenesis	4/89	276/21288	0.0144927536231884	3.46653639472399	2.67240895873995	0.0286289915116791	0.476065444783812	0.460692055755111	DCHS1/BMPR1A/EMP2/BBS5	4
GO:0009205	purine ribonucleoside triphosphate metabolic process	4/89	279/21288	0.014336917562724	3.42926180983448	2.6464779495531	0.029624171279129	0.476065444783812	0.460692055755111	NDUFA5/NME1/HKDC1/APP	4
GO:0001658	branching involved in ureteric bud morphogenesis	2/89	65/21288	0.0307692307692308	7.35972342264477	3.32725484651134	0.030321744995707	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	2/89	66/21288	0.0303030303030303	7.24821246169561	3.29404211444572	0.0311857810450378	0.476065444783812	0.460692055755111	FAF1/ITM2C	2
GO:0009144	purine nucleoside triphosphate metabolic process	4/89	285/21288	0.0140350877192982	3.35706682436428	2.59566239355364	0.0316757228093245	0.476065444783812	0.460692055755111	NDUFA5/NME1/HKDC1/APP	4
GO:0009199	ribonucleoside triphosphate metabolic process	4/89	286/21288	0.013986013986014	3.3453288284749	2.58732495502508	0.0320256037942924	0.476065444783812	0.460692055755111	NDUFA5/NME1/HKDC1/APP	4
GO:0042593	glucose homeostasis	4/89	286/21288	0.013986013986014	3.3453288284749	2.58732495502508	0.0320256037942924	0.476065444783812	0.460692055755111	BACE2/HKDC1/TRA2B/CCDC186	4
GO:0033500	carbohydrate homeostasis	4/89	287/21288	0.0139372822299652	3.33367263046627	2.57902433274225	0.0323777627037579	0.476065444783812	0.460692055755111	BACE2/HKDC1/TRA2B/CCDC186	4
GO:0048645	animal organ formation	2/89	69/21288	0.0289855072463768	6.93307278944797	3.19842603131373	0.0338356904392142	0.476065444783812	0.460692055755111	BMPR1A/EMP2	2
GO:0044839	cell cycle G2/M phase transition	3/89	169/21288	0.0177514792899408	4.24599428229506	2.74504187360951	0.033975894581636	0.476065444783812	0.460692055755111	FOXO4/ATAD5/APP	3
GO:0048762	mesenchymal cell differentiation	4/89	293/21288	0.0136518771331058	3.26540629673659	2.52997669091413	0.0345386414337482	0.476065444783812	0.460692055755111	TCF21/BMPR1A/PHLDB1/EMP2	4
GO:0006631	fatty acid metabolic process	5/89	434/21288	0.0115207373271889	2.75565681147414	2.39433190097307	0.0354797228205283	0.476065444783812	0.460692055755111	FADS2/AACS/PECR/ACBD4/FAAH	5
GO:0006611	protein export from nucleus	2/89	71/21288	0.028169014084507	6.7377749643931	3.13779988932112	0.0356495299951023	0.476065444783812	0.460692055755111	NXT1/PTPN14	2
GO:0070050	neuron cellular homeostasis	2/89	72/21288	0.0277777777777778	6.64419475655431	3.10835799726043	0.0365703425722208	0.476065444783812	0.460692055755111	ATP6V0A1/APP	2
GO:0060675	ureteric bud morphogenesis	2/89	73/21288	0.0273972602739726	6.55317839002617	3.07947074704761	0.0375002952015276	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0009141	nucleoside triphosphate metabolic process	4/89	301/21288	0.0132890365448505	3.17861808951435	2.46651475527568	0.0375479837656988	0.476065444783812	0.460692055755111	NDUFA5/NME1/HKDC1/APP	4
GO:0072171	mesonephric tubule morphogenesis	2/89	74/21288	0.027027027027027	6.46462192529608	3.05111968494926	0.0384392972559542	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0051148	negative regulation of muscle cell differentiation	2/89	75/21288	0.0266666666666667	6.37842696629214	3.02328721427852	0.0393872586912731	0.476065444783812	0.460692055755111	FOXO4/BMPR1A	2
GO:0016052	carbohydrate catabolic process	3/89	180/21288	0.0166666666666667	3.98651685393258	2.60718726269213	0.0397880113511925	0.476065444783812	0.460692055755111	HKDC1/NEU3/APP	3
GO:0001678	intracellular glucose homeostasis	3/89	181/21288	0.0165745856353591	3.96449189893848	2.59520008182355	0.0403399096629284	0.476065444783812	0.460692055755111	HKDC1/TRA2B/CCDC186	3
GO:0003170	heart valve development	2/89	76/21288	0.0263157894736842	6.29450029568303	2.99595654471193	0.040344090042899	0.476065444783812	0.460692055755111	DCHS1/BMPR1A	2
GO:0006183	GTP biosynthetic process	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	NME1	1
GO:0006265	DNA topological change	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	TOP3A	1
GO:0008343	adult feeding behavior	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	USP46	1
GO:0015886	heme transport	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	PGRMC2	1
GO:0034651	cortisol biosynthetic process	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0035635	entry of bacterium into host cell	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	EXOC7	1
GO:0035733	hepatic stellate cell activation	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	RPS6KA1	1
GO:0035907	dorsal aorta development	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0036109	alpha-linolenic acid metabolic process	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	FADS2	1
GO:0048340	paraxial mesoderm morphogenesis	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0048382	mesendoderm development	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0051124	synaptic assembly at neuromuscular junction	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	APP	1
GO:0060539	diaphragm development	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	TCF21	1
GO:0060926	cardiac pacemaker cell development	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0070922	RISC complex assembly	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	CLP1	1
GO:1902645	tertiary alcohol biosynthetic process	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	CACNA1H	1
GO:1905770	regulation of mesodermal cell differentiation	1/89	10/21288	0.1	23.9191011235955	4.69706666904563	0.041038265669013	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0120254	olefinic compound metabolic process	3/89	183/21288	0.0163934426229508	3.92116411862221	2.57148129764368	0.0414553771916181	0.476065444783812	0.460692055755111	CACNA1H/FADS2/FAAH	3
GO:0003162	atrioventricular node development	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0007168	receptor guanylyl cyclase signaling pathway	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	GNG7	1
GO:0010172	embryonic body morphogenesis	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	PHLDB1	1
GO:0032060	bleb assembly	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	EMP2	1
GO:0032342	aldosterone biosynthetic process	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0046051	UTP metabolic process	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	NME1	1
GO:0048304	positive regulation of isotype switching to IgG isotypes	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	ATAD5	1
GO:0060052	neurofilament cytoskeleton organization	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	ARHGEF28	1
GO:0110011	regulation of basement membrane organization	1/89	11/21288	0.0909090909090909	21.7446373850868	4.45904175910451	0.045049337872954	0.476065444783812	0.460692055755111	PHLDB1	1
GO:0001570	vasculogenesis	2/89	83/21288	0.0240963855421687	5.76363882496277	2.8174309427819	0.0472828723975806	0.476065444783812	0.460692055755111	EMP2/RRAS	2
GO:0072078	nephron tubule morphogenesis	2/89	84/21288	0.0238095238095238	5.69502407704655	2.79359287897587	0.0483075108687548	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0001967	suckling behavior	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	APP	1
GO:0042276	error-prone translesion synthesis	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	REV3L	1
GO:0060920	cardiac pacemaker cell differentiation	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0062042	regulation of cardiac epithelial to mesenchymal transition	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	EMP2	1
GO:0150003	regulation of spontaneous synaptic transmission	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	APP	1
GO:1902043	positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	FAF1	1
GO:1990034	calcium ion export across plasma membrane	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	SLC35G1	1
GO:1990535	neuron projection maintenance	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	APP	1
GO:2000344	positive regulation of acrosome reaction	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	CACNA1H	1
GO:2001046	positive regulation of integrin-mediated signaling pathway	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	EMP2	1
GO:2001214	positive regulation of vasculogenesis	1/89	12/21288	0.0833333333333333	19.9325842696629	4.25059842276861	0.0490438205974598	0.476065444783812	0.460692055755111	RRAS	1
GO:0021536	diencephalon development	2/89	85/21288	0.0235294117647059	5.62802379378718	2.77013500465487	0.0493402396389834	0.476065444783812	0.460692055755111	KCNC1/BMPR1A	2
GO:0051304	chromosome separation	2/89	85/21288	0.0235294117647059	5.62802379378718	2.77013500465487	0.0493402396389834	0.476065444783812	0.460692055755111	DLGAP5/TOP3A	2
GO:2000401	regulation of lymphocyte migration	2/89	85/21288	0.0235294117647059	5.62802379378718	2.77013500465487	0.0493402396389834	0.476065444783812	0.460692055755111	ABL2/APP	2
GO:0045766	positive regulation of angiogenesis	3/89	197/21288	0.0152284263959391	3.64250270917698	2.41431823435635	0.0496945699545877	0.476065444783812	0.460692055755111	EMP2/PAK4/RRAS	3
GO:0072088	nephron epithelium morphogenesis	2/89	86/21288	0.0232558139534884	5.56258165665012	2.74704647292439	0.0503809748676755	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:1904018	positive regulation of vasculature development	3/89	200/21288	0.015	3.58786516853933	2.38250319973001	0.0515568914780258	0.476065444783812	0.460692055755111	EMP2/PAK4/RRAS	3
GO:0061333	renal tubule morphogenesis	2/89	88/21288	0.0227272727272727	5.43615934627171	2.70193619502186	0.0524861320625828	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0072028	nephron morphogenesis	2/89	88/21288	0.0227272727272727	5.43615934627171	2.70193619502186	0.0524861320625828	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0006241	CTP biosynthetic process	1/89	13/21288	0.0769230769230769	18.3993085566119	4.06596305028417	0.0530217816788108	0.476065444783812	0.460692055755111	NME1	1
GO:0007501	mesodermal cell fate specification	1/89	13/21288	0.0769230769230769	18.3993085566119	4.06596305028417	0.0530217816788108	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0021978	telencephalon regionalization	1/89	13/21288	0.0769230769230769	18.3993085566119	4.06596305028417	0.0530217816788108	0.476065444783812	0.460692055755111	TRA2B	1
GO:0032341	aldosterone metabolic process	1/89	13/21288	0.0769230769230769	18.3993085566119	4.06596305028417	0.0530217816788108	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0034650	cortisol metabolic process	1/89	13/21288	0.0769230769230769	18.3993085566119	4.06596305028417	0.0530217816788108	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0052651	monoacylglycerol catabolic process	1/89	13/21288	0.0769230769230769	18.3993085566119	4.06596305028417	0.0530217816788108	0.476065444783812	0.460692055755111	FAAH	1
GO:1901678	iron coordination entity transport	1/89	13/21288	0.0769230769230769	18.3993085566119	4.06596305028417	0.0530217816788108	0.476065444783812	0.460692055755111	PGRMC2	1
GO:0072678	T cell migration	2/89	90/21288	0.0222222222222222	5.31535580524345	2.65818355145154	0.0546223225846919	0.476065444783812	0.460692055755111	ABL2/APP	2
GO:0051650	establishment of vesicle localization	3/89	206/21288	0.0145631067961165	3.48336424130032	2.32066618962462	0.0553821352945407	0.476065444783812	0.460692055755111	EXOC7/CCDC186/BBS5	3
GO:1901568	fatty acid derivative metabolic process	2/89	92/21288	0.0217391304347826	5.19980459208598	2.6157159962992	0.0567888951495776	0.476065444783812	0.460692055755111	AACS/PECR	2
GO:0001977	renal system process involved in regulation of blood volume	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	EMP2	1
GO:0003222	ventricular trabecula myocardium morphogenesis	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0009209	pyrimidine ribonucleoside triphosphate biosynthetic process	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	NME1	1
GO:0014004	microglia differentiation	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	APP	1
GO:0034309	primary alcohol biosynthetic process	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0035865	cellular response to potassium ion	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0043252	sodium-independent organic anion transport	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	SLCO3A1	1
GO:0045842	positive regulation of mitotic metaphase/anaphase transition	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	DLGAP5	1
GO:0048149	behavioral response to ethanol	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	USP46	1
GO:0048388	endosomal lumen acidification	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	ATP6V0A1	1
GO:0072075	metanephric mesenchyme development	1/89	14/21288	0.0714285714285714	17.0850722311396	3.90082980118107	0.0569832886790734	0.476065444783812	0.460692055755111	TCF21	1
GO:0006839	mitochondrial transport	3/89	211/21288	0.014218009478673	3.40082006496619	2.27086328068662	0.0586710349752637	0.476065444783812	0.460692055755111	TIMM9/SFXN5/SLC35F6	3
GO:0006689	ganglioside catabolic process	1/89	15/21288	0.0666666666666667	15.9460674157303	3.75191285294616	0.0609284088871945	0.476065444783812	0.460692055755111	NEU3	1
GO:0044854	plasma membrane raft assembly	1/89	15/21288	0.0666666666666667	15.9460674157303	3.75191285294616	0.0609284088871945	0.476065444783812	0.460692055755111	EMP2	1
GO:0046036	CTP metabolic process	1/89	15/21288	0.0666666666666667	15.9460674157303	3.75191285294616	0.0609284088871945	0.476065444783812	0.460692055755111	NME1	1
GO:0048070	regulation of developmental pigmentation	1/89	15/21288	0.0666666666666667	15.9460674157303	3.75191285294616	0.0609284088871945	0.476065444783812	0.460692055755111	VPS33A	1
GO:0051220	cytoplasmic sequestering of protein	1/89	15/21288	0.0666666666666667	15.9460674157303	3.75191285294616	0.0609284088871945	0.476065444783812	0.460692055755111	FAF1	1
GO:0060766	negative regulation of androgen receptor signaling pathway	1/89	15/21288	0.0666666666666667	15.9460674157303	3.75191285294616	0.0609284088871945	0.476065444783812	0.460692055755111	TCF21	1
GO:1901203	positive regulation of extracellular matrix assembly	1/89	15/21288	0.0666666666666667	15.9460674157303	3.75191285294616	0.0609284088871945	0.476065444783812	0.460692055755111	PHLDB1	1
GO:0051453	regulation of intracellular pH	2/89	96/21288	0.0208333333333333	4.98314606741573	2.53437235548409	0.0612106236248254	0.476065444783812	0.460692055755111	VPS33A/ATP6V0A1	2
GO:0071677	positive regulation of mononuclear cell migration	2/89	96/21288	0.0208333333333333	4.98314606741573	2.53437235548409	0.0612106236248254	0.476065444783812	0.460692055755111	ABL2/APP	2
GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	2/89	96/21288	0.0208333333333333	4.98314606741573	2.53437235548409	0.0612106236248254	0.476065444783812	0.460692055755111	ATAD5/USP28	2
GO:0042770	signal transduction in response to DNA damage	3/89	216/21288	0.0138888888888889	3.32209737827715	2.22253685257327	0.0620505465536004	0.476065444783812	0.460692055755111	FOXO4/ATAD5/USP28	3
GO:0034243	regulation of transcription elongation by RNA polymerase II	2/89	97/21288	0.0206185567010309	4.93177342754546	2.514740467603	0.0623340502978295	0.476065444783812	0.460692055755111	INTS2/MED4	2
GO:0014910	regulation of smooth muscle cell migration	2/89	98/21288	0.0204081632653061	4.88144920889704	2.49537611020268	0.0634645190410393	0.476065444783812	0.460692055755111	FOXO4/BMPR1A	2
GO:0060021	roof of mouth development	2/89	99/21288	0.0202020202020202	4.83214164113041	2.47627267637472	0.0646019528748453	0.476065444783812	0.460692055755111	TCF21/BMPR1A	2
GO:0001768	establishment of T cell polarity	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	ABL2	1
GO:0009950	dorsal/ventral axis specification	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0016322	neuron remodeling	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	APP	1
GO:0045039	protein insertion into mitochondrial inner membrane	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	TIMM9	1
GO:0048302	regulation of isotype switching to IgG isotypes	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	ATAD5	1
GO:0060033	anatomical structure regression	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0070317	negative regulation of G0 to G1 transition	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	FOXO4	1
GO:0072537	fibroblast activation	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	RPS6KA1	1
GO:1902101	positive regulation of metaphase/anaphase transition of cell cycle	1/89	16/21288	0.0625	14.9494382022472	3.61665508221425	0.0648572093200922	0.476065444783812	0.460692055755111	DLGAP5	1
GO:0006096	glycolytic process	2/89	100/21288	0.02	4.7838202247191	2.45742378851412	0.0657462753271653	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0030641	regulation of cellular pH	2/89	100/21288	0.02	4.7838202247191	2.45742378851412	0.0657462753271653	0.476065444783812	0.460692055755111	VPS33A/ATP6V0A1	2
GO:0046032	ADP catabolic process	2/89	102/21288	0.0196078431372549	4.69001982815598	2.42046522626383	0.0680552827197585	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0001767	establishment of lymphocyte polarity	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	ABL2	1
GO:0003188	heart valve formation	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	DCHS1	1
GO:0006705	mineralocorticoid biosynthetic process	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0006878	intracellular copper ion homeostasis	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	APP	1
GO:0009208	pyrimidine ribonucleoside triphosphate metabolic process	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	NME1	1
GO:0048291	isotype switching to IgG isotypes	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	ATAD5	1
GO:0060046	regulation of acrosome reaction	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0072074	kidney mesenchyme development	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	TCF21	1
GO:0120305	regulation of pigmentation	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	VPS33A	1
GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	ATAD5	1
GO:1990403	embryonic brain development	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	TRA2B	1
GO:2000310	regulation of NMDA receptor activity	1/89	17/21288	0.0588235294117647	14.0700594844679	3.4930324242142	0.0687697567237452	0.476065444783812	0.460692055755111	APP	1
GO:0035023	regulation of Rho protein signal transduction	2/89	103/21288	0.0194174757281553	4.64448565506709	2.40234385427268	0.0692198172282083	0.476065444783812	0.460692055755111	ABL2/ARHGEF28	2
GO:0019364	pyridine nucleotide catabolic process	2/89	104/21288	0.0192307692307692	4.59982713915298	2.38445361529182	0.0703909394859586	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0001657	ureteric bud development	2/89	105/21288	0.019047619047619	4.55601926163724	2.36678913600062	0.0715685755165692	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0009137	purine nucleoside diphosphate catabolic process	2/89	105/21288	0.019047619047619	4.55601926163724	2.36678913600062	0.0715685755165692	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0009181	purine ribonucleoside diphosphate catabolic process	2/89	105/21288	0.019047619047619	4.55601926163724	2.36678913600062	0.0715685755165692	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0060993	kidney morphogenesis	2/89	105/21288	0.019047619047619	4.55601926163724	2.36678913600062	0.0715685755165692	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0001946	lymphangiogenesis	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	PTPN14	1
GO:0007176	regulation of epidermal growth factor-activated receptor activity	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	APP	1
GO:0009148	pyrimidine nucleoside triphosphate biosynthetic process	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	NME1	1
GO:0010470	regulation of gastrulation	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	PHLDB1	1
GO:0046184	aldehyde biosynthetic process	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0048532	anatomical structure arrangement	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0048557	embryonic digestive tract morphogenesis	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	TCF21	1
GO:0051382	kinetochore assembly	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	DLGAP5	1
GO:0072224	metanephric glomerulus development	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	TCF21	1
GO:1901970	positive regulation of mitotic sister chromatid separation	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	DLGAP5	1
GO:2000369	regulation of clathrin-dependent endocytosis	1/89	18/21288	0.0555555555555556	13.2883895131086	3.37941885315631	0.072666117574274	0.476065444783812	0.460692055755111	NEU3	1
GO:0072163	mesonephric epithelium development	2/89	106/21288	0.0188679245283019	4.51303794784821	2.34934521887161	0.072752651834428	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0072164	mesonephric tubule development	2/89	106/21288	0.0188679245283019	4.51303794784821	2.34934521887161	0.072752651834428	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:1901992	positive regulation of mitotic cell cycle phase transition	2/89	106/21288	0.0188679245283019	4.51303794784821	2.34934521887161	0.072752651834428	0.476065444783812	0.460692055755111	DLGAP5/APP	2
GO:0007517	muscle organ development	4/89	379/21288	0.0105540897097625	2.52444339035309	1.9402550446946	0.0745529610228268	0.476065444783812	0.460692055755111	CACNA1H/TCF21/FOXO4/BMPR1A	4
GO:0009191	ribonucleoside diphosphate catabolic process	2/89	108/21288	0.0185185185185185	4.4294631710362	2.31509911615536	0.0751398338271917	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0033555	multicellular organismal response to stress	2/89	108/21288	0.0185185185185185	4.4294631710362	2.31509911615536	0.0751398338271917	0.476065444783812	0.460692055755111	USP46/GNG7	2
GO:0046031	ADP metabolic process	2/89	108/21288	0.0185185185185185	4.4294631710362	2.31509911615536	0.0751398338271917	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0072080	nephron tubule development	2/89	108/21288	0.0185185185185185	4.4294631710362	2.31509911615536	0.0751398338271917	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0072526	pyridine-containing compound catabolic process	2/89	108/21288	0.0185185185185185	4.4294631710362	2.31509911615536	0.0751398338271917	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0007631	feeding behavior	2/89	109/21288	0.018348623853211	4.38882589423771	2.29828735006541	0.0763427949604763	0.476065444783812	0.460692055755111	USP46/APP	2
GO:0021549	cerebellum development	2/89	109/21288	0.018348623853211	4.38882589423771	2.29828735006541	0.0763427949604763	0.476065444783812	0.460692055755111	KCNC1/CLP1	2
GO:0001765	membrane raft assembly	1/89	19/21288	0.0526315789473684	12.5890005913661	3.27449096041053	0.0765463580790172	0.476065444783812	0.460692055755111	EMP2	1
GO:0008212	mineralocorticoid metabolic process	1/89	19/21288	0.0526315789473684	12.5890005913661	3.27449096041053	0.0765463580790172	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0010755	regulation of plasminogen activation	1/89	19/21288	0.0526315789473684	12.5890005913661	3.27449096041053	0.0765463580790172	0.476065444783812	0.460692055755111	PLGRKT	1
GO:0048339	paraxial mesoderm development	1/89	19/21288	0.0526315789473684	12.5890005913661	3.27449096041053	0.0765463580790172	0.476065444783812	0.460692055755111	BMPR1A	1
GO:1902165	regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1/89	19/21288	0.0526315789473684	12.5890005913661	3.27449096041053	0.0765463580790172	0.476065444783812	0.460692055755111	ATAD5	1
GO:0001823	mesonephros development	2/89	110/21288	0.0181818181818182	4.34892747701736	2.28167697219072	0.077551907292369	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0006885	regulation of pH	2/89	110/21288	0.0181818181818182	4.34892747701736	2.28167697219072	0.077551907292369	0.476065444783812	0.460692055755111	VPS33A/ATP6V0A1	2
GO:0045765	regulation of angiogenesis	4/89	386/21288	0.0103626943005181	2.47866332887	1.89960620285471	0.0785395424921978	0.476065444783812	0.460692055755111	FOXO4/EMP2/PAK4/RRAS	4
GO:0007173	epidermal growth factor receptor signaling pathway	2/89	111/21288	0.018018018018018	4.30974795019739	2.26526356069145	0.0787670997506646	0.476065444783812	0.460692055755111	ABL2/NEU3	2
GO:0014909	smooth muscle cell migration	2/89	111/21288	0.018018018018018	4.30974795019739	2.26526356069145	0.0787670997506646	0.476065444783812	0.460692055755111	FOXO4/BMPR1A	2
GO:0009134	nucleoside diphosphate catabolic process	2/89	112/21288	0.0178571428571429	4.27126805778491	2.24904283053566	0.0799883017377884	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0032784	regulation of DNA-templated transcription elongation	2/89	112/21288	0.0178571428571429	4.27126805778491	2.24904283053566	0.0799883017377884	0.476065444783812	0.460692055755111	INTS2/MED4	2
GO:0061326	renal tubule development	2/89	112/21288	0.0178571428571429	4.27126805778491	2.24904283053566	0.0799883017377884	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0009070	serine family amino acid biosynthetic process	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	SEPHS1	1
GO:0030813	positive regulation of nucleotide catabolic process	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	APP	1
GO:0033123	positive regulation of purine nucleotide catabolic process	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	APP	1
GO:0036342	post-anal tail morphogenesis	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	DCHS1	1
GO:0044857	plasma membrane raft organization	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	EMP2	1
GO:0045821	positive regulation of glycolytic process	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	APP	1
GO:0048368	lateral mesoderm development	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0055070	copper ion homeostasis	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	APP	1
GO:1900272	negative regulation of long-term synaptic potentiation	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	APP	1
GO:1903232	melanosome assembly	1/89	20/21288	0.05	11.9595505617978	3.17715909570735	0.0804105441776098	0.476065444783812	0.460692055755111	AP1S1	1
GO:0010810	regulation of cell-substrate adhesion	3/89	242/21288	0.012396694214876	2.96517782523911	1.99213745505576	0.0810296418177881	0.476065444783812	0.460692055755111	SPOCK2/EMP2/RRAS	3
GO:1901990	regulation of mitotic cell cycle phase transition	4/89	391/21288	0.010230179028133	2.44696686686399	1.87111094825471	0.0814517034878942	0.476065444783812	0.460692055755111	FOXO4/ATAD5/DLGAP5/APP	4
GO:0042982	amyloid precursor protein metabolic process	2/89	114/21288	0.0175438596491228	4.19633353045535	2.21716292589035	0.0824484542654789	0.476065444783812	0.460692055755111	BACE2/ITM2C	2
GO:1901342	regulation of vasculature development	4/89	395/21288	0.010126582278481	2.42218745555398	1.84862803632445	0.0838198218671383	0.476065444783812	0.460692055755111	FOXO4/EMP2/PAK4/RRAS	4
GO:0001787	natural killer cell proliferation	1/89	21/21288	0.0476190476190476	11.3900481540931	3.08651675008179	0.0842587415430505	0.476065444783812	0.460692055755111	EMP2	1
GO:0003215	cardiac right ventricle morphogenesis	1/89	21/21288	0.0476190476190476	11.3900481540931	3.08651675008179	0.0842587415430505	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0006700	C21-steroid hormone biosynthetic process	1/89	21/21288	0.0476190476190476	11.3900481540931	3.08651675008179	0.0842587415430505	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0021554	optic nerve development	1/89	21/21288	0.0476190476190476	11.3900481540931	3.08651675008179	0.0842587415430505	0.476065444783812	0.460692055755111	KCNC1	1
GO:0032402	melanosome transport	1/89	21/21288	0.0476190476190476	11.3900481540931	3.08651675008179	0.0842587415430505	0.476065444783812	0.460692055755111	BBS5	1
GO:0060973	cell migration involved in heart development	1/89	21/21288	0.0476190476190476	11.3900481540931	3.08651675008179	0.0842587415430505	0.476065444783812	0.460692055755111	DCHS1	1
GO:2001044	regulation of integrin-mediated signaling pathway	1/89	21/21288	0.0476190476190476	11.3900481540931	3.08651675008179	0.0842587415430505	0.476065444783812	0.460692055755111	EMP2	1
GO:0001676	long-chain fatty acid metabolic process	2/89	117/21288	0.0170940170940171	4.08873523480265	2.17068833847428	0.0861820165818783	0.476065444783812	0.460692055755111	FADS2/FAAH	2
GO:0033108	mitochondrial respiratory chain complex assembly	2/89	118/21288	0.0169491525423729	4.05408493620263	2.15554072036312	0.0874378194397957	0.476065444783812	0.460692055755111	COX20/NDUFA5	2
GO:0006388	tRNA splicing, via endonucleolytic cleavage and ligation	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	CLP1	1
GO:0006704	glucocorticoid biosynthetic process	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0007530	sex determination	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	TCF21	1
GO:0032401	establishment of melanosome localization	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	BBS5	1
GO:0034472	snRNA 3'-end processing	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	INTS2	1
GO:0043651	linoleic acid metabolic process	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	FADS2	1
GO:0051383	kinetochore organization	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	DLGAP5	1
GO:0051904	pigment granule transport	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	BBS5	1
GO:0060008	Sertoli cell differentiation	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	TCF21	1
GO:0098801	regulation of renal system process	1/89	22/21288	0.0454545454545455	10.8723186925434	3.0018027295673	0.0880910155827678	0.476065444783812	0.460692055755111	EMP2	1
GO:0010389	regulation of G2/M transition of mitotic cell cycle	2/89	119/21288	0.0168067226890756	4.02001699556227	2.14055919458855	0.088699150712121	0.476065444783812	0.460692055755111	FOXO4/APP	2
GO:0007040	lysosome organization	2/89	120/21288	0.0166666666666667	3.98651685393258	2.12574039554558	0.0899659435039857	0.476065444783812	0.460692055755111	VPS33A/ATP6V0A1	2
GO:0009135	purine nucleoside diphosphate metabolic process	2/89	120/21288	0.0166666666666667	3.98651685393258	2.12574039554558	0.0899659435039857	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0009179	purine ribonucleoside diphosphate metabolic process	2/89	120/21288	0.0166666666666667	3.98651685393258	2.12574039554558	0.0899659435039857	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0022037	metencephalon development	2/89	120/21288	0.0166666666666667	3.98651685393258	2.12574039554558	0.0899659435039857	0.476065444783812	0.460692055755111	KCNC1/CLP1	2
GO:0080171	lytic vacuole organization	2/89	120/21288	0.0166666666666667	3.98651685393258	2.12574039554558	0.0899659435039857	0.476065444783812	0.460692055755111	VPS33A/ATP6V0A1	2
GO:0031589	cell-substrate adhesion	4/89	408/21288	0.00980392156862745	2.34500991407799	1.77739873153082	0.0917485014546986	0.476065444783812	0.460692055755111	NID2/SPOCK2/EMP2/RRAS	4
GO:0000394	RNA splicing, via endonucleolytic cleavage and ligation	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	CLP1	1
GO:0009147	pyrimidine nucleoside triphosphate metabolic process	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	NME1	1
GO:0009220	pyrimidine ribonucleotide biosynthetic process	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	NME1	1
GO:0035235	ionotropic glutamate receptor signaling pathway	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	APP	1
GO:0036303	lymph vessel morphogenesis	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	PTPN14	1
GO:0046039	GTP metabolic process	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	NME1	1
GO:0046462	monoacylglycerol metabolic process	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	FAAH	1
GO:0046835	carbohydrate phosphorylation	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	HKDC1	1
GO:0051151	negative regulation of smooth muscle cell differentiation	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	FOXO4	1
GO:0051905	establishment of pigment granule localization	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	BBS5	1
GO:0060004	reflex	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	USP46	1
GO:0098814	spontaneous synaptic transmission	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	APP	1
GO:1902644	tertiary alcohol metabolic process	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	CACNA1H	1
GO:2000114	regulation of establishment of cell polarity	1/89	23/21288	0.0434782608695652	10.399609184172	2.92237246599518	0.0919074314396818	0.476065444783812	0.460692055755111	ABL2	1
GO:0046034	ATP metabolic process	3/89	256/21288	0.01171875	2.80301966292135	1.88050592039075	0.0921738272126065	0.476065444783812	0.460692055755111	NDUFA5/HKDC1/APP	3
GO:0016579	protein deubiquitination	2/89	122/21288	0.0163934426229508	3.92116411862221	2.0965779930716	0.0925156483205504	0.476065444783812	0.460692055755111	USP46/USP28	2
GO:0009306	protein secretion	4/89	411/21288	0.0097323600973236	2.32789305339129	1.76134532204876	0.0936279456715638	0.476065444783812	0.460692055755111	AP1S1/AACS/SERGEF/CCDC186	4
GO:0035592	establishment of protein localization to extracellular region	4/89	412/21288	0.00970873786407767	2.32224282753354	1.75602514250582	0.0942585207655693	0.476065444783812	0.460692055755111	AP1S1/AACS/SERGEF/CCDC186	4
GO:0014812	muscle cell migration	2/89	124/21288	0.0161290322580645	3.85791953606379	2.06802845109544	0.0950864077099372	0.476065444783812	0.460692055755111	FOXO4/BMPR1A	2
GO:0033559	unsaturated fatty acid metabolic process	2/89	124/21288	0.0161290322580645	3.85791953606379	2.06802845109544	0.0950864077099372	0.476065444783812	0.460692055755111	FADS2/FAAH	2
GO:0003148	outflow tract septum morphogenesis	1/89	24/21288	0.0416666666666667	9.96629213483146	2.84767596510528	0.0957080539932612	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0035024	negative regulation of Rho protein signal transduction	1/89	24/21288	0.0416666666666667	9.96629213483146	2.84767596510528	0.0957080539932612	0.476065444783812	0.460692055755111	ABL2	1
GO:0043555	regulation of translation in response to stress	1/89	24/21288	0.0416666666666667	9.96629213483146	2.84767596510528	0.0957080539932612	0.476065444783812	0.460692055755111	RPS6KA1	1
GO:0071636	positive regulation of transforming growth factor beta production	1/89	24/21288	0.0416666666666667	9.96629213483146	2.84767596510528	0.0957080539932612	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0097401	synaptic vesicle lumen acidification	1/89	24/21288	0.0416666666666667	9.96629213483146	2.84767596510528	0.0957080539932612	0.476065444783812	0.460692055755111	ATP6V0A1	1
GO:1903975	regulation of glial cell migration	1/89	24/21288	0.0416666666666667	9.96629213483146	2.84767596510528	0.0957080539932612	0.476065444783812	0.460692055755111	RRAS	1
GO:1905906	regulation of amyloid fibril formation	1/89	24/21288	0.0416666666666667	9.96629213483146	2.84767596510528	0.0957080539932612	0.476065444783812	0.460692055755111	APP	1
GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	2/89	126/21288	0.0158730158730159	3.79668271803103	2.04006808717499	0.0976777025916567	0.476065444783812	0.460692055755111	ATAD5/USP28	2
GO:0034308	primary alcohol metabolic process	2/89	126/21288	0.0158730158730159	3.79668271803103	2.04006808717499	0.0976777025916567	0.476065444783812	0.460692055755111	CACNA1H/PECR	2
GO:0071692	protein localization to extracellular region	4/89	419/21288	0.00954653937947494	2.28344640798048	1.71920821129109	0.0987293649915215	0.476065444783812	0.460692055755111	AP1S1/AACS/SERGEF/CCDC186	4
GO:0009206	purine ribonucleoside triphosphate biosynthetic process	2/89	127/21288	0.015748031496063	3.76678757851898	2.02630179944777	0.0989808905510302	0.476065444783812	0.460692055755111	NDUFA5/NME1	2
GO:0001710	mesodermal cell fate commitment	1/89	25/21288	0.04	9.5676404494382	2.77724064965091	0.0994929478605767	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0007042	lysosomal lumen acidification	1/89	25/21288	0.04	9.5676404494382	2.77724064965091	0.0994929478605767	0.476065444783812	0.460692055755111	ATP6V0A1	1
GO:0016973	poly(A)+ mRNA export from nucleus	1/89	25/21288	0.04	9.5676404494382	2.77724064965091	0.0994929478605767	0.476065444783812	0.460692055755111	NXT1	1
GO:0021871	forebrain regionalization	1/89	25/21288	0.04	9.5676404494382	2.77724064965091	0.0994929478605767	0.476065444783812	0.460692055755111	TRA2B	1
GO:1901029	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	1/89	25/21288	0.04	9.5676404494382	2.77724064965091	0.0994929478605767	0.476065444783812	0.460692055755111	SLC35F6	1
GO:0009145	purine nucleoside triphosphate biosynthetic process	2/89	128/21288	0.015625	3.7373595505618	2.01267450162497	0.100289020904672	0.476065444783812	0.460692055755111	NDUFA5/NME1	2
GO:0051099	positive regulation of binding	2/89	128/21288	0.015625	3.7373595505618	2.01267450162497	0.100289020904672	0.476065444783812	0.460692055755111	NME1/APP	2
GO:0072009	nephron epithelium development	2/89	129/21288	0.0155038759689922	3.70838777110008	1.99918357966332	0.101602030728815	0.476065444783812	0.460692055755111	TCF21/DCHS1	2
GO:0006090	pyruvate metabolic process	2/89	130/21288	0.0153846153846154	3.67986171132239	1.98582648904077	0.102919857528599	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0006368	transcription elongation by RNA polymerase II	2/89	130/21288	0.0153846153846154	3.67986171132239	1.98582648904077	0.102919857528599	0.476065444783812	0.460692055755111	INTS2/MED4	2
GO:0006906	vesicle fusion	2/89	130/21288	0.0153846153846154	3.67986171132239	1.98582648904077	0.102919857528599	0.476065444783812	0.460692055755111	VPS8/VPS33A	2
GO:0009185	ribonucleoside diphosphate metabolic process	2/89	130/21288	0.0153846153846154	3.67986171132239	1.98582648904077	0.102919857528599	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0002053	positive regulation of mesenchymal cell proliferation	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0003071	renal system process involved in regulation of systemic arterial blood pressure	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	EMP2	1
GO:0009313	oligosaccharide catabolic process	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	NEU3	1
GO:0010954	positive regulation of protein processing	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	PLGRKT	1
GO:0019985	translesion synthesis	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	REV3L	1
GO:0032469	endoplasmic reticulum calcium ion homeostasis	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	APP	1
GO:0032878	regulation of establishment or maintenance of cell polarity	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	ABL2	1
GO:0033617	mitochondrial cytochrome c oxidase assembly	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	COX20	1
GO:0042659	regulation of cell fate specification	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0060155	platelet dense granule organization	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	AP1S1	1
GO:0072202	cell differentiation involved in metanephros development	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	TCF21	1
GO:1900273	positive regulation of long-term synaptic potentiation	1/89	26/21288	0.0384615384615385	9.19965427830596	2.71065786257647	0.10326217739735	0.476065444783812	0.460692055755111	APP	1
GO:0038127	ERBB signaling pathway	2/89	132/21288	0.0151515151515152	3.6241062308478	1.95950395718751	0.105569714205704	0.476065444783812	0.460692055755111	ABL2/NEU3	2
GO:0090174	organelle membrane fusion	2/89	132/21288	0.0151515151515152	3.6241062308478	1.95950395718751	0.105569714205704	0.476065444783812	0.460692055755111	VPS8/VPS33A	2
GO:0065004	protein-DNA complex assembly	3/89	273/21288	0.010989010989011	2.62847265094456	1.7546546094444	0.106509454657953	0.476065444783812	0.460692055755111	MED4/ASF1B/DLGAP5	3
GO:0009201	ribonucleoside triphosphate biosynthetic process	2/89	133/21288	0.0150375939849624	3.59685731181887	1.94653375364383	0.106901621216149	0.476065444783812	0.460692055755111	NDUFA5/NME1	2
GO:0010717	regulation of epithelial to mesenchymal transition	2/89	133/21288	0.0150375939849624	3.59685731181887	1.94653375364383	0.106901621216149	0.476065444783812	0.460692055755111	PHLDB1/EMP2	2
GO:0000395	mRNA 5'-splice site recognition	1/89	27/21288	0.037037037037037	8.85892634207241	2.64757214150292	0.107015806698998	0.476065444783812	0.460692055755111	SNRPC	1
GO:0000413	protein peptidyl-prolyl isomerization	1/89	27/21288	0.037037037037037	8.85892634207241	2.64757214150292	0.107015806698998	0.476065444783812	0.460692055755111	PPIL3	1
GO:0009642	response to light intensity	1/89	27/21288	0.037037037037037	8.85892634207241	2.64757214150292	0.107015806698998	0.476065444783812	0.460692055755111	KCNC1	1
GO:0022038	corpus callosum development	1/89	27/21288	0.037037037037037	8.85892634207241	2.64757214150292	0.107015806698998	0.476065444783812	0.460692055755111	KCNC1	1
GO:0032042	mitochondrial DNA metabolic process	1/89	27/21288	0.037037037037037	8.85892634207241	2.64757214150292	0.107015806698998	0.476065444783812	0.460692055755111	TOP3A	1
GO:0035902	response to immobilization stress	1/89	27/21288	0.037037037037037	8.85892634207241	2.64757214150292	0.107015806698998	0.476065444783812	0.460692055755111	FOXO4	1
GO:1902254	negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator	1/89	27/21288	0.037037037037037	8.85892634207241	2.64757214150292	0.107015806698998	0.476065444783812	0.460692055755111	ATAD5	1
GO:0007026	negative regulation of microtubule depolymerization	1/89	28/21288	0.0357142857142857	8.54253611556982	2.58767261588438	0.110753899601674	0.476065444783812	0.460692055755111	TRIM54	1
GO:0016180	snRNA processing	1/89	28/21288	0.0357142857142857	8.54253611556982	2.58767261588438	0.110753899601674	0.476065444783812	0.460692055755111	INTS2	1
GO:0031639	plasminogen activation	1/89	28/21288	0.0357142857142857	8.54253611556982	2.58767261588438	0.110753899601674	0.476065444783812	0.460692055755111	PLGRKT	1
GO:0048169	regulation of long-term neuronal synaptic plasticity	1/89	28/21288	0.0357142857142857	8.54253611556982	2.58767261588438	0.110753899601674	0.476065444783812	0.460692055755111	APP	1
GO:0120255	olefinic compound biosynthetic process	1/89	28/21288	0.0357142857142857	8.54253611556982	2.58767261588438	0.110753899601674	0.476065444783812	0.460692055755111	CACNA1H	1
GO:1903319	positive regulation of protein maturation	1/89	28/21288	0.0357142857142857	8.54253611556982	2.58767261588438	0.110753899601674	0.476065444783812	0.460692055755111	PLGRKT	1
GO:0009132	nucleoside diphosphate metabolic process	2/89	137/21288	0.0145985401459854	3.49183958008694	1.89587393914419	0.112274359836165	0.476065444783812	0.460692055755111	HKDC1/APP	2
GO:0007160	cell-matrix adhesion	3/89	282/21288	0.0106382978723404	2.54458522591442	1.69184002841107	0.114433617971335	0.476065444783812	0.460692055755111	NID2/EMP2/RRAS	3
GO:0003094	glomerular filtration	1/89	29/21288	0.0344827586206897	8.24796590468811	2.53068604733975	0.114476519683304	0.476065444783812	0.460692055755111	EMP2	1
GO:0007398	ectoderm development	1/89	29/21288	0.0344827586206897	8.24796590468811	2.53068604733975	0.114476519683304	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0010800	positive regulation of peptidyl-threonine phosphorylation	1/89	29/21288	0.0344827586206897	8.24796590468811	2.53068604733975	0.114476519683304	0.476065444783812	0.460692055755111	APP	1
GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	1/89	29/21288	0.0344827586206897	8.24796590468811	2.53068604733975	0.114476519683304	0.476065444783812	0.460692055755111	APP	1
GO:0030220	platelet formation	1/89	29/21288	0.0344827586206897	8.24796590468811	2.53068604733975	0.114476519683304	0.476065444783812	0.460692055755111	VPS33A	1
GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	1/89	29/21288	0.0344827586206897	8.24796590468811	2.53068604733975	0.114476519683304	0.476065444783812	0.460692055755111	NEU3	1
GO:0045830	positive regulation of isotype switching	1/89	29/21288	0.0344827586206897	8.24796590468811	2.53068604733975	0.114476519683304	0.476065444783812	0.460692055755111	ATAD5	1
GO:1901201	regulation of extracellular matrix assembly	1/89	29/21288	0.0344827586206897	8.24796590468811	2.53068604733975	0.114476519683304	0.476065444783812	0.460692055755111	PHLDB1	1
GO:0007006	mitochondrial membrane organization	2/89	139/21288	0.0143884892086331	3.44159728397058	1.87124675688622	0.11498696019728	0.476065444783812	0.460692055755111	TIMM9/SLC35F6	2
GO:0032543	mitochondrial translation	2/89	140/21288	0.0142857142857143	3.41701444622793	1.85910174749124	0.116349612182774	0.476065444783812	0.460692055755111	MRPL1/MRPL51	2
GO:0030900	forebrain development	4/89	447/21288	0.00894854586129754	2.14041173365508	1.57888575999355	0.117576990871254	0.476065444783812	0.460692055755111	KCNC1/BMPR1A/TRA2B/APP	4
GO:0001952	regulation of cell-matrix adhesion	2/89	141/21288	0.0141843971631206	3.39278030121922	1.84706655395075	0.117716421325502	0.476065444783812	0.460692055755111	EMP2/RRAS	2
GO:0009142	nucleoside triphosphate biosynthetic process	2/89	141/21288	0.0141843971631206	3.39278030121922	1.84706655395075	0.117716421325502	0.476065444783812	0.460692055755111	NDUFA5/NME1	2
GO:0070646	protein modification by small protein removal	2/89	141/21288	0.0141843971631206	3.39278030121922	1.84706655395075	0.117716421325502	0.476065444783812	0.460692055755111	USP46/USP28	2
GO:0001835	blastocyst hatching	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	ASF1B	1
GO:0015732	prostaglandin transport	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	SLCO3A1	1
GO:0035188	hatching	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	ASF1B	1
GO:0043931	ossification involved in bone maturation	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	DCHS1	1
GO:0048668	collateral sprouting	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	APP	1
GO:0060037	pharyngeal system development	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0060765	regulation of androgen receptor signaling pathway	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	TCF21	1
GO:0071684	organism emergence from protective structure	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	ASF1B	1
GO:0072012	glomerulus vasculature development	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	TCF21	1
GO:1905820	positive regulation of chromosome separation	1/89	30/21288	0.0333333333333333	7.97303370786517	2.47637115448577	0.118183730264619	0.476065444783812	0.460692055755111	DLGAP5	1
GO:2001233	regulation of apoptotic signaling pathway	4/89	450/21288	0.00888888888888889	2.12614232209738	1.56446577309233	0.119684701086669	0.476065444783812	0.460692055755111	FAF1/ATAD5/ITM2C/SLC35F6	4
GO:0090068	positive regulation of cell cycle process	3/89	289/21288	0.0103806228373702	2.48295167372964	1.64464117537497	0.120748132291612	0.476065444783812	0.460692055755111	ATAD5/DLGAP5/APP	3
GO:0045931	positive regulation of mitotic cell cycle	2/89	144/21288	0.0138888888888889	3.32209737827715	1.81160138940568	0.121841218355789	0.476065444783812	0.460692055755111	DLGAP5/APP	2
GO:0001945	lymph vessel development	1/89	31/21288	0.032258064516129	7.71583907212758	2.42451395103052	0.121875594410186	0.476065444783812	0.460692055755111	PTPN14	1
GO:0008535	respiratory chain complex IV assembly	1/89	31/21288	0.032258064516129	7.71583907212758	2.42451395103052	0.121875594410186	0.476065444783812	0.460692055755111	COX20	1
GO:0009218	pyrimidine ribonucleotide metabolic process	1/89	31/21288	0.032258064516129	7.71583907212758	2.42451395103052	0.121875594410186	0.476065444783812	0.460692055755111	NME1	1
GO:0034508	centromere complex assembly	1/89	31/21288	0.032258064516129	7.71583907212758	2.42451395103052	0.121875594410186	0.476065444783812	0.460692055755111	DLGAP5	1
GO:0060045	positive regulation of cardiac muscle cell proliferation	1/89	31/21288	0.032258064516129	7.71583907212758	2.42451395103052	0.121875594410186	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0072574	hepatocyte proliferation	1/89	31/21288	0.032258064516129	7.71583907212758	2.42451395103052	0.121875594410186	0.476065444783812	0.460692055755111	RPS6KA1	1
GO:0072575	epithelial cell proliferation involved in liver morphogenesis	1/89	31/21288	0.032258064516129	7.71583907212758	2.42451395103052	0.121875594410186	0.476065444783812	0.460692055755111	RPS6KA1	1
GO:1901186	positive regulation of ERBB signaling pathway	1/89	31/21288	0.032258064516129	7.71583907212758	2.42451395103052	0.121875594410186	0.476065444783812	0.460692055755111	NEU3	1
GO:0010951	negative regulation of endopeptidase activity	2/89	146/21288	0.0136986301369863	3.27658919501308	1.78847391335827	0.12461082463582	0.476065444783812	0.460692055755111	RPS6KA1/SPOCK2	2
GO:0006221	pyrimidine nucleotide biosynthetic process	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	NME1	1
GO:0008211	glucocorticoid metabolic process	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	CACNA1H	1
GO:0031114	regulation of microtubule depolymerization	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	TRIM54	1
GO:0035795	negative regulation of mitochondrial membrane permeability	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	SLC35F6	1
GO:0036344	platelet morphogenesis	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	VPS33A	1
GO:0051156	glucose 6-phosphate metabolic process	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	HKDC1	1
GO:0060325	face morphogenesis	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	RRAS	1
GO:0061384	heart trabecula morphogenesis	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	BMPR1A	1
GO:0061437	renal system vasculature development	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	TCF21	1
GO:0061440	kidney vasculature development	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	TCF21	1
GO:0097205	renal filtration	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	EMP2	1
GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	ATAD5	1
GO:1903580	positive regulation of ATP metabolic process	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	APP	1
GO:1990806	ligand-gated ion channel signaling pathway	1/89	32/21288	0.03125	7.4747191011236	2.37492388991858	0.125552174929426	0.476065444783812	0.460692055755111	APP	1
GO:0006275	regulation of DNA replication	2/89	147/21288	0.0136054421768707	3.25429947259803	1.77705987010697	0.126001382392157	0.476474908017555	0.461088296358113	FAF1/ATAD5	2
GO:0009154	purine ribonucleotide catabolic process	2/89	148/21288	0.0135135135135135	3.23231096264804	1.76574345124278	0.127395702861854	0.476474908017555	0.461088296358113	HKDC1/APP	2
GO:0006354	DNA-templated transcription elongation	2/89	149/21288	0.0134228187919463	3.21061760048262	1.75452307482474	0.128793731253588	0.476474908017555	0.461088296358113	INTS2/MED4	2
GO:0006260	DNA replication	3/89	298/21288	0.0100671140939597	2.40796320036196	1.58594368734932	0.129052451310849	0.476474908017555	0.461088296358113	FAF1/REV3L/ATAD5	3
GO:0010464	regulation of mesenchymal cell proliferation	1/89	33/21288	0.0303030303030303	7.24821246169561	2.3274306537386	0.129213534377642	0.476474908017555	0.461088296358113	BMPR1A	1
GO:0045907	positive regulation of vasoconstriction	1/89	33/21288	0.0303030303030303	7.24821246169561	2.3274306537386	0.129213534377642	0.476474908017555	0.461088296358113	FAAH	1
GO:0046479	glycosphingolipid catabolic process	1/89	33/21288	0.0303030303030303	7.24821246169561	2.3274306537386	0.129213534377642	0.476474908017555	0.461088296358113	NEU3	1
GO:0051642	centrosome localization	1/89	33/21288	0.0303030303030303	7.24821246169561	2.3274306537386	0.129213534377642	0.476474908017555	0.461088296358113	DLGAP5	1
GO:0061842	microtubule organizing center localization	1/89	33/21288	0.0303030303030303	7.24821246169561	2.3274306537386	0.129213534377642	0.476474908017555	0.461088296358113	DLGAP5	1
GO:0070977	bone maturation	1/89	33/21288	0.0303030303030303	7.24821246169561	2.3274306537386	0.129213534377642	0.476474908017555	0.461088296358113	DCHS1	1
GO:0072576	liver morphogenesis	1/89	33/21288	0.0303030303030303	7.24821246169561	2.3274306537386	0.129213534377642	0.476474908017555	0.461088296358113	RPS6KA1	1
GO:1901136	carbohydrate derivative catabolic process	3/89	300/21288	0.01	2.39191011235955	1.5731887628085	0.13092524044545	0.481582866975157	0.46603130606124	HKDC1/NEU3/APP	3
GO:0000077	DNA damage checkpoint signaling	2/89	151/21288	0.0132450331125828	3.16809286405238	1.7323643023663	0.131600694549773	0.481659397975434	0.466105365676852	FOXO4/USP28	2
GO:0010996	response to auditory stimulus	1/89	34/21288	0.0294117647058824	7.03502974223397	2.28188146708539	0.13285973505703	0.481659397975434	0.466105365676852	KCNC1	1
GO:0099022	vesicle tethering	1/89	34/21288	0.0294117647058824	7.03502974223397	2.28188146708539	0.13285973505703	0.481659397975434	0.466105365676852	EXOC7	1
GO:0000086	G2/M transition of mitotic cell cycle	2/89	152/21288	0.0131578947368421	3.14725014784151	1.72142292005803	0.133009521776947	0.481659397975434	0.466105365676852	FOXO4/APP	2
GO:0071675	regulation of mononuclear cell migration	2/89	152/21288	0.0131578947368421	3.14725014784151	1.72142292005803	0.133009521776947	0.481659397975434	0.466105365676852	ABL2/APP	2
GO:0009261	ribonucleotide catabolic process	2/89	154/21288	0.012987012987013	3.10637676929812	1.69980894861969	0.135837601021792	0.481659397975434	0.466105365676852	HKDC1/APP	2
GO:0010466	negative regulation of peptidase activity	2/89	154/21288	0.012987012987013	3.10637676929812	1.69980894861969	0.135837601021792	0.481659397975434	0.466105365676852	RPS6KA1/SPOCK2	2
GO:0048565	digestive tract development	2/89	154/21288	0.012987012987013	3.10637676929812	1.69980894861969	0.135837601021792	0.481659397975434	0.466105365676852	TCF21/DCHS1	2
GO:0006301	postreplication repair	1/89	35/21288	0.0285714285714286	6.83402889245586	2.2381388333759	0.136490839017693	0.481659397975434	0.466105365676852	REV3L	1
GO:0010863	positive regulation of phospholipase C activity	1/89	35/21288	0.0285714285714286	6.83402889245586	2.2381388333759	0.136490839017693	0.481659397975434	0.466105365676852	ABL2	1
GO:0016188	synaptic vesicle maturation	1/89	35/21288	0.0285714285714286	6.83402889245586	2.2381388333759	0.136490839017693	0.481659397975434	0.466105365676852	ATP6V0A1	1
GO:0046514	ceramide catabolic process	1/89	35/21288	0.0285714285714286	6.83402889245586	2.2381388333759	0.136490839017693	0.481659397975434	0.466105365676852	NEU3	1
GO:1905709	negative regulation of membrane permeability	1/89	35/21288	0.0285714285714286	6.83402889245586	2.2381388333759	0.136490839017693	0.481659397975434	0.466105365676852	SLC35F6	1
GO:0072676	lymphocyte migration	2/89	155/21288	0.0129032258064516	3.08633562885103	1.68913356997425	0.137256747613587	0.481659397975434	0.466105365676852	ABL2/APP	2
GO:0006195	purine nucleotide catabolic process	2/89	157/21288	0.0127388535031847	3.04701925141344	1.66803928294627	0.140104993948606	0.481659397975434	0.466105365676852	HKDC1/APP	2
GO:0043401	steroid hormone mediated signaling pathway	2/89	157/21288	0.0127388535031847	3.04701925141344	1.66803928294627	0.140104993948606	0.481659397975434	0.466105365676852	TCF21/PGRMC2	2
GO:0000002	mitochondrial genome maintenance	1/89	36/21288	0.0277777777777778	6.64419475655431	2.19607861905469	0.140106908058648	0.481659397975434	0.466105365676852	TOP3A	1
GO:0007617	mating behavior	1/89	36/21288	0.0277777777777778	6.64419475655431	2.19607861905469	0.140106908058648	0.481659397975434	0.466105365676852	APP	1
GO:0031579	membrane raft organization	1/89	36/21288	0.0277777777777778	6.64419475655431	2.19607861905469	0.140106908058648	0.481659397975434	0.466105365676852	EMP2	1
GO:0048026	positive regulation of mRNA splicing, via spliceosome	1/89	36/21288	0.0277777777777778	6.64419475655431	2.19607861905469	0.140106908058648	0.481659397975434	0.466105365676852	TRA2B	1
GO:0060317	cardiac epithelial to mesenchymal transition	1/89	36/21288	0.0277777777777778	6.64419475655431	2.19607861905469	0.140106908058648	0.481659397975434	0.466105365676852	EMP2	1
GO:0099505	regulation of presynaptic membrane potential	1/89	36/21288	0.0277777777777778	6.64419475655431	2.19607861905469	0.140106908058648	0.481659397975434	0.466105365676852	KCNC1	1
GO:1901028	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	1/89	36/21288	0.0277777777777778	6.64419475655431	2.19607861905469	0.140106908058648	0.481659397975434	0.466105365676852	SLC35F6	1
GO:2000352	negative regulation of endothelial cell apoptotic process	1/89	36/21288	0.0277777777777778	6.64419475655431	2.19607861905469	0.140106908058648	0.481659397975434	0.466105365676852	PAK4	1
GO:0007035	vacuolar acidification	1/89	37/21288	0.027027027027027	6.46462192529608	2.15558842383725	0.143708003728833	0.481659397975434	0.466105365676852	ATP6V0A1	1
GO:0019377	glycolipid catabolic process	1/89	37/21288	0.027027027027027	6.46462192529608	2.15558842383725	0.143708003728833	0.481659397975434	0.466105365676852	NEU3	1
GO:0048799	animal organ maturation	1/89	37/21288	0.027027027027027	6.46462192529608	2.15558842383725	0.143708003728833	0.481659397975434	0.466105365676852	DCHS1	1
GO:0099174	regulation of presynapse organization	1/89	37/21288	0.027027027027027	6.46462192529608	2.15558842383725	0.143708003728833	0.481659397975434	0.466105365676852	APP	1
GO:1900274	regulation of phospholipase C activity	1/89	37/21288	0.027027027027027	6.46462192529608	2.15558842383725	0.143708003728833	0.481659397975434	0.466105365676852	ABL2	1
GO:1905606	regulation of presynapse assembly	1/89	37/21288	0.027027027027027	6.46462192529608	2.15558842383725	0.143708003728833	0.481659397975434	0.466105365676852	APP	1
GO:0008277	regulation of G protein-coupled receptor signaling pathway	2/89	160/21288	0.0125	2.98988764044944	1.63701966975418	0.144401474963233	0.481659397975434	0.466105365676852	GNG7/RGS13	2
GO:0031570	DNA integrity checkpoint signaling	2/89	160/21288	0.0125	2.98988764044944	1.63701966975418	0.144401474963233	0.481659397975434	0.466105365676852	FOXO4/USP28	2
GO:0071333	cellular response to glucose stimulus	2/89	160/21288	0.0125	2.98988764044944	1.63701966975418	0.144401474963233	0.481659397975434	0.466105365676852	TRA2B/CCDC186	2
GO:0072073	kidney epithelium development	2/89	160/21288	0.0125	2.98988764044944	1.63701966975418	0.144401474963233	0.481659397975434	0.466105365676852	TCF21/DCHS1	2
GO:0006261	DNA-templated DNA replication	2/89	162/21288	0.0123456790123457	2.95297544735747	1.61674005783017	0.147281278483734	0.481659397975434	0.466105365676852	REV3L/ATAD5	2
GO:0030534	adult behavior	2/89	162/21288	0.0123456790123457	2.95297544735747	1.61674005783017	0.147281278483734	0.481659397975434	0.466105365676852	USP46/APP	2
GO:0072523	purine-containing compound catabolic process	2/89	162/21288	0.0123456790123457	2.95297544735747	1.61674005783017	0.147281278483734	0.481659397975434	0.466105365676852	HKDC1/APP	2
GO:0008207	C21-steroid hormone metabolic process	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	CACNA1H	1
GO:0016486	peptide hormone processing	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	BACE2	1
GO:0021955	central nervous system neuron axonogenesis	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	ARHGEF28	1
GO:0032228	regulation of synaptic transmission, GABAergic	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	USP46	1
GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	TCF21	1
GO:0035137	hindlimb morphogenesis	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	BMPR1A	1
GO:0045981	positive regulation of nucleotide metabolic process	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	APP	1
GO:0046825	regulation of protein export from nucleus	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	PTPN14	1
GO:0055023	positive regulation of cardiac muscle tissue growth	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	BMPR1A	1
GO:1900544	positive regulation of purine nucleotide metabolic process	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	APP	1
GO:1901381	positive regulation of potassium ion transmembrane transport	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	KCNC1	1
GO:1901797	negative regulation of signal transduction by p53 class mediator	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	ATAD5	1
GO:1903055	positive regulation of extracellular matrix organization	1/89	38/21288	0.0263157894736842	6.29450029568303	2.11656618781638	0.147294187328106	0.481659397975434	0.466105365676852	PHLDB1	1
GO:0007266	Rho protein signal transduction	2/89	163/21288	0.0122699386503067	2.93485903357	1.60671674117435	0.1487256751495	0.481659397975434	0.466105365676852	ABL2/ARHGEF28	2
GO:0071331	cellular response to hexose stimulus	2/89	163/21288	0.0122699386503067	2.93485903357	1.60671674117435	0.1487256751495	0.481659397975434	0.466105365676852	TRA2B/CCDC186	2
GO:0044772	mitotic cell cycle phase transition	4/89	492/21288	0.00813008130081301	1.94464236777199	1.3735820696068	0.150851570410414	0.481659397975434	0.466105365676852	FOXO4/ATAD5/DLGAP5/APP	4
GO:0003161	cardiac conduction system development	1/89	39/21288	0.0256410256410256	6.13310285220397	2.07891899576422	0.150865519908238	0.481659397975434	0.466105365676852	BMPR1A	1
GO:0009069	serine family amino acid metabolic process	1/89	39/21288	0.0256410256410256	6.13310285220397	2.07891899576422	0.150865519908238	0.481659397975434	0.466105365676852	SEPHS1	1
GO:0035909	aorta morphogenesis	1/89	39/21288	0.0256410256410256	6.13310285220397	2.07891899576422	0.150865519908238	0.481659397975434	0.466105365676852	BMPR1A	1
GO:0045191	regulation of isotype switching	1/89	39/21288	0.0256410256410256	6.13310285220397	2.07891899576422	0.150865519908238	0.481659397975434	0.466105365676852	ATAD5	1
GO:0048261	negative regulation of receptor-mediated endocytosis	1/89	39/21288	0.0256410256410256	6.13310285220397	2.07891899576422	0.150865519908238	0.481659397975434	0.466105365676852	NEU3	1
GO:0048536	spleen development	1/89	39/21288	0.0256410256410256	6.13310285220397	2.07891899576422	0.150865519908238	0.481659397975434	0.466105365676852	TCF21	1
GO:0090151	establishment of protein localization to mitochondrial membrane	1/89	39/21288	0.0256410256410256	6.13310285220397	2.07891899576422	0.150865519908238	0.481659397975434	0.466105365676852	TIMM9	1
GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	1/89	39/21288	0.0256410256410256	6.13310285220397	2.07891899576422	0.150865519908238	0.481659397975434	0.466105365676852	ATAD5	1
GO:0030902	hindbrain development	2/89	165/21288	0.0121212121212121	2.89928498467824	1.58689741752157	0.151623211924158	0.481991891353734	0.466427121980848	KCNC1/CLP1	2
GO:0071326	cellular response to monosaccharide stimulus	2/89	165/21288	0.0121212121212121	2.89928498467824	1.58689741752157	0.151623211924158	0.481991891353734	0.466427121980848	TRA2B/CCDC186	2
GO:0048732	gland development	4/89	495/21288	0.00808080808080808	1.93285665645216	1.3606721113236	0.153189446869287	0.482912756939992	0.467318250426854	TCF21/RPS6KA1/NME1/BMPR1A	4
GO:0001573	ganglioside metabolic process	1/89	40/21288	0.025	5.97977528089888	2.04256204643893	0.154422062273909	0.482912756939992	0.467318250426854	NEU3	1
GO:0050685	positive regulation of mRNA processing	1/89	40/21288	0.025	5.97977528089888	2.04256204643893	0.154422062273909	0.482912756939992	0.467318250426854	TRA2B	1
GO:0060323	head morphogenesis	1/89	40/21288	0.025	5.97977528089888	2.04256204643893	0.154422062273909	0.482912756939992	0.467318250426854	RRAS	1
GO:1902229	regulation of intrinsic apoptotic signaling pathway in response to DNA damage	1/89	40/21288	0.025	5.97977528089888	2.04256204643893	0.154422062273909	0.482912756939992	0.467318250426854	ATAD5	1
GO:0055123	digestive system development	2/89	167/21288	0.0119760479041916	2.86456300881383	1.5673738878923	0.154532082220798	0.482912756939992	0.467318250426854	TCF21/DCHS1	2
GO:0072006	nephron development	2/89	167/21288	0.0119760479041916	2.86456300881383	1.5673738878923	0.154532082220798	0.482912756939992	0.467318250426854	TCF21/DCHS1	2
GO:2001235	positive regulation of apoptotic signaling pathway	2/89	167/21288	0.0119760479041916	2.86456300881383	1.5673738878923	0.154532082220798	0.482912756939992	0.467318250426854	FAF1/ITM2C	2
GO:0048568	embryonic organ development	4/89	500/21288	0.008	1.91352808988764	1.33935313939366	0.157116813195865	0.48540982416866	0.46973468087258	TCF21/BMPR1A/TRA2B/BBS5	4
GO:0000731	DNA synthesis involved in DNA repair	1/89	41/21288	0.024390243902439	5.83392710331598	2.0074177606225	0.1579638749837	0.48540982416866	0.46973468087258	REV3L	1
GO:0007212	dopamine receptor signaling pathway	1/89	41/21288	0.024390243902439	5.83392710331598	2.0074177606225	0.1579638749837	0.48540982416866	0.46973468087258	GNAO1	1
GO:0007340	acrosome reaction	1/89	41/21288	0.024390243902439	5.83392710331598	2.0074177606225	0.1579638749837	0.48540982416866	0.46973468087258	CACNA1H	1
GO:0017004	cytochrome complex assembly	1/89	41/21288	0.024390243902439	5.83392710331598	2.0074177606225	0.1579638749837	0.48540982416866	0.46973468087258	COX20	1
GO:0018208	peptidyl-proline modification	1/89	41/21288	0.024390243902439	5.83392710331598	2.0074177606225	0.1579638749837	0.48540982416866	0.46973468087258	PPIL3	1
GO:0031111	negative regulation of microtubule polymerization or depolymerization	1/89	41/21288	0.024390243902439	5.83392710331598	2.0074177606225	0.1579638749837	0.48540982416866	0.46973468087258	TRIM54	1
GO:0033260	nuclear DNA replication	1/89	41/21288	0.024390243902439	5.83392710331598	2.0074177606225	0.1579638749837	0.48540982416866	0.46973468087258	ATAD5	1
GO:0035640	exploration behavior	1/89	42/21288	0.0238095238095238	5.69502407704655	1.9734150063305	0.161491018351067	0.490121917835028	0.474294608802354	ABL2	1
GO:0048143	astrocyte activation	1/89	42/21288	0.0238095238095238	5.69502407704655	1.9734150063305	0.161491018351067	0.490121917835028	0.474294608802354	APP	1
GO:0048333	mesodermal cell differentiation	1/89	42/21288	0.0238095238095238	5.69502407704655	1.9734150063305	0.161491018351067	0.490121917835028	0.474294608802354	BMPR1A	1
GO:0060421	positive regulation of heart growth	1/89	42/21288	0.0238095238095238	5.69502407704655	1.9734150063305	0.161491018351067	0.490121917835028	0.474294608802354	BMPR1A	1
GO:0072528	pyrimidine-containing compound biosynthetic process	1/89	42/21288	0.0238095238095238	5.69502407704655	1.9734150063305	0.161491018351067	0.490121917835028	0.474294608802354	NME1	1
GO:0140448	signaling receptor ligand precursor processing	1/89	42/21288	0.0238095238095238	5.69502407704655	1.9734150063305	0.161491018351067	0.490121917835028	0.474294608802354	BACE2	1
GO:0048284	organelle fusion	2/89	172/21288	0.0116279069767442	2.78129082832506	1.51980466956652	0.161851332816083	0.490206808837211	0.474376758453708	VPS8/VPS33A	2
GO:0006904	vesicle docking involved in exocytosis	1/89	43/21288	0.0232558139534884	5.56258165665012	1.94048842341168	0.165003552445332	0.49467528426192	0.478700935207253	EXOC7	1
GO:0019098	reproductive behavior	1/89	43/21288	0.0232558139534884	5.56258165665012	1.94048842341168	0.165003552445332	0.49467528426192	0.478700935207253	APP	1
GO:0043388	positive regulation of DNA binding	1/89	43/21288	0.0232558139534884	5.56258165665012	1.94048842341168	0.165003552445332	0.49467528426192	0.478700935207253	NME1	1
GO:0060391	positive regulation of SMAD protein signal transduction	1/89	43/21288	0.0232558139534884	5.56258165665012	1.94048842341168	0.165003552445332	0.49467528426192	0.478700935207253	BMPR1A	1
GO:0060412	ventricular septum morphogenesis	1/89	43/21288	0.0232558139534884	5.56258165665012	1.94048842341168	0.165003552445332	0.49467528426192	0.478700935207253	BMPR1A	1
GO:0140053	mitochondrial gene expression	2/89	175/21288	0.0114285714285714	2.73361155698234	1.49207409378749	0.166273292077815	0.49747080286973	0.48140617926234	MRPL1/MRPL51	2
GO:0051147	regulation of muscle cell differentiation	2/89	176/21288	0.0113636363636364	2.71807967313585	1.48296018441419	0.167752071533714	0.499867283863089	0.483725271663406	FOXO4/BMPR1A	2
GO:0071322	cellular response to carbohydrate stimulus	2/89	176/21288	0.0113636363636364	2.71807967313585	1.48296018441419	0.167752071533714	0.499867283863089	0.483725271663406	TRA2B/CCDC186	2
GO:0000462	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	1/89	44/21288	0.0227272727272727	5.43615934627171	1.90857783280008	0.168501537092654	0.500080014510392	0.483931132685882	TSR2	1
GO:0014912	negative regulation of smooth muscle cell migration	1/89	44/21288	0.0227272727272727	5.43615934627171	1.90857783280008	0.168501537092654	0.500080014510392	0.483931132685882	BMPR1A	1
GO:0019362	pyridine nucleotide metabolic process	2/89	177/21288	0.0112994350282486	2.70272329080175	1.47390961807011	0.169233172464427	0.500238335440942	0.484084341022599	HKDC1/APP	2
GO:0046496	nicotinamide nucleotide metabolic process	2/89	177/21288	0.0112994350282486	2.70272329080175	1.47390961807011	0.169233172464427	0.500238335440942	0.484084341022599	HKDC1/APP	2
GO:0010518	positive regulation of phospholipase activity	1/89	45/21288	0.0222222222222222	5.31535580524345	1.87762771814853	0.171985031877006	0.500740917944271	0.484570693832244	ABL2	1
GO:0043268	positive regulation of potassium ion transport	1/89	45/21288	0.0222222222222222	5.31535580524345	1.87762771814853	0.171985031877006	0.500740917944271	0.484570693832244	KCNC1	1
GO:0044786	cell cycle DNA replication	1/89	45/21288	0.0222222222222222	5.31535580524345	1.87762771814853	0.171985031877006	0.500740917944271	0.484570693832244	ATAD5	1
GO:0097345	mitochondrial outer membrane permeabilization	1/89	45/21288	0.0222222222222222	5.31535580524345	1.87762771814853	0.171985031877006	0.500740917944271	0.484570693832244	SLC35F6	1
GO:0002687	positive regulation of leukocyte migration	2/89	181/21288	0.0110497237569061	2.64299459929232	1.43832395698092	0.17517990506465	0.500740917944271	0.484570693832244	ABL2/APP	2
GO:0009166	nucleotide catabolic process	2/89	181/21288	0.0110497237569061	2.64299459929232	1.43832395698092	0.17517990506465	0.500740917944271	0.484570693832244	HKDC1/APP	2
GO:0070507	regulation of microtubule cytoskeleton organization	2/89	181/21288	0.0110497237569061	2.64299459929232	1.43832395698092	0.17517990506465	0.500740917944271	0.484570693832244	PHLDB1/TRIM54	2
GO:0010799	regulation of peptidyl-threonine phosphorylation	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	APP	1
GO:0021983	pituitary gland development	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	BMPR1A	1
GO:0030890	positive regulation of B cell proliferation	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	ATAD5	1
GO:0046461	neutral lipid catabolic process	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	FAAH	1
GO:0046464	acylglycerol catabolic process	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	FAAH	1
GO:0071634	regulation of transforming growth factor beta production	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	BMPR1A	1
GO:0090148	membrane fission	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	EXOC7	1
GO:0098703	calcium ion import across plasma membrane	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	CACNA1H	1
GO:1902656	calcium ion import into cytosol	1/89	46/21288	0.0217391304347826	5.19980459208598	1.84758676958133	0.175454096141137	0.500740917944271	0.484570693832244	CACNA1H	1
GO:0051056	regulation of small GTPase mediated signal transduction	3/89	346/21288	0.00867052023121387	2.07391050204585	1.30494319573572	0.176434593726903	0.500740917944271	0.484570693832244	ARHGEF40/ABL2/ARHGEF28	3
GO:0009416	response to light stimulus	3/89	347/21288	0.00864553314121038	2.06793381472007	1.29958566746467	0.177470043229418	0.500740917944271	0.484570693832244	KCNC1/USP28/APP	3
GO:0000724	double-strand break repair via homologous recombination	2/89	183/21288	0.0109289617486339	2.61410941241481	1.42088975416177	0.178166057577336	0.500740917944271	0.484570693832244	REV3L/TOP3A	2
GO:2001236	regulation of extrinsic apoptotic signaling pathway	2/89	183/21288	0.0109289617486339	2.61410941241481	1.42088975416177	0.178166057577336	0.500740917944271	0.484570693832244	FAF1/ITM2C	2
GO:0007007	inner mitochondrial membrane organization	1/89	47/21288	0.0212765957446809	5.08917045182883	1.81840748094786	0.178908788987546	0.500740917944271	0.484570693832244	TIMM9	1
GO:0007019	microtubule depolymerization	1/89	47/21288	0.0212765957446809	5.08917045182883	1.81840748094786	0.178908788987546	0.500740917944271	0.484570693832244	TRIM54	1
GO:0035329	hippo signaling	1/89	47/21288	0.0212765957446809	5.08917045182883	1.81840748094786	0.178908788987546	0.500740917944271	0.484570693832244	DCHS1	1
GO:0045022	early endosome to late endosome transport	1/89	47/21288	0.0212765957446809	5.08917045182883	1.81840748094786	0.178908788987546	0.500740917944271	0.484570693832244	EMP2	1
GO:0055010	ventricular cardiac muscle tissue morphogenesis	1/89	47/21288	0.0212765957446809	5.08917045182883	1.81840748094786	0.178908788987546	0.500740917944271	0.484570693832244	BMPR1A	1
GO:0060795	cell fate commitment involved in formation of primary germ layer	1/89	47/21288	0.0212765957446809	5.08917045182883	1.81840748094786	0.178908788987546	0.500740917944271	0.484570693832244	BMPR1A	1
GO:0070316	regulation of G0 to G1 transition	1/89	47/21288	0.0212765957446809	5.08917045182883	1.81840748094786	0.178908788987546	0.500740917944271	0.484570693832244	FOXO4	1
GO:0072210	metanephric nephron development	1/89	47/21288	0.0212765957446809	5.08917045182883	1.81840748094786	0.178908788987546	0.500740917944271	0.484570693832244	TCF21	1
GO:0006633	fatty acid biosynthetic process	2/89	184/21288	0.0108695652173913	2.59990229604299	1.4122595819723	0.179662179833844	0.500948422031984	0.484771497074306	FADS2/PECR	2
GO:0072524	pyridine-containing compound metabolic process	2/89	184/21288	0.0108695652173913	2.59990229604299	1.4122595819723	0.179662179833844	0.500948422031984	0.484771497074306	HKDC1/APP	2
GO:0008038	neuron recognition	1/89	48/21288	0.0208333333333333	4.98314606741573	1.79004579331028	0.18234916927944	0.505569300869906	0.489243155739227	APP	1
GO:0060043	regulation of cardiac muscle cell proliferation	1/89	48/21288	0.0208333333333333	4.98314606741573	1.79004579331028	0.18234916927944	0.505569300869906	0.489243155739227	BMPR1A	1
GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	1/89	48/21288	0.0208333333333333	4.98314606741573	1.79004579331028	0.18234916927944	0.505569300869906	0.489243155739227	FAF1	1
GO:0048754	branching morphogenesis of an epithelial tube	2/89	187/21288	0.0106951871657754	2.55819263353963	1.38670786055823	0.184162223838679	0.505569300869906	0.489243155739227	TCF21/DCHS1	2
GO:0000725	recombinational repair	2/89	188/21288	0.0106382978723404	2.54458522591442	1.37830115287247	0.185665991958145	0.505569300869906	0.489243155739227	REV3L/TOP3A	2
GO:0046661	male sex differentiation	2/89	188/21288	0.0106382978723404	2.54458522591442	1.37830115287247	0.185665991958145	0.505569300869906	0.489243155739227	TCF21/BMPR1A	2
GO:0006623	protein targeting to vacuole	1/89	49/21288	0.0204081632653061	4.88144920889704	1.76246077851491	0.185775295641687	0.505569300869906	0.489243155739227	VPS8	1
GO:0007095	mitotic G2 DNA damage checkpoint signaling	1/89	49/21288	0.0204081632653061	4.88144920889704	1.76246077851491	0.185775295641687	0.505569300869906	0.489243155739227	FOXO4	1
GO:0042181	ketone biosynthetic process	1/89	49/21288	0.0204081632653061	4.88144920889704	1.76246077851491	0.185775295641687	0.505569300869906	0.489243155739227	CACNA1H	1
GO:0045023	G0 to G1 transition	1/89	49/21288	0.0204081632653061	4.88144920889704	1.76246077851491	0.185775295641687	0.505569300869906	0.489243155739227	FOXO4	1
GO:0048566	embryonic digestive tract development	1/89	49/21288	0.0204081632653061	4.88144920889704	1.76246077851491	0.185775295641687	0.505569300869906	0.489243155739227	TCF21	1
GO:0051353	positive regulation of oxidoreductase activity	1/89	49/21288	0.0204081632653061	4.88144920889704	1.76246077851491	0.185775295641687	0.505569300869906	0.489243155739227	ABL2	1
GO:0061383	trabecula morphogenesis	1/89	49/21288	0.0204081632653061	4.88144920889704	1.76246077851491	0.185775295641687	0.505569300869906	0.489243155739227	BMPR1A	1
GO:0021953	central nervous system neuron differentiation	2/89	189/21288	0.0105820105820106	2.53112181202069	1.36994854482657	0.187171568090373	0.507365743692948	0.490981586760134	BMPR1A/ARHGEF28	2
GO:0051168	nuclear export	2/89	189/21288	0.0105820105820106	2.53112181202069	1.36994854482657	0.187171568090373	0.507365743692948	0.490981586760134	NXT1/PTPN14	2
GO:1901292	nucleoside phosphate catabolic process	2/89	190/21288	0.0105263157894737	2.51780011827321	1.36164935535223	0.188678911464387	0.507365743692948	0.490981586760134	HKDC1/APP	2
GO:0007595	lactation	1/89	50/21288	0.02	4.7838202247191	1.73561435762246	0.189187226461777	0.507365743692948	0.490981586760134	NME1	1
GO:0010453	regulation of cell fate commitment	1/89	50/21288	0.02	4.7838202247191	1.73561435762246	0.189187226461777	0.507365743692948	0.490981586760134	BMPR1A	1
GO:0030149	sphingolipid catabolic process	1/89	50/21288	0.02	4.7838202247191	1.73561435762246	0.189187226461777	0.507365743692948	0.490981586760134	NEU3	1
GO:0045292	mRNA cis splicing, via spliceosome	1/89	50/21288	0.02	4.7838202247191	1.73561435762246	0.189187226461777	0.507365743692948	0.490981586760134	SNRPC	1
GO:0071604	transforming growth factor beta production	1/89	50/21288	0.02	4.7838202247191	1.73561435762246	0.189187226461777	0.507365743692948	0.490981586760134	BMPR1A	1
GO:0007034	vacuolar transport	2/89	192/21288	0.0104166666666667	2.49157303370787	1.34520856877311	0.191698738362062	0.510695905336117	0.49420420883909	VPS8/VPS33A	2
GO:0014075	response to amine	1/89	51/21288	0.0196078431372549	4.69001982815598	1.70947104974311	0.192585019890768	0.510695905336117	0.49420420883909	KCNC1	1
GO:0045840	positive regulation of mitotic nuclear division	1/89	51/21288	0.0196078431372549	4.69001982815598	1.70947104974311	0.192585019890768	0.510695905336117	0.49420420883909	DLGAP5	1
GO:0090102	cochlea development	1/89	51/21288	0.0196078431372549	4.69001982815598	1.70947104974311	0.192585019890768	0.510695905336117	0.49420420883909	DCHS1	1
GO:0045787	positive regulation of cell cycle	3/89	362/21288	0.00828729281767956	1.98224594946924	1.22131015250488	0.193200695571635	0.510695905336117	0.49420420883909	ATAD5/DLGAP5/APP	3
GO:0046394	carboxylic acid biosynthetic process	3/89	362/21288	0.00828729281767956	1.98224594946924	1.22131015250488	0.193200695571635	0.510695905336117	0.49420420883909	FADS2/SEPHS1/PECR	3
GO:0072331	signal transduction by p53 class mediator	2/89	194/21288	0.0103092783505155	2.46588671377273	1.32897358438108	0.194725152491535	0.510695905336117	0.49420420883909	ATAD5/USP28	2
GO:0006310	DNA recombination	3/89	364/21288	0.00824175824175824	1.97135448820842	1.21115752918891	0.195324816272988	0.510695905336117	0.49420420883909	REV3L/ATAD5/TOP3A	3
GO:0008542	visual learning	1/89	52/21288	0.0192307692307692	4.59982713915298	1.68399774746685	0.195968733844232	0.510695905336117	0.49420420883909	APP	1
GO:0032968	positive regulation of transcription elongation by RNA polymerase II	1/89	52/21288	0.0192307692307692	4.59982713915298	1.68399774746685	0.195968733844232	0.510695905336117	0.49420420883909	MED4	1
GO:0042551	neuron maturation	1/89	52/21288	0.0192307692307692	4.59982713915298	1.68399774746685	0.195968733844232	0.510695905336117	0.49420420883909	APP	1
GO:0048066	developmental pigmentation	1/89	52/21288	0.0192307692307692	4.59982713915298	1.68399774746685	0.195968733844232	0.510695905336117	0.49420420883909	VPS33A	1
GO:0048286	lung alveolus development	1/89	52/21288	0.0192307692307692	4.59982713915298	1.68399774746685	0.195968733844232	0.510695905336117	0.49420420883909	TCF21	1
GO:0048546	digestive tract morphogenesis	1/89	52/21288	0.0192307692307692	4.59982713915298	1.68399774746685	0.195968733844232	0.510695905336117	0.49420420883909	TCF21	1
GO:0099054	presynapse assembly	1/89	52/21288	0.0192307692307692	4.59982713915298	1.68399774746685	0.195968733844232	0.510695905336117	0.49420420883909	APP	1
GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	1/89	52/21288	0.0192307692307692	4.59982713915298	1.68399774746685	0.195968733844232	0.510695905336117	0.49420420883909	SLC35F6	1
GO:0016053	organic acid biosynthetic process	3/89	365/21288	0.00821917808219178	1.96595351700785	1.20610530795161	0.196389102984069	0.510888759967376	0.494390835693675	FADS2/SEPHS1/PECR	3
GO:0016241	regulation of macroautophagy	2/89	197/21288	0.0101522842639594	2.42833513945132	1.30499604029669	0.199276436066416	0.512237244520421	0.495695774179976	EXOC7/ATP6V0A1	2
GO:0006376	mRNA splice site recognition	1/89	53/21288	0.0188679245283019	4.51303794784821	1.65916351562029	0.199338426003201	0.512237244520421	0.495695774179976	SNRPC	1
GO:0007215	glutamate receptor signaling pathway	1/89	53/21288	0.0188679245283019	4.51303794784821	1.65916351562029	0.199338426003201	0.512237244520421	0.495695774179976	APP	1
GO:0030501	positive regulation of bone mineralization	1/89	53/21288	0.0188679245283019	4.51303794784821	1.65916351562029	0.199338426003201	0.512237244520421	0.495695774179976	BMPR1A	1
GO:0060324	face development	1/89	53/21288	0.0188679245283019	4.51303794784821	1.65916351562029	0.199338426003201	0.512237244520421	0.495695774179976	RRAS	1
GO:0072583	clathrin-dependent endocytosis	1/89	53/21288	0.0188679245283019	4.51303794784821	1.65916351562029	0.199338426003201	0.512237244520421	0.495695774179976	NEU3	1
GO:0098927	vesicle-mediated transport between endosomal compartments	1/89	53/21288	0.0188679245283019	4.51303794784821	1.65916351562029	0.199338426003201	0.512237244520421	0.495695774179976	EMP2	1
GO:0021700	developmental maturation	3/89	370/21288	0.00810810810810811	1.93938657758882	1.18108098930715	0.201732229563637	0.515472201512544	0.49882626601321	DCHS1/ATP6V0A1/APP	3
GO:0006220	pyrimidine nucleotide metabolic process	1/89	54/21288	0.0185185185185185	4.4294631710362	1.63493941053626	0.202694153815102	0.515472201512544	0.49882626601321	NME1	1
GO:0046622	positive regulation of organ growth	1/89	54/21288	0.0185185185185185	4.4294631710362	1.63493941053626	0.202694153815102	0.515472201512544	0.49882626601321	BMPR1A	1
GO:0048013	ephrin receptor signaling pathway	1/89	54/21288	0.0185185185185185	4.4294631710362	1.63493941053626	0.202694153815102	0.515472201512544	0.49882626601321	ARHGEF28	1
GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	1/89	54/21288	0.0185185185185185	4.4294631710362	1.63493941053626	0.202694153815102	0.515472201512544	0.49882626601321	SLC35F6	1
GO:1990089	response to nerve growth factor	1/89	54/21288	0.0185185185185185	4.4294631710362	1.63493941053626	0.202694153815102	0.515472201512544	0.49882626601321	KCNC1	1
GO:0002204	somatic recombination of immunoglobulin genes involved in immune response	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	ATAD5	1
GO:0002208	somatic diversification of immunoglobulins involved in immune response	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	ATAD5	1
GO:0006636	unsaturated fatty acid biosynthetic process	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	FADS2	1
GO:0021695	cerebellar cortex development	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	CLP1	1
GO:0033120	positive regulation of RNA splicing	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	TRA2B	1
GO:0045190	isotype switching	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	ATAD5	1
GO:0051150	regulation of smooth muscle cell differentiation	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	FOXO4	1
GO:0060193	positive regulation of lipase activity	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	ABL2	1
GO:0098815	modulation of excitatory postsynaptic potential	1/89	55/21288	0.0181818181818182	4.34892747701736	1.61129831740743	0.206035974494694	0.515964452257511	0.499302620703789	APP	1
GO:0061025	membrane fusion	2/89	203/21288	0.00985221674876847	2.35656168705374	1.25833219832255	0.208417185531029	0.516574944654374	0.499893398716382	VPS8/VPS33A	2
GO:0007520	myoblast fusion	1/89	56/21288	0.0178571428571429	4.27126805778491	1.58821480362101	0.209363945024999	0.516574944654374	0.499893398716382	CACNA1H	1
GO:0010517	regulation of phospholipase activity	1/89	56/21288	0.0178571428571429	4.27126805778491	1.58821480362101	0.209363945024999	0.516574944654374	0.499893398716382	ABL2	1
GO:0030521	androgen receptor signaling pathway	1/89	56/21288	0.0178571428571429	4.27126805778491	1.58821480362101	0.209363945024999	0.516574944654374	0.499893398716382	TCF21	1
GO:0035794	positive regulation of mitochondrial membrane permeability	1/89	56/21288	0.0178571428571429	4.27126805778491	1.58821480362101	0.209363945024999	0.516574944654374	0.499893398716382	SLC35F6	1
GO:0050885	neuromuscular process controlling balance	1/89	56/21288	0.0178571428571429	4.27126805778491	1.58821480362101	0.209363945024999	0.516574944654374	0.499893398716382	APP	1
GO:0120178	steroid hormone biosynthetic process	1/89	56/21288	0.0178571428571429	4.27126805778491	1.58821480362101	0.209363945024999	0.516574944654374	0.499893398716382	CACNA1H	1
GO:0007528	neuromuscular junction development	1/89	57/21288	0.0175438596491228	4.19633353045535	1.56566498624942	0.212678122158231	0.516574944654374	0.499893398716382	APP	1
GO:0014911	positive regulation of smooth muscle cell migration	1/89	57/21288	0.0175438596491228	4.19633353045535	1.56566498624942	0.212678122158231	0.516574944654374	0.499893398716382	FOXO4	1
GO:0046466	membrane lipid catabolic process	1/89	57/21288	0.0175438596491228	4.19633353045535	1.56566498624942	0.212678122158231	0.516574944654374	0.499893398716382	NEU3	1
GO:0099172	presynapse organization	1/89	57/21288	0.0175438596491228	4.19633353045535	1.56566498624942	0.212678122158231	0.516574944654374	0.499893398716382	APP	1
GO:1903351	cellular response to dopamine	1/89	57/21288	0.0175438596491228	4.19633353045535	1.56566498624942	0.212678122158231	0.516574944654374	0.499893398716382	GNAO1	1
GO:1904646	cellular response to amyloid-beta	1/89	57/21288	0.0175438596491228	4.19633353045535	1.56566498624942	0.212678122158231	0.516574944654374	0.499893398716382	APP	1
GO:0016236	macroautophagy	3/89	381/21288	0.0078740157480315	1.88339378925949	1.12736751316104	0.213607319602374	0.516574944654374	0.499893398716382	VPS33A/EXOC7/ATP6V0A1	3
GO:0000381	regulation of alternative mRNA splicing, via spliceosome	1/89	58/21288	0.0172413793103448	4.12398295234405	1.54362641210787	0.215978562416717	0.516574944654374	0.499893398716382	TRA2B	1
GO:0006110	regulation of glycolytic process	1/89	58/21288	0.0172413793103448	4.12398295234405	1.54362641210787	0.215978562416717	0.516574944654374	0.499893398716382	APP	1
GO:0006509	membrane protein ectodomain proteolysis	1/89	58/21288	0.0172413793103448	4.12398295234405	1.54362641210787	0.215978562416717	0.516574944654374	0.499893398716382	BACE2	1
GO:0030811	regulation of nucleotide catabolic process	1/89	58/21288	0.0172413793103448	4.12398295234405	1.54362641210787	0.215978562416717	0.516574944654374	0.499893398716382	APP	1
GO:0033121	regulation of purine nucleotide catabolic process	1/89	58/21288	0.0172413793103448	4.12398295234405	1.54362641210787	0.215978562416717	0.516574944654374	0.499893398716382	APP	1
GO:0042733	embryonic digit morphogenesis	1/89	58/21288	0.0172413793103448	4.12398295234405	1.54362641210787	0.215978562416717	0.516574944654374	0.499893398716382	BMPR1A	1
GO:0051452	intracellular pH reduction	1/89	58/21288	0.0172413793103448	4.12398295234405	1.54362641210787	0.215978562416717	0.516574944654374	0.499893398716382	ATP6V0A1	1
GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process	1/89	58/21288	0.0172413793103448	4.12398295234405	1.54362641210787	0.215978562416717	0.516574944654374	0.499893398716382	SLC35F6	1
GO:0001837	epithelial to mesenchymal transition	2/89	209/21288	0.00956937799043062	2.28890919843019	1.21329109529122	0.217602149421589	0.516574944654374	0.499893398716382	PHLDB1/EMP2	2
GO:0000377	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	3/89	385/21288	0.00779220779220779	1.86382606157887	1.10827338281669	0.217963713783543	0.516574944654374	0.499893398716382	PPIL3/SNRPC/TRA2B	3
GO:0000398	mRNA splicing, via spliceosome	3/89	385/21288	0.00779220779220779	1.86382606157887	1.10827338281669	0.217963713783543	0.516574944654374	0.499893398716382	PPIL3/SNRPC/TRA2B	3
GO:0030324	lung development	2/89	210/21288	0.00952380952380952	2.27800963081862	1.20593422227241	0.219136728132358	0.516574944654374	0.499893398716382	TCF21/BMPR1A	2
GO:0003229	ventricular cardiac muscle tissue development	1/89	59/21288	0.0169491525423729	4.05408493620263	1.52207794899262	0.21926532209382	0.516574944654374	0.499893398716382	BMPR1A	1
GO:0007157	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	1/89	59/21288	0.0169491525423729	4.05408493620263	1.52207794899262	0.21926532209382	0.516574944654374	0.499893398716382	DCHS1	1
GO:0016339	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	1/89	59/21288	0.0169491525423729	4.05408493620263	1.52207794899262	0.21926532209382	0.516574944654374	0.499893398716382	DCHS1	1
GO:0099601	regulation of neurotransmitter receptor activity	1/89	59/21288	0.0169491525423729	4.05408493620263	1.52207794899262	0.21926532209382	0.516574944654374	0.499893398716382	APP	1
GO:1901570	fatty acid derivative biosynthetic process	1/89	59/21288	0.0169491525423729	4.05408493620263	1.52207794899262	0.21926532209382	0.516574944654374	0.499893398716382	AACS	1
GO:1903350	response to dopamine	1/89	59/21288	0.0169491525423729	4.05408493620263	1.52207794899262	0.21926532209382	0.516574944654374	0.499893398716382	GNAO1	1
GO:0000375	RNA splicing, via transesterification reactions	3/89	389/21288	0.0077120822622108	1.84466075503307	1.08940386048785	0.22233906780777	0.516574944654374	0.499893398716382	PPIL3/SNRPC/TRA2B	3
GO:0060562	epithelial tube morphogenesis	3/89	389/21288	0.0077120822622108	1.84466075503307	1.08940386048785	0.22233906780777	0.516574944654374	0.499893398716382	TCF21/DCHS1/BBS5	3
GO:0002381	immunoglobulin production involved in immunoglobulin-mediated immune response	1/89	60/21288	0.0166666666666667	3.98651685393258	1.50099968688711	0.222538457254858	0.516574944654374	0.499893398716382	ATAD5	1
GO:0007632	visual behavior	1/89	60/21288	0.0166666666666667	3.98651685393258	1.50099968688711	0.222538457254858	0.516574944654374	0.499893398716382	APP	1
GO:0010965	regulation of mitotic sister chromatid separation	1/89	60/21288	0.0166666666666667	3.98651685393258	1.50099968688711	0.222538457254858	0.516574944654374	0.499893398716382	DLGAP5	1
GO:0060038	cardiac muscle cell proliferation	1/89	60/21288	0.0166666666666667	3.98651685393258	1.50099968688711	0.222538457254858	0.516574944654374	0.499893398716382	BMPR1A	1
GO:0071868	cellular response to monoamine stimulus	1/89	60/21288	0.0166666666666667	3.98651685393258	1.50099968688711	0.222538457254858	0.516574944654374	0.499893398716382	GNAO1	1
GO:0071870	cellular response to catecholamine stimulus	1/89	60/21288	0.0166666666666667	3.98651685393258	1.50099968688711	0.222538457254858	0.516574944654374	0.499893398716382	GNAO1	1
GO:0170038	proteinogenic amino acid biosynthetic process	1/89	60/21288	0.0166666666666667	3.98651685393258	1.50099968688711	0.222538457254858	0.516574944654374	0.499893398716382	SEPHS1	1
GO:0007626	locomotory behavior	2/89	214/21288	0.00934579439252336	2.23543001155098	1.17691769348449	0.225284480708307	0.516574944654374	0.499893398716382	GNG7/APP	2
GO:0030323	respiratory tube development	2/89	214/21288	0.00934579439252336	2.23543001155098	1.17691769348449	0.225284480708307	0.516574944654374	0.499893398716382	TCF21/BMPR1A	2
GO:0002639	positive regulation of immunoglobulin production	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	ATAD5	1
GO:0006826	iron ion transport	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	PGRMC2	1
GO:0014002	astrocyte development	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	APP	1
GO:0051058	negative regulation of small GTPase mediated signal transduction	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	ABL2	1
GO:0055008	cardiac muscle tissue morphogenesis	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	BMPR1A	1
GO:0060612	adipose tissue development	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	PGRMC2	1
GO:0170034	L-amino acid biosynthetic process	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	SEPHS1	1
GO:1905710	positive regulation of membrane permeability	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	SLC35F6	1
GO:1990000	amyloid fibril formation	1/89	61/21288	0.0163934426229508	3.92116411862221	1.48037284807272	0.225798023738008	0.516574944654374	0.499893398716382	APP	1
GO:0030705	cytoskeleton-dependent intracellular transport	2/89	216/21288	0.00925925925925926	2.2147315855181	1.16264965459881	0.228363542814732	0.516574944654374	0.499893398716382	CCDC186/APP	2
GO:0002714	positive regulation of B cell mediated immunity	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	ATAD5	1
GO:0002891	positive regulation of immunoglobulin mediated immune response	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	ATAD5	1
GO:0016073	snRNA metabolic process	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	INTS2	1
GO:0031638	zymogen activation	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	PLGRKT	1
GO:0032786	positive regulation of DNA-templated transcription, elongation	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	MED4	1
GO:0045778	positive regulation of ossification	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	BMPR1A	1
GO:0048168	regulation of neuronal synaptic plasticity	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	APP	1
GO:0061097	regulation of protein tyrosine kinase activity	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	APP	1
GO:0071867	response to monoamine	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	GNAO1	1
GO:0071869	response to catecholamine	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	GNAO1	1
GO:1900271	regulation of long-term synaptic potentiation	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	APP	1
GO:1904707	positive regulation of vascular associated smooth muscle cell proliferation	1/89	62/21288	0.0161290322580645	3.85791953606379	1.46017970520957	0.229044077155227	0.516574944654374	0.499893398716382	BMPR1A	1
GO:0016447	somatic recombination of immunoglobulin gene segments	1/89	63/21288	0.0158730158730159	3.79668271803103	1.44040350656452	0.232276672893152	0.517534882956796	0.500822338119119	ATAD5	1
GO:0030490	maturation of SSU-rRNA	1/89	63/21288	0.0158730158730159	3.79668271803103	1.44040350656452	0.232276672893152	0.517534882956796	0.500822338119119	TSR2	1
GO:0051306	mitotic sister chromatid separation	1/89	63/21288	0.0158730158730159	3.79668271803103	1.44040350656452	0.232276672893152	0.517534882956796	0.500822338119119	DLGAP5	1
GO:0051480	regulation of cytosolic calcium ion concentration	1/89	63/21288	0.0158730158730159	3.79668271803103	1.44040350656452	0.232276672893152	0.517534882956796	0.500822338119119	SLC35G1	1
GO:0060425	lung morphogenesis	1/89	63/21288	0.0158730158730159	3.79668271803103	1.44040350656452	0.232276672893152	0.517534882956796	0.500822338119119	TCF21	1
GO:0061005	cell differentiation involved in kidney development	1/89	63/21288	0.0158730158730159	3.79668271803103	1.44040350656452	0.232276672893152	0.517534882956796	0.500822338119119	TCF21	1
GO:0070169	positive regulation of biomineral tissue development	1/89	63/21288	0.0158730158730159	3.79668271803103	1.44040350656452	0.232276672893152	0.517534882956796	0.500822338119119	BMPR1A	1
GO:1902895	positive regulation of miRNA transcription	1/89	63/21288	0.0158730158730159	3.79668271803103	1.44040350656452	0.232276672893152	0.517534882956796	0.500822338119119	BMPR1A	1
GO:0000075	cell cycle checkpoint signaling	2/89	219/21288	0.0091324200913242	2.18439279667539	1.1415380688193	0.232987866619235	0.517555878408691	0.500842655573371	FOXO4/USP28	2
GO:0007369	gastrulation	2/89	219/21288	0.0091324200913242	2.18439279667539	1.1415380688193	0.232987866619235	0.517555878408691	0.500842655573371	BMPR1A/PHLDB1	2
GO:0061138	morphogenesis of a branching epithelium	2/89	220/21288	0.00909090909090909	2.17446373850868	1.13457665696518	0.234530705014433	0.518010818437077	0.501282904407263	TCF21/DCHS1	2
GO:0019369	arachidonic acid metabolic process	1/89	64/21288	0.015625	3.7373595505618	1.42102840765972	0.235495866114	0.518010818437077	0.501282904407263	FAAH	1
GO:0021545	cranial nerve development	1/89	64/21288	0.015625	3.7373595505618	1.42102840765972	0.235495866114	0.518010818437077	0.501282904407263	KCNC1	1
GO:0032092	positive regulation of protein binding	1/89	64/21288	0.015625	3.7373595505618	1.42102840765972	0.235495866114	0.518010818437077	0.501282904407263	APP	1
GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	1/89	64/21288	0.015625	3.7373595505618	1.42102840765972	0.235495866114	0.518010818437077	0.501282904407263	RPS6KA1	1
GO:0009749	response to glucose	2/89	221/21288	0.00904977375565611	2.16462453607199	1.12765245744367	0.236074188113155	0.518010818437077	0.501282904407263	TRA2B/CCDC186	2
GO:0007566	embryo implantation	1/89	65/21288	0.0153846153846154	3.67986171132239	1.40203940869955	0.238701711756474	0.518010818437077	0.501282904407263	EMP2	1
GO:0010823	negative regulation of mitochondrion organization	1/89	65/21288	0.0153846153846154	3.67986171132239	1.40203940869955	0.238701711756474	0.518010818437077	0.501282904407263	SLC35F6	1
GO:0042058	regulation of epidermal growth factor receptor signaling pathway	1/89	65/21288	0.0153846153846154	3.67986171132239	1.40203940869955	0.238701711756474	0.518010818437077	0.501282904407263	NEU3	1
GO:0050850	positive regulation of calcium-mediated signaling	1/89	65/21288	0.0153846153846154	3.67986171132239	1.40203940869955	0.238701711756474	0.518010818437077	0.501282904407263	APP	1
GO:0085029	extracellular matrix assembly	1/89	65/21288	0.0153846153846154	3.67986171132239	1.40203940869955	0.238701711756474	0.518010818437077	0.501282904407263	PHLDB1	1
GO:0097352	autophagosome maturation	1/89	65/21288	0.0153846153846154	3.67986171132239	1.40203940869955	0.238701711756474	0.518010818437077	0.501282904407263	VPS33A	1
GO:0099518	vesicle cytoskeletal trafficking	1/89	65/21288	0.0153846153846154	3.67986171132239	1.40203940869955	0.238701711756474	0.518010818437077	0.501282904407263	CCDC186	1
GO:1904036	negative regulation of epithelial cell apoptotic process	1/89	65/21288	0.0153846153846154	3.67986171132239	1.40203940869955	0.238701711756474	0.518010818437077	0.501282904407263	PAK4	1
GO:0006066	alcohol metabolic process	3/89	404/21288	0.00742574257425743	1.77617087551452	1.02055338801482	0.238900660528511	0.518010818437077	0.501282904407263	CACNA1H/PECR/APP	3
GO:0010506	regulation of autophagy	3/89	404/21288	0.00742574257425743	1.77617087551452	1.02055338801482	0.238900660528511	0.518010818437077	0.501282904407263	ABL2/EXOC7/ATP6V0A1	3
GO:0009755	hormone-mediated signaling pathway	2/89	223/21288	0.00896860986547085	2.14521086310274	1.11391410872968	0.239162960919085	0.518010818437077	0.501282904407263	TCF21/PGRMC2	2
GO:0006120	mitochondrial electron transport, NADH to ubiquinone	1/89	66/21288	0.0151515151515152	3.6241062308478	1.38342229720632	0.24189426453665	0.522392445375634	0.505523037237724	NDUFA5	1
GO:0048278	vesicle docking	1/89	66/21288	0.0151515151515152	3.6241062308478	1.38342229720632	0.24189426453665	0.522392445375634	0.505523037237724	EXOC7	1
GO:0010718	positive regulation of epithelial to mesenchymal transition	1/89	67/21288	0.0149253731343284	3.57001509307396	1.3651635953593	0.245073578948874	0.525412106031381	0.508445185212169	EMP2	1
GO:0035904	aorta development	1/89	67/21288	0.0149253731343284	3.57001509307396	1.3651635953593	0.245073578948874	0.525412106031381	0.508445185212169	BMPR1A	1
GO:0040014	regulation of multicellular organism growth	1/89	67/21288	0.0149253731343284	3.57001509307396	1.3651635953593	0.245073578948874	0.525412106031381	0.508445185212169	APP	1
GO:0044818	mitotic G2/M transition checkpoint	1/89	67/21288	0.0149253731343284	3.57001509307396	1.3651635953593	0.245073578948874	0.525412106031381	0.508445185212169	FOXO4	1
GO:0072666	establishment of protein localization to vacuole	1/89	67/21288	0.0149253731343284	3.57001509307396	1.3651635953593	0.245073578948874	0.525412106031381	0.508445185212169	VPS8	1
GO:0030073	insulin secretion	2/89	228/21288	0.0087719298245614	2.09816676522768	1.080192312541	0.246893970011337	0.528360131556005	0.511298011339835	AACS/CCDC186	2
GO:0016445	somatic diversification of immunoglobulins	1/89	68/21288	0.0147058823529412	3.51751487111699	1.34725051158747	0.248239709266652	0.528360131556005	0.511298011339835	ATAD5	1
GO:0030888	regulation of B cell proliferation	1/89	68/21288	0.0147058823529412	3.51751487111699	1.34725051158747	0.248239709266652	0.528360131556005	0.511298011339835	ATAD5	1
GO:0033363	secretory granule organization	1/89	68/21288	0.0147058823529412	3.51751487111699	1.34725051158747	0.248239709266652	0.528360131556005	0.511298011339835	AP1S1	1
GO:0071715	icosanoid transport	1/89	68/21288	0.0147058823529412	3.51751487111699	1.34725051158747	0.248239709266652	0.528360131556005	0.511298011339835	SLCO3A1	1
GO:0051346	negative regulation of hydrolase activity	2/89	230/21288	0.00869565217391304	2.07992183683439	1.06694547610702	0.249989359672519	0.529927857914369	0.512815111744431	RPS6KA1/SPOCK2	2
GO:0000387	spliceosomal snRNP assembly	1/89	69/21288	0.0144927536231884	3.46653639472399	1.32967089601507	0.251392709543526	0.529927857914369	0.512815111744431	SNRPC	1
GO:0001756	somitogenesis	1/89	69/21288	0.0144927536231884	3.46653639472399	1.32967089601507	0.251392709543526	0.529927857914369	0.512815111744431	BMPR1A	1
GO:0043470	regulation of carbohydrate catabolic process	1/89	69/21288	0.0144927536231884	3.46653639472399	1.32967089601507	0.251392709543526	0.529927857914369	0.512815111744431	APP	1
GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	1/89	69/21288	0.0144927536231884	3.46653639472399	1.32967089601507	0.251392709543526	0.529927857914369	0.512815111744431	RGS13	1
GO:0055021	regulation of cardiac muscle tissue growth	1/89	69/21288	0.0144927536231884	3.46653639472399	1.32967089601507	0.251392709543526	0.529927857914369	0.512815111744431	BMPR1A	1
GO:0007416	synapse assembly	2/89	231/21288	0.00865800865800866	2.07091784619874	1.06037246861155	0.251537573961741	0.529927857914369	0.512815111744431	SPOCK2/APP	2
GO:0001947	heart looping	1/89	70/21288	0.0142857142857143	3.41701444622793	1.31241319940222	0.254532633613964	0.529927857914369	0.512815111744431	BBS5	1
GO:0006903	vesicle targeting	1/89	70/21288	0.0142857142857143	3.41701444622793	1.31241319940222	0.254532633613964	0.529927857914369	0.512815111744431	EXOC7	1
GO:0051785	positive regulation of nuclear division	1/89	70/21288	0.0142857142857143	3.41701444622793	1.31241319940222	0.254532633613964	0.529927857914369	0.512815111744431	DLGAP5	1
GO:0051932	synaptic transmission, GABAergic	1/89	70/21288	0.0142857142857143	3.41701444622793	1.31241319940222	0.254532633613964	0.529927857914369	0.512815111744431	USP46	1
GO:1904645	response to amyloid-beta	1/89	70/21288	0.0142857142857143	3.41701444622793	1.31241319940222	0.254532633613964	0.529927857914369	0.512815111744431	APP	1
GO:0009746	response to hexose	2/89	233/21288	0.00858369098712446	2.05314172734725	1.04732556387768	0.254634893930272	0.529927857914369	0.512815111744431	TRA2B/CCDC186	2
GO:0050679	positive regulation of epithelial cell proliferation	2/89	234/21288	0.00854700854700855	2.04436761740133	1.04085099716908	0.256183941303894	0.529927857914369	0.512815111744431	NME1/BMPR1A	2
GO:0008652	amino acid biosynthetic process	1/89	71/21288	0.0140845070422535	3.36888748219655	1.29546643526072	0.257659535094233	0.529927857914369	0.512815111744431	SEPHS1	1
GO:0019229	regulation of vasoconstriction	1/89	71/21288	0.0140845070422535	3.36888748219655	1.29546643526072	0.257659535094233	0.529927857914369	0.512815111744431	FAAH	1
GO:0032007	negative regulation of TOR signaling	1/89	71/21288	0.0140845070422535	3.36888748219655	1.29546643526072	0.257659535094233	0.529927857914369	0.512815111744431	RPS6KA1	1
GO:0044458	motile cilium assembly	1/89	71/21288	0.0140845070422535	3.36888748219655	1.29546643526072	0.257659535094233	0.529927857914369	0.512815111744431	BBS5	1
GO:0050878	regulation of body fluid levels	3/89	421/21288	0.00712589073634204	1.70444901118258	0.945921615428786	0.257921136207608	0.529927857914369	0.512815111744431	NME1/F5/EMP2	3
GO:0000768	syncytium formation by plasma membrane fusion	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	CACNA1H	1
GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	ATAD5	1
GO:0003208	cardiac ventricle morphogenesis	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	BMPR1A	1
GO:0016444	somatic cell DNA recombination	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	ATAD5	1
GO:0030225	macrophage differentiation	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	APP	1
GO:0032835	glomerulus development	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	TCF21	1
GO:0045911	positive regulation of DNA recombination	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	ATAD5	1
GO:0046902	regulation of mitochondrial membrane permeability	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	SLC35F6	1
GO:0071709	membrane assembly	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	EMP2	1
GO:0140253	cell-cell fusion	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	CACNA1H	1
GO:1901184	regulation of ERBB signaling pathway	1/89	72/21288	0.0138888888888889	3.32209737827715	1.2788201448583	0.260773467383276	0.529927857914369	0.512815111744431	NEU3	1
GO:0001763	morphogenesis of a branching structure	2/89	237/21288	0.00843881856540084	2.01848954629498	1.02161892433785	0.260832288031072	0.529927857914369	0.512815111744431	TCF21/DCHS1	2
GO:0009152	purine ribonucleotide biosynthetic process	2/89	237/21288	0.00843881856540084	2.01848954629498	1.02161892433785	0.260832288031072	0.529927857914369	0.512815111744431	NDUFA5/NME1	2
GO:0060541	respiratory system development	2/89	237/21288	0.00843881856540084	2.01848954629498	1.02161892433785	0.260832288031072	0.529927857914369	0.512815111744431	TCF21/BMPR1A	2
GO:0048857	neural nucleus development	1/89	73/21288	0.0136986301369863	3.27658919501308	1.26246436485438	0.263874483663578	0.531714294267455	0.514543859430272	KCNC1	1
GO:0060191	regulation of lipase activity	1/89	73/21288	0.0136986301369863	3.27658919501308	1.26246436485438	0.263874483663578	0.531714294267455	0.514543859430272	ABL2	1
GO:0060411	cardiac septum morphogenesis	1/89	73/21288	0.0136986301369863	3.27658919501308	1.26246436485438	0.263874483663578	0.531714294267455	0.514543859430272	BMPR1A	1
GO:1901607	alpha-amino acid biosynthetic process	1/89	73/21288	0.0136986301369863	3.27658919501308	1.26246436485438	0.263874483663578	0.531714294267455	0.514543859430272	SEPHS1	1
GO:1901880	negative regulation of protein depolymerization	1/89	73/21288	0.0136986301369863	3.27658919501308	1.26246436485438	0.263874483663578	0.531714294267455	0.514543859430272	TRIM54	1
GO:2000630	positive regulation of miRNA metabolic process	1/89	73/21288	0.0136986301369863	3.27658919501308	1.26246436485438	0.263874483663578	0.531714294267455	0.514543859430272	BMPR1A	1
GO:0034284	response to monosaccharide	2/89	240/21288	0.00833333333333333	1.99325842696629	1.00266766047746	0.26548184885834	0.532979658876123	0.515768362130971	TRA2B/CCDC186	2
GO:0001774	microglial cell activation	1/89	74/21288	0.0135135135135135	3.23231096264804	1.24638959733604	0.266962636902038	0.532979658876123	0.515768362130971	APP	1
GO:0035773	insulin secretion involved in cellular response to glucose stimulus	1/89	74/21288	0.0135135135135135	3.23231096264804	1.24638959733604	0.266962636902038	0.532979658876123	0.515768362130971	CCDC186	1
GO:0045600	positive regulation of fat cell differentiation	1/89	74/21288	0.0135135135135135	3.23231096264804	1.24638959733604	0.266962636902038	0.532979658876123	0.515768362130971	ADIRF	1
GO:0050435	amyloid-beta metabolic process	1/89	74/21288	0.0135135135135135	3.23231096264804	1.24638959733604	0.266962636902038	0.532979658876123	0.515768362130971	BACE2	1
GO:0051123	RNA polymerase II preinitiation complex assembly	1/89	74/21288	0.0135135135135135	3.23231096264804	1.24638959733604	0.266962636902038	0.532979658876123	0.515768362130971	MED4	1
GO:0071383	cellular response to steroid hormone stimulus	2/89	241/21288	0.00829875518672199	1.98498764511166	0.99641154257527	0.267031842650478	0.532979658876123	0.515768362130971	TCF21/PGRMC2	2
GO:0002520	immune system development	2/89	242/21288	0.00826446280991736	1.97678521682608	0.99018541273598	0.26858186099075	0.53349318215374	0.5162653024089	TCF21/ATAD5	2
GO:0033619	membrane protein proteolysis	1/89	75/21288	0.0133333333333333	3.18921348314607	1.23058678204652	0.270037979850832	0.53349318215374	0.5162653024089	BACE2	1
GO:0046503	glycerolipid catabolic process	1/89	75/21288	0.0133333333333333	3.18921348314607	1.23058678204652	0.270037979850832	0.53349318215374	0.5162653024089	FAAH	1
GO:0060415	muscle tissue morphogenesis	1/89	75/21288	0.0133333333333333	3.18921348314607	1.23058678204652	0.270037979850832	0.53349318215374	0.5162653024089	BMPR1A	1
GO:0060420	regulation of heart growth	1/89	75/21288	0.0133333333333333	3.18921348314607	1.23058678204652	0.270037979850832	0.53349318215374	0.5162653024089	BMPR1A	1
GO:0061371	determination of heart left/right asymmetry	1/89	75/21288	0.0133333333333333	3.18921348314607	1.23058678204652	0.270037979850832	0.53349318215374	0.5162653024089	BBS5	1
GO:0003143	embryonic heart tube morphogenesis	1/89	76/21288	0.0131578947368421	3.14725014784151	1.21504727061868	0.273100565048272	0.53349318215374	0.5162653024089	BBS5	1
GO:0006949	syncytium formation	1/89	76/21288	0.0131578947368421	3.14725014784151	1.21504727061868	0.273100565048272	0.53349318215374	0.5162653024089	CACNA1H	1
GO:0010257	NADH dehydrogenase complex assembly	1/89	76/21288	0.0131578947368421	3.14725014784151	1.21504727061868	0.273100565048272	0.53349318215374	0.5162653024089	NDUFA5	1
GO:0032981	mitochondrial respiratory chain complex I assembly	1/89	76/21288	0.0131578947368421	3.14725014784151	1.21504727061868	0.273100565048272	0.53349318215374	0.5162653024089	NDUFA5	1
GO:0033143	regulation of intracellular steroid hormone receptor signaling pathway	1/89	76/21288	0.0131578947368421	3.14725014784151	1.21504727061868	0.273100565048272	0.53349318215374	0.5162653024089	TCF21	1
GO:0035019	somatic stem cell population maintenance	1/89	76/21288	0.0131578947368421	3.14725014784151	1.21504727061868	0.273100565048272	0.53349318215374	0.5162653024089	BMPR1A	1
GO:0044091	membrane biogenesis	1/89	76/21288	0.0131578947368421	3.14725014784151	1.21504727061868	0.273100565048272	0.53349318215374	0.5162653024089	EMP2	1
GO:1905818	regulation of chromosome separation	1/89	76/21288	0.0131578947368421	3.14725014784151	1.21504727061868	0.273100565048272	0.53349318215374	0.5162653024089	DLGAP5	1
GO:0000380	alternative mRNA splicing, via spliceosome	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	TRA2B	1
GO:0002269	leukocyte activation involved in inflammatory response	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	APP	1
GO:0003281	ventricular septum development	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	BMPR1A	1
GO:0008333	endosome to lysosome transport	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	VPS33A	1
GO:0008347	glial cell migration	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	RRAS	1
GO:0045665	negative regulation of neuron differentiation	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	APP	1
GO:0060261	positive regulation of transcription initiation by RNA polymerase II	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	MED4	1
GO:2000117	negative regulation of cysteine-type endopeptidase activity	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	RPS6KA1	1
GO:2000351	regulation of endothelial cell apoptotic process	1/89	77/21288	0.012987012987013	3.10637676929812	1.19976280264436	0.276150444819661	0.53349318215374	0.5162653024089	PAK4	1
GO:0007411	axon guidance	2/89	247/21288	0.00809716599190283	1.93676932174862	0.959494509697438	0.276331383840988	0.53349318215374	0.5162653024089	ARHGEF40/APP	2
GO:0097485	neuron projection guidance	2/89	247/21288	0.00809716599190283	1.93676932174862	0.959494509697438	0.276331383840988	0.53349318215374	0.5162653024089	ARHGEF40/APP	2
GO:0072330	monocarboxylic acid biosynthetic process	2/89	248/21288	0.00806451612903226	1.9289597680319	0.953442318913064	0.277880990279198	0.535783608708258	0.518481765144262	FADS2/PECR	2
GO:0002200	somatic diversification of immune receptors	1/89	78/21288	0.0128205128205128	3.06655142610199	1.18472548342672	0.279187671278152	0.536899367842599	0.519561493519761	ATAD5	1
GO:0051341	regulation of oxidoreductase activity	1/89	78/21288	0.0128205128205128	3.06655142610199	1.18472548342672	0.279187671278152	0.536899367842599	0.519561493519761	ABL2	1
GO:0045913	positive regulation of carbohydrate metabolic process	1/89	79/21288	0.0126582278481013	3.02773431944247	1.16992776327722	0.282212296325593	0.541304469545189	0.523824343053185	APP	1
GO:0050709	negative regulation of protein secretion	1/89	79/21288	0.0126582278481013	3.02773431944247	1.16992776327722	0.282212296325593	0.541304469545189	0.523824343053185	SERGEF	1
GO:0009260	ribonucleotide biosynthetic process	2/89	252/21288	0.00793650793650794	1.89834135901552	0.929511206312882	0.284077564047359	0.544174554506305	0.526601745520464	NDUFA5/NME1	2
GO:0042446	hormone biosynthetic process	1/89	80/21288	0.0125	2.98988764044944	1.15536241823191	0.28522437165338	0.544955891436185	0.527357851052608	CACNA1H	1
GO:0071300	cellular response to retinoic acid	1/89	80/21288	0.0125	2.98988764044944	1.15536241823191	0.28522437165338	0.544955891436185	0.527357851052608	ABL2	1
GO:0010594	regulation of endothelial cell migration	2/89	254/21288	0.0078740157480315	1.88339378925949	0.917708620134165	0.287174388176183	0.546440005650843	0.528794039366667	EMP2/RRAS	2
GO:0003151	outflow tract morphogenesis	1/89	81/21288	0.0123456790123457	2.95297544735747	1.14102253207317	0.288223948743292	0.546440005650843	0.528794039366667	BMPR1A	1
GO:0006406	mRNA export from nucleus	1/89	81/21288	0.0123456790123457	2.95297544735747	1.14102253207317	0.288223948743292	0.546440005650843	0.528794039366667	NXT1	1
GO:0008088	axo-dendritic transport	1/89	81/21288	0.0123456790123457	2.95297544735747	1.14102253207317	0.288223948743292	0.546440005650843	0.528794039366667	APP	1
GO:0014032	neural crest cell development	1/89	81/21288	0.0123456790123457	2.95297544735747	1.14102253207317	0.288223948743292	0.546440005650843	0.528794039366667	BMPR1A	1
GO:1903578	regulation of ATP metabolic process	1/89	81/21288	0.0123456790123457	2.95297544735747	1.14102253207317	0.288223948743292	0.546440005650843	0.528794039366667	APP	1
GO:0071674	mononuclear cell migration	2/89	256/21288	0.0078125	1.8686797752809	0.90601200526713	0.290269974266932	0.547150788848876	0.529481869530116	ABL2/APP	2
GO:0006687	glycosphingolipid metabolic process	1/89	82/21288	0.0121951219512195	2.91696355165799	1.12690147955363	0.291211078868338	0.547150788848876	0.529481869530116	NEU3	1
GO:0010972	negative regulation of G2/M transition of mitotic cell cycle	1/89	82/21288	0.0121951219512195	2.91696355165799	1.12690147955363	0.291211078868338	0.547150788848876	0.529481869530116	FOXO4	1
GO:0022617	extracellular matrix disassembly	1/89	82/21288	0.0121951219512195	2.91696355165799	1.12690147955363	0.291211078868338	0.547150788848876	0.529481869530116	TPSAB1	1
GO:0042776	proton motive force-driven mitochondrial ATP synthesis	1/89	82/21288	0.0121951219512195	2.91696355165799	1.12690147955363	0.291211078868338	0.547150788848876	0.529481869530116	NDUFA5	1
GO:0048644	muscle organ morphogenesis	1/89	82/21288	0.0121951219512195	2.91696355165799	1.12690147955363	0.291211078868338	0.547150788848876	0.529481869530116	BMPR1A	1
GO:0044242	cellular lipid catabolic process	2/89	258/21288	0.00775193798449612	1.85419388555004	0.894419421531342	0.293364129272005	0.547150788848876	0.529481869530116	NEU3/FAAH	2
GO:0046434	organophosphate catabolic process	2/89	258/21288	0.00775193798449612	1.85419388555004	0.894419421531342	0.293364129272005	0.547150788848876	0.529481869530116	HKDC1/APP	2
GO:0002712	regulation of B cell mediated immunity	1/89	83/21288	0.0120481927710843	2.88181941248139	1.1129929107281	0.294185813093591	0.547150788848876	0.529481869530116	ATAD5	1
GO:0002889	regulation of immunoglobulin mediated immune response	1/89	83/21288	0.0120481927710843	2.88181941248139	1.1129929107281	0.294185813093591	0.547150788848876	0.529481869530116	ATAD5	1
GO:0052372	modulation by symbiont of entry into host	1/89	83/21288	0.0120481927710843	2.88181941248139	1.1129929107281	0.294185813093591	0.547150788848876	0.529481869530116	EXOC7	1
GO:0061900	glial cell activation	1/89	83/21288	0.0120481927710843	2.88181941248139	1.1129929107281	0.294185813093591	0.547150788848876	0.529481869530116	APP	1
GO:0072577	endothelial cell apoptotic process	1/89	83/21288	0.0120481927710843	2.88181941248139	1.1129929107281	0.294185813093591	0.547150788848876	0.529481869530116	PAK4	1
GO:2000144	positive regulation of DNA-templated transcription initiation	1/89	83/21288	0.0120481927710843	2.88181941248139	1.1129929107281	0.294185813093591	0.547150788848876	0.529481869530116	MED4	1
GO:0046390	ribose phosphate biosynthetic process	2/89	259/21288	0.00772200772200772	1.84703483579888	0.888661549007809	0.294910610675604	0.547150788848876	0.529481869530116	NDUFA5/NME1	2
GO:0051090	regulation of DNA-binding transcription factor activity	3/89	455/21288	0.00659340659340659	1.57708359056674	0.806237626802297	0.29651959824974	0.547150788848876	0.529481869530116	FAF1/SLCO3A1/APP	3
GO:0009311	oligosaccharide metabolic process	1/89	84/21288	0.0119047619047619	2.84751203852327	1.09929073630811	0.297148202277022	0.547150788848876	0.529481869530116	NEU3	1
GO:0034394	protein localization to cell surface	1/89	84/21288	0.0119047619047619	2.84751203852327	1.09929073630811	0.297148202277022	0.547150788848876	0.529481869530116	EMP2	1
GO:0045806	negative regulation of endocytosis	1/89	84/21288	0.0119047619047619	2.84751203852327	1.09929073630811	0.297148202277022	0.547150788848876	0.529481869530116	NEU3	1
GO:1902750	negative regulation of cell cycle G2/M phase transition	1/89	84/21288	0.0119047619047619	2.84751203852327	1.09929073630811	0.297148202277022	0.547150788848876	0.529481869530116	FOXO4	1
GO:0007033	vacuole organization	2/89	261/21288	0.00766283524904215	1.83288131215291	0.877221485087154	0.298002264152973	0.547150788848876	0.529481869530116	VPS33A/ATP6V0A1	2
GO:0003002	regionalization	3/89	457/21288	0.00656455142231947	1.57018169301502	0.798382218339543	0.298805590657667	0.547150788848876	0.529481869530116	BMPR1A/TRA2B/BBS5	3
GO:0016358	dendrite development	2/89	262/21288	0.00763358778625954	1.82588558195386	0.871538839703925	0.299547389968655	0.547150788848876	0.529481869530116	PAK4/APP	2
GO:0008344	adult locomotory behavior	1/89	85/21288	0.0117647058823529	2.81401189689359	1.08578911396072	0.300098297070332	0.547150788848876	0.529481869530116	APP	1
GO:0032147	activation of protein kinase activity	1/89	85/21288	0.0117647058823529	2.81401189689359	1.08578911396072	0.300098297070332	0.547150788848876	0.529481869530116	EMP2	1
GO:0048844	artery morphogenesis	1/89	85/21288	0.0117647058823529	2.81401189689359	1.08578911396072	0.300098297070332	0.547150788848876	0.529481869530116	BMPR1A	1
GO:0051145	smooth muscle cell differentiation	1/89	85/21288	0.0117647058823529	2.81401189689359	1.08578911396072	0.300098297070332	0.547150788848876	0.529481869530116	FOXO4	1
GO:0060390	regulation of SMAD protein signal transduction	1/89	85/21288	0.0117647058823529	2.81401189689359	1.08578911396072	0.300098297070332	0.547150788848876	0.529481869530116	BMPR1A	1
GO:0070613	regulation of protein processing	1/89	85/21288	0.0117647058823529	2.81401189689359	1.08578911396072	0.300098297070332	0.547150788848876	0.529481869530116	PLGRKT	1
GO:0140056	organelle localization by membrane tethering	1/89	85/21288	0.0117647058823529	2.81401189689359	1.08578911396072	0.300098297070332	0.547150788848876	0.529481869530116	EXOC7	1
GO:1903053	regulation of extracellular matrix organization	1/89	85/21288	0.0117647058823529	2.81401189689359	1.08578911396072	0.300098297070332	0.547150788848876	0.529481869530116	PHLDB1	1
GO:0009743	response to carbohydrate	2/89	264/21288	0.00757575757575758	1.8120531154239	0.86024720911579	0.302636125580947	0.549427346295702	0.531684911027277	TRA2B/CCDC186	2
GO:0014855	striated muscle cell proliferation	1/89	86/21288	0.0116279069767442	2.78129082832506	1.07248243548053	0.303036147919776	0.549427346295702	0.531684911027277	BMPR1A	1
GO:0050871	positive regulation of B cell activation	1/89	86/21288	0.0116279069767442	2.78129082832506	1.07248243548053	0.303036147919776	0.549427346295702	0.531684911027277	ATAD5	1
GO:0072527	pyrimidine-containing compound metabolic process	1/89	86/21288	0.0116279069767442	2.78129082832506	1.07248243548053	0.303036147919776	0.549427346295702	0.531684911027277	NME1	1
GO:0022618	protein-RNA complex assembly	2/89	265/21288	0.00754716981132075	1.80521517913928	0.854637787310179	0.304179690292139	0.549427346295702	0.531684911027277	CLP1/SNRPC	2
GO:0048863	stem cell differentiation	2/89	265/21288	0.00754716981132075	1.80521517913928	0.854637787310179	0.304179690292139	0.549427346295702	0.531684911027277	FOXO4/BMPR1A	2
GO:0042692	muscle cell differentiation	3/89	462/21288	0.00649350649350649	1.55318838464906	0.778907085176885	0.304525358691922	0.549427346295702	0.531684911027277	CACNA1H/FOXO4/BMPR1A	3
GO:0050900	leukocyte migration	3/89	463/21288	0.00647948164146868	1.5498337661077	0.775039690035542	0.305670044422684	0.549427346295702	0.531684911027277	ABL2/EMP2/APP	3
GO:0097191	extrinsic apoptotic signaling pathway	2/89	266/21288	0.0075187969924812	1.79842865590944	0.84905234142372	0.305722689871294	0.549427346295702	0.531684911027277	FAF1/ITM2C	2
GO:0001707	mesoderm formation	1/89	87/21288	0.0114942528735632	2.74932196822937	1.05936531476966	0.305961805066985	0.549427346295702	0.531684911027277	BMPR1A	1
GO:0090559	regulation of membrane permeability	1/89	87/21288	0.0114942528735632	2.74932196822937	1.05936531476966	0.305961805066985	0.549427346295702	0.531684911027277	SLC35F6	1
GO:0140029	exocytic process	1/89	87/21288	0.0114942528735632	2.74932196822937	1.05936531476966	0.305961805066985	0.549427346295702	0.531684911027277	EXOC7	1
GO:0051098	regulation of binding	2/89	267/21288	0.00749063670411985	1.79169296805959	0.84349066007738	0.307265102256241	0.549427346295702	0.531684911027277	NME1/APP	2
GO:0006081	cellular aldehyde metabolic process	1/89	88/21288	0.0113636363636364	2.71807967313585	1.04643257656614	0.308875318549794	0.549427346295702	0.531684911027277	CACNA1H	1
GO:0045185	maintenance of protein location	1/89	88/21288	0.0113636363636364	2.71807967313585	1.04643257656614	0.308875318549794	0.549427346295702	0.531684911027277	FAF1	1
GO:0045669	positive regulation of osteoblast differentiation	1/89	88/21288	0.0113636363636364	2.71807967313585	1.04643257656614	0.308875318549794	0.549427346295702	0.531684911027277	BMPR1A	1
GO:0048864	stem cell development	1/89	88/21288	0.0113636363636364	2.71807967313585	1.04643257656614	0.308875318549794	0.549427346295702	0.531684911027277	BMPR1A	1
GO:0061053	somite development	1/89	88/21288	0.0113636363636364	2.71807967313585	1.04643257656614	0.308875318549794	0.549427346295702	0.531684911027277	BMPR1A	1
GO:0140115	export across plasma membrane	1/89	88/21288	0.0113636363636364	2.71807967313585	1.04643257656614	0.308875318549794	0.549427346295702	0.531684911027277	SLC35G1	1
GO:0043254	regulation of protein-containing complex assembly	3/89	467/21288	0.00642398286937901	1.53655895868922	0.759660674300446	0.310250862983429	0.549427346295702	0.531684911027277	VPS8/FAF1/VPS33A	3
GO:0009314	response to radiation	3/89	468/21288	0.00641025641025641	1.53327571305099	0.755838335161085	0.311396532369056	0.549427346295702	0.531684911027277	KCNC1/USP28/APP	3
GO:0000281	mitotic cytokinesis	1/89	89/21288	0.0112359550561798	2.68753945208938	1.03367924586621	0.311776738203053	0.549427346295702	0.531684911027277	EXOC7	1
GO:0021954	central nervous system neuron development	1/89	89/21288	0.0112359550561798	2.68753945208938	1.03367924586621	0.311776738203053	0.549427346295702	0.531684911027277	ARHGEF28	1
GO:0048332	mesoderm morphogenesis	1/89	89/21288	0.0112359550561798	2.68753945208938	1.03367924586621	0.311776738203053	0.549427346295702	0.531684911027277	BMPR1A	1
GO:0051101	regulation of DNA binding	1/89	89/21288	0.0112359550561798	2.68753945208938	1.03367924586621	0.311776738203053	0.549427346295702	0.531684911027277	NME1	1
GO:0060260	regulation of transcription initiation by RNA polymerase II	1/89	89/21288	0.0112359550561798	2.68753945208938	1.03367924586621	0.311776738203053	0.549427346295702	0.531684911027277	MED4	1
GO:1901879	regulation of protein depolymerization	1/89	89/21288	0.0112359550561798	2.68753945208938	1.03367924586621	0.311776738203053	0.549427346295702	0.531684911027277	TRIM54	1
GO:1903317	regulation of protein maturation	1/89	89/21288	0.0112359550561798	2.68753945208938	1.03367924586621	0.311776738203053	0.549427346295702	0.531684911027277	PLGRKT	1
GO:0002685	regulation of leukocyte migration	2/89	271/21288	0.00738007380073801	1.7652473153945	0.821477445608726	0.313428445239024	0.55109988857116	0.533303442570914	ABL2/APP	2
GO:0035050	embryonic heart tube development	1/89	90/21288	0.0111111111111111	2.65767790262172	1.02110053799032	0.314666113659438	0.55109988857116	0.533303442570914	BBS5	1
GO:0043242	negative regulation of protein-containing complex disassembly	1/89	90/21288	0.0111111111111111	2.65767790262172	1.02110053799032	0.314666113659438	0.55109988857116	0.533303442570914	TRIM54	1
GO:0072665	protein localization to vacuole	1/89	90/21288	0.0111111111111111	2.65767790262172	1.02110053799032	0.314666113659438	0.55109988857116	0.533303442570914	VPS8	1
GO:1901379	regulation of potassium ion transmembrane transport	1/89	90/21288	0.0111111111111111	2.65767790262172	1.02110053799032	0.314666113659438	0.55109988857116	0.533303442570914	KCNC1	1
GO:0032984	protein-containing complex disassembly	2/89	272/21288	0.00735294117647059	1.75875743555849	0.816031508766363	0.314967597332534	0.55109988857116	0.533303442570914	VPS33A/TRIM54	2
GO:0002312	B cell activation involved in immune response	1/89	91/21288	0.010989010989011	2.62847265094456	1.00869184924729	0.317543494350273	0.55339949768364	0.535528791335604	ATAD5	1
GO:0002637	regulation of immunoglobulin production	1/89	91/21288	0.010989010989011	2.62847265094456	1.00869184924729	0.317543494350273	0.55339949768364	0.535528791335604	ATAD5	1
GO:0015986	proton motive force-driven ATP synthesis	1/89	91/21288	0.010989010989011	2.62847265094456	1.00869184924729	0.317543494350273	0.55339949768364	0.535528791335604	NDUFA5	1
GO:0016485	protein processing	2/89	274/21288	0.0072992700729927	1.74591979004347	0.805207095085213	0.318043733914976	0.55339949768364	0.535528791335604	BACE2/PLGRKT	2
GO:0071826	protein-RNA complex organization	2/89	275/21288	0.00727272727272727	1.73957099080695	0.799828233692658	0.319580677074005	0.55339949768364	0.535528791335604	CLP1/SNRPC	2
GO:0030071	regulation of mitotic metaphase/anaphase transition	1/89	92/21288	0.0108695652173913	2.59990229604299	0.996448748153991	0.320408929506324	0.55339949768364	0.535528791335604	DLGAP5	1
GO:0032722	positive regulation of chemokine production	1/89	92/21288	0.0108695652173913	2.59990229604299	0.996448748153991	0.320408929506324	0.55339949768364	0.535528791335604	APP	1
GO:0042310	vasoconstriction	1/89	92/21288	0.0108695652173913	2.59990229604299	0.996448748153991	0.320408929506324	0.55339949768364	0.535528791335604	FAAH	1
GO:0043903	regulation of biological process involved in symbiotic interaction	1/89	92/21288	0.0108695652173913	2.59990229604299	0.996448748153991	0.320408929506324	0.55339949768364	0.535528791335604	EXOC7	1
GO:0070897	transcription preinitiation complex assembly	1/89	92/21288	0.0108695652173913	2.59990229604299	0.996448748153991	0.320408929506324	0.55339949768364	0.535528791335604	MED4	1
GO:1901224	positive regulation of non-canonical NF-kappaB signal transduction	1/89	92/21288	0.0108695652173913	2.59990229604299	0.996448748153991	0.320408929506324	0.55339949768364	0.535528791335604	APP	1
GO:0051223	regulation of protein transport	3/89	478/21288	0.00627615062761506	1.50119881528842	0.718095970801652	0.322860515980357	0.554172688363511	0.5362770136813	AACS/SERGEF/PTPN14	3
GO:0032418	lysosome localization	1/89	93/21288	0.010752688172043	2.57194635737586	0.984366967172259	0.323262468158614	0.554172688363511	0.5362770136813	VPS33A	1
GO:1902893	regulation of miRNA transcription	1/89	93/21288	0.010752688172043	2.57194635737586	0.984366967172259	0.323262468158614	0.554172688363511	0.5362770136813	BMPR1A	1
GO:1990849	vacuolar localization	1/89	93/21288	0.010752688172043	2.57194635737586	0.984366967172259	0.323262468158614	0.554172688363511	0.5362770136813	VPS33A	1
GO:0042445	hormone metabolic process	2/89	278/21288	0.00719424460431655	1.72079864198529	0.783822773466407	0.324186761841495	0.554172688363511	0.5362770136813	CACNA1H/BACE2	2
GO:0045861	negative regulation of proteolysis	2/89	279/21288	0.00716845878136201	1.71463090491724	0.778530714259044	0.325720475077489	0.554172688363511	0.5362770136813	RPS6KA1/SPOCK2	2
GO:0055013	cardiac muscle cell development	1/89	94/21288	0.0106382978723404	2.54458522591442	0.972442394927025	0.326104159139218	0.554172688363511	0.5362770136813	BMPR1A	1
GO:0061614	miRNA transcription	1/89	94/21288	0.0106382978723404	2.54458522591442	0.972442394927025	0.326104159139218	0.554172688363511	0.5362770136813	BMPR1A	1
GO:2001234	negative regulation of apoptotic signaling pathway	2/89	280/21288	0.00714285714285714	1.70850722311396	0.773259900856722	0.32725333118853	0.554172688363511	0.5362770136813	ATAD5/SLC35F6	2
GO:0034470	ncRNA processing	3/89	482/21288	0.00622406639004149	1.48874073383375	0.70323795864597	0.327448353488409	0.554172688363511	0.5362770136813	INTS2/CLP1/TSR2	3
GO:0007409	axonogenesis	3/89	483/21288	0.0062111801242236	1.48565845488171	0.699544272397058	0.328595384267947	0.554172688363511	0.5362770136813	ARHGEF40/ARHGEF28/APP	3
GO:0045927	positive regulation of growth	2/89	281/21288	0.00711743772241993	1.70242712623456	0.768010155765281	0.328785310669252	0.554172688363511	0.5362770136813	RPS6KA1/BMPR1A	2
GO:0007492	endoderm development	1/89	95/21288	0.0105263157894737	2.51780011827321	0.960671068872985	0.32893405108206	0.554172688363511	0.5362770136813	BMPR1A	1
GO:0008306	associative learning	1/89	95/21288	0.0105263157894737	2.51780011827321	0.960671068872985	0.32893405108206	0.554172688363511	0.5362770136813	APP	1
GO:0022406	membrane docking	1/89	95/21288	0.0105263157894737	2.51780011827321	0.960671068872985	0.32893405108206	0.554172688363511	0.5362770136813	EXOC7	1
GO:0055017	cardiac muscle tissue growth	1/89	95/21288	0.0105263157894737	2.51780011827321	0.960671068872985	0.32893405108206	0.554172688363511	0.5362770136813	BMPR1A	1
GO:0070509	calcium ion import	1/89	95/21288	0.0105263157894737	2.51780011827321	0.960671068872985	0.32893405108206	0.554172688363511	0.5362770136813	CACNA1H	1
GO:0071103	DNA conformation change	1/89	95/21288	0.0105263157894737	2.51780011827321	0.960671068872985	0.32893405108206	0.554172688363511	0.5362770136813	TOP3A	1
GO:0030072	peptide hormone secretion	2/89	282/21288	0.00709219858156028	1.69639015060961	0.762781303631239	0.330316394188523	0.554172688363511	0.5362770136813	AACS/CCDC186	2
GO:0007091	metaphase/anaphase transition of mitotic cell cycle	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	DLGAP5	1
GO:0009953	dorsal/ventral pattern formation	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	BMPR1A	1
GO:0010232	vascular transport	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	SLCO3A1	1
GO:0014033	neural crest cell differentiation	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	BMPR1A	1
GO:0030500	regulation of bone mineralization	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	BMPR1A	1
GO:0032088	negative regulation of NF-kappaB transcription factor activity	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	FAF1	1
GO:0034644	cellular response to UV	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	USP28	1
GO:0150104	transport across blood-brain barrier	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	SLCO3A1	1
GO:1902099	regulation of metaphase/anaphase transition of cell cycle	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	DLGAP5	1
GO:2000243	positive regulation of reproductive process	1/89	96/21288	0.0104166666666667	2.49157303370787	0.949049168379444	0.331752192423715	0.554172688363511	0.5362770136813	CACNA1H	1
GO:0042391	regulation of membrane potential	3/89	487/21288	0.00616016427104723	1.47345592137139	0.684851595842415	0.333183489287592	0.555037657785628	0.537114050995405	CACNA1H/KCNC1/APP	3
GO:0006164	purine nucleotide biosynthetic process	2/89	284/21288	0.00704225352112676	1.68444374109828	0.752385587324504	0.333375796882858	0.555037657785628	0.537114050995405	NDUFA5/NME1	2
GO:0021675	nerve development	1/89	97/21288	0.0103092783505155	2.46588671377273	0.937573008205403	0.334558631404194	0.555037657785628	0.537114050995405	KCNC1	1
GO:0032731	positive regulation of interleukin-1 beta production	1/89	97/21288	0.0103092783505155	2.46588671377273	0.937573008205403	0.334558631404194	0.555037657785628	0.537114050995405	APP	1
GO:0033273	response to vitamin	1/89	97/21288	0.0103092783505155	2.46588671377273	0.937573008205403	0.334558631404194	0.555037657785628	0.537114050995405	F5	1
GO:0042475	odontogenesis of dentin-containing tooth	1/89	97/21288	0.0103092783505155	2.46588671377273	0.937573008205403	0.334558631404194	0.555037657785628	0.537114050995405	BMPR1A	1
GO:1903522	regulation of blood circulation	2/89	285/21288	0.00701754385964912	1.67853341218214	0.747218382849978	0.334904078257091	0.555037657785628	0.537114050995405	CACNA1H/FAAH	2
GO:0032886	regulation of microtubule-based process	2/89	286/21288	0.00699300699300699	1.67266441423745	0.742071390665339	0.336431388066066	0.555973506927266	0.538019679138893	PHLDB1/TRIM54	2
GO:0051091	positive regulation of DNA-binding transcription factor activity	2/89	286/21288	0.00699300699300699	1.67266441423745	0.742071390665339	0.336431388066066	0.555973506927266	0.538019679138893	SLCO3A1/APP	2
GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	1/89	98/21288	0.0102040816326531	2.44072460444852	0.926239032339071	0.337353416067731	0.555973506927266	0.538019679138893	FAF1	1
GO:0032024	positive regulation of insulin secretion	1/89	98/21288	0.0102040816326531	2.44072460444852	0.926239032339071	0.337353416067731	0.555973506927266	0.538019679138893	AACS	1
GO:2000142	regulation of DNA-templated transcription initiation	1/89	98/21288	0.0102040816326531	2.44072460444852	0.926239032339071	0.337353416067731	0.555973506927266	0.538019679138893	MED4	1
GO:0002790	peptide secretion	2/89	287/21288	0.00696864111498258	1.66683631523314	0.736944445630673	0.337957707833649	0.556347789123473	0.538381874791386	AACS/CCDC186	2
GO:0071695	anatomical structure maturation	2/89	290/21288	0.00689655172413793	1.64959318093762	0.721682271084343	0.34253054463742	0.561988461254434	0.543840394976637	DCHS1/APP	2
GO:0044784	metaphase/anaphase transition of cell cycle	1/89	100/21288	0.01	2.39191011235955	0.903984021027226	0.342908213646773	0.561988461254434	0.543840394976637	DLGAP5	1
GO:1900542	regulation of purine nucleotide metabolic process	1/89	100/21288	0.01	2.39191011235955	0.903984021027226	0.342908213646773	0.561988461254434	0.543840394976637	APP	1
GO:2000027	regulation of animal organ morphogenesis	1/89	100/21288	0.01	2.39191011235955	0.903984021027226	0.342908213646773	0.561988461254434	0.543840394976637	BMPR1A	1
GO:0006140	regulation of nucleotide metabolic process	1/89	101/21288	0.0099009900990099	2.36822783401936	0.893056468896674	0.345668321678935	0.563382071244672	0.545189001682623	APP	1
GO:0006405	RNA export from nucleus	1/89	101/21288	0.0099009900990099	2.36822783401936	0.893056468896674	0.345668321678935	0.563382071244672	0.545189001682623	NXT1	1
GO:0033138	positive regulation of peptidyl-serine phosphorylation	1/89	101/21288	0.0099009900990099	2.36822783401936	0.893056468896674	0.345668321678935	0.563382071244672	0.545189001682623	APP	1
GO:0055006	cardiac cell development	1/89	101/21288	0.0099009900990099	2.36822783401936	0.893056468896674	0.345668321678935	0.563382071244672	0.545189001682623	BMPR1A	1
GO:0106027	neuron projection organization	1/89	101/21288	0.0099009900990099	2.36822783401936	0.893056468896674	0.345668321678935	0.563382071244672	0.545189001682623	APP	1
GO:0051656	establishment of organelle localization	3/89	500/21288	0.006	1.43514606741573	0.637981752219295	0.348088067280433	0.565680686842401	0.547413389015733	EXOC7/CCDC186/BBS5	3
GO:0001656	metanephros development	1/89	102/21288	0.00980392156862745	2.34500991407799	0.882258057576016	0.348416965629025	0.565680686842401	0.547413389015733	TCF21	1
GO:0006898	receptor-mediated endocytosis	2/89	294/21288	0.00680272108843537	1.62714973629901	0.701603680724794	0.348612708026944	0.565680686842401	0.547413389015733	AP1S1/NEU3	2
GO:0072522	purine-containing compound biosynthetic process	2/89	294/21288	0.00680272108843537	1.62714973629901	0.701603680724794	0.348612708026944	0.565680686842401	0.547413389015733	NDUFA5/NME1	2
GO:0009798	axis specification	1/89	103/21288	0.00970873786407767	2.32224282753354	0.871585795972316	0.351154192574132	0.568553714650762	0.550193639298079	BMPR1A	1
GO:0060419	heart growth	1/89	103/21288	0.00970873786407767	2.32224282753354	0.871585795972316	0.351154192574132	0.568553714650762	0.550193639298079	BMPR1A	1
GO:0018105	peptidyl-serine phosphorylation	2/89	297/21288	0.00673400673400673	1.6107138803768	0.686742613829255	0.353162507117489	0.569839599197969	0.551437999295233	RPS6KA1/APP	2
GO:0007032	endosome organization	1/89	104/21288	0.00961538461538462	2.29991356957649	0.861036791692414	0.35388004940023	0.569839599197969	0.551437999295233	ATP6V0A1	1
GO:0007589	body fluid secretion	1/89	104/21288	0.00961538461538462	2.29991356957649	0.861036791692414	0.35388004940023	0.569839599197969	0.551437999295233	NME1	1
GO:0061515	myeloid cell development	1/89	104/21288	0.00961538461538462	2.29991356957649	0.861036791692414	0.35388004940023	0.569839599197969	0.551437999295233	APP	1
GO:1904705	regulation of vascular associated smooth muscle cell proliferation	1/89	104/21288	0.00961538461538462	2.29991356957649	0.861036791692414	0.35388004940023	0.569839599197969	0.551437999295233	BMPR1A	1
GO:0046620	regulation of organ growth	1/89	105/21288	0.00952380952380952	2.27800963081862	0.850608246855509	0.356594582802957	0.572315672732558	0.55383411398776	BMPR1A	1
GO:0060395	SMAD protein signal transduction	1/89	105/21288	0.00952380952380952	2.27800963081862	0.850608246855509	0.356594582802957	0.572315672732558	0.55383411398776	BMPR1A	1
GO:0060996	dendritic spine development	1/89	105/21288	0.00952380952380952	2.27800963081862	0.850608246855509	0.356594582802957	0.572315672732558	0.55383411398776	PAK4	1
GO:0050708	regulation of protein secretion	2/89	301/21288	0.00664451827242525	1.58930904475718	0.667184148202408	0.359212276526885	0.572315672732558	0.55383411398776	AACS/SERGEF	2
GO:0018107	peptidyl-threonine phosphorylation	1/89	106/21288	0.00943396226415094	2.2565189739241	0.84029745412178	0.359297839288372	0.572315672732558	0.55383411398776	APP	1
GO:0043266	regulation of potassium ion transport	1/89	106/21288	0.00943396226415094	2.2565189739241	0.84029745412178	0.359297839288372	0.572315672732558	0.55383411398776	KCNC1	1
GO:0048708	astrocyte differentiation	1/89	106/21288	0.00943396226415094	2.2565189739241	0.84029745412178	0.359297839288372	0.572315672732558	0.55383411398776	APP	1
GO:1990542	mitochondrial transmembrane transport	1/89	106/21288	0.00943396226415094	2.2565189739241	0.84029745412178	0.359297839288372	0.572315672732558	0.55383411398776	SFXN5	1
GO:1990874	vascular associated smooth muscle cell proliferation	1/89	106/21288	0.00943396226415094	2.2565189739241	0.84029745412178	0.359297839288372	0.572315672732558	0.55383411398776	BMPR1A	1
GO:2000772	regulation of cellular senescence	1/89	106/21288	0.00943396226415094	2.2565189739241	0.84029745412178	0.359297839288372	0.572315672732558	0.55383411398776	BMPR1A	1
GO:0003018	vascular process in circulatory system	2/89	302/21288	0.00662251655629139	1.58404643202619	0.662339351235877	0.360721640173784	0.57327131643054	0.554758897469982	SLCO3A1/FAAH	2
GO:1901988	negative regulation of cell cycle phase transition	2/89	302/21288	0.00662251655629139	1.58404643202619	0.662339351235877	0.360721640173784	0.57327131643054	0.554758897469982	FOXO4/USP28	2
GO:0033045	regulation of sister chromatid segregation	1/89	107/21288	0.00934579439252336	2.23543001155098	0.830101792923969	0.361989865173715	0.57327131643054	0.554758897469982	DLGAP5	1
GO:0035282	segmentation	1/89	107/21288	0.00934579439252336	2.23543001155098	0.830101792923969	0.361989865173715	0.57327131643054	0.554758897469982	BMPR1A	1
GO:2000628	regulation of miRNA metabolic process	1/89	107/21288	0.00934579439252336	2.23543001155098	0.830101792923969	0.361989865173715	0.57327131643054	0.554758897469982	BMPR1A	1
GO:0061448	connective tissue development	2/89	303/21288	0.0066006600660066	1.5788185560129	0.657512205208357	0.362229740280179	0.57327131643054	0.554758897469982	PGRMC2/BMPR1A	2
GO:0050848	regulation of calcium-mediated signaling	1/89	108/21288	0.00925925925925926	2.2147315855181	0.820018725889759	0.364670706588169	0.576411812737846	0.557797978999121	APP	1
GO:0000245	spliceosomal complex assembly	1/89	109/21288	0.0091743119266055	2.19441294711885	0.810045795443586	0.36734040947361	0.576411812737846	0.557797978999121	SNRPC	1
GO:0003073	regulation of systemic arterial blood pressure	1/89	109/21288	0.0091743119266055	2.19441294711885	0.810045795443586	0.36734040947361	0.576411812737846	0.557797978999121	EMP2	1
GO:0016101	diterpenoid metabolic process	1/89	109/21288	0.0091743119266055	2.19441294711885	0.810045795443586	0.36734040947361	0.576411812737846	0.557797978999121	PECR	1
GO:0019646	aerobic electron transport chain	1/89	109/21288	0.0091743119266055	2.19441294711885	0.810045795443586	0.36734040947361	0.576411812737846	0.557797978999121	NDUFA5	1
GO:0042100	B cell proliferation	1/89	109/21288	0.0091743119266055	2.19441294711885	0.810045795443586	0.36734040947361	0.576411812737846	0.557797978999121	ATAD5	1
GO:0150076	neuroinflammatory response	1/89	109/21288	0.0091743119266055	2.19441294711885	0.810045795443586	0.36734040947361	0.576411812737846	0.557797978999121	APP	1
GO:1990830	cellular response to leukemia inhibitory factor	1/89	109/21288	0.0091743119266055	2.19441294711885	0.810045795443586	0.36734040947361	0.576411812737846	0.557797978999121	SPOCK2	1
GO:0021537	telencephalon development	2/89	307/21288	0.00651465798045603	1.55824763020166	0.638377438740446	0.368249192299483	0.577223760511941	0.558583706871859	KCNC1/TRA2B	2
GO:0000041	transition metal ion transport	1/89	110/21288	0.00909090909090909	2.17446373850868	0.800180620577347	0.369999019585365	0.578123468102133	0.559454360568415	PGRMC2	1
GO:0031110	regulation of microtubule polymerization or depolymerization	1/89	110/21288	0.00909090909090909	2.17446373850868	0.800180620577347	0.369999019585365	0.578123468102133	0.559454360568415	TRIM54	1
GO:0044773	mitotic DNA damage checkpoint signaling	1/89	110/21288	0.00909090909090909	2.17446373850868	0.800180620577347	0.369999019585365	0.578123468102133	0.559454360568415	FOXO4	1
GO:0018108	peptidyl-tyrosine phosphorylation	2/89	309/21288	0.00647249190938511	1.54816188502236	0.62891250330113	0.371250934345857	0.57874304326899	0.560053928044781	ABL2/APP	2
GO:0018209	peptidyl-serine modification	2/89	309/21288	0.00647249190938511	1.54816188502236	0.62891250330113	0.371250934345857	0.57874304326899	0.560053928044781	RPS6KA1/APP	2
GO:0051262	protein tetramerization	1/89	111/21288	0.00900900900900901	2.15487397509869	0.790420893780124	0.372646582492953	0.57874304326899	0.560053928044781	KCNC1	1
GO:1990823	response to leukemia inhibitory factor	1/89	111/21288	0.00900900900900901	2.15487397509869	0.790420893780124	0.372646582492953	0.57874304326899	0.560053928044781	SPOCK2	1
GO:0007548	sex differentiation	2/89	310/21288	0.00645161290322581	1.54316781442552	0.624205196924502	0.372749756681722	0.57874304326899	0.560053928044781	TCF21/BMPR1A	2
GO:0043542	endothelial cell migration	2/89	310/21288	0.00645161290322581	1.54316781442552	0.624205196924502	0.372749756681722	0.57874304326899	0.560053928044781	EMP2/RRAS	2
GO:0018212	peptidyl-tyrosine modification	2/89	311/21288	0.00643086816720257	1.5382058600383	0.619514496863411	0.374247193540332	0.579625797677209	0.560908176021621	ABL2/APP	2
GO:0003279	cardiac septum development	1/89	112/21288	0.00892857142857143	2.13563402889246	0.780764378117751	0.375283143580837	0.579625797677209	0.560908176021621	BMPR1A	1
GO:0009062	fatty acid catabolic process	1/89	112/21288	0.00892857142857143	2.13563402889246	0.780764378117751	0.375283143580837	0.579625797677209	0.560908176021621	FAAH	1
GO:0032732	positive regulation of interleukin-1 production	1/89	112/21288	0.00892857142857143	2.13563402889246	0.780764378117751	0.375283143580837	0.579625797677209	0.560908176021621	APP	1
GO:0045104	intermediate filament cytoskeleton organization	1/89	112/21288	0.00892857142857143	2.13563402889246	0.780764378117751	0.375283143580837	0.579625797677209	0.560908176021621	ARHGEF28	1
GO:0045103	intermediate filament-based process	1/89	113/21288	0.00884955752212389	2.11673461270757	0.771208904453609	0.377908748049165	0.580641045179707	0.561890638546785	ARHGEF28	1
GO:0045995	regulation of embryonic development	1/89	113/21288	0.00884955752212389	2.11673461270757	0.771208904453609	0.377908748049165	0.580641045179707	0.561890638546785	PHLDB1	1
GO:0046330	positive regulation of JNK cascade	1/89	113/21288	0.00884955752212389	2.11673461270757	0.771208904453609	0.377908748049165	0.580641045179707	0.561890638546785	APP	1
GO:0048534	hematopoietic or lymphoid organ development	1/89	113/21288	0.00884955752212389	2.11673461270757	0.771208904453609	0.377908748049165	0.580641045179707	0.561890638546785	TCF21	1
GO:0120162	positive regulation of cold-induced thermogenesis	1/89	113/21288	0.00884955752212389	2.11673461270757	0.771208904453609	0.377908748049165	0.580641045179707	0.561890638546785	SFXN5	1
GO:0044774	mitotic DNA integrity checkpoint signaling	1/89	114/21288	0.0087719298245614	2.09816676522768	0.761752368802661	0.380523440914507	0.584050026377625	0.56518953489246	FOXO4	1
GO:0048562	embryonic organ morphogenesis	2/89	316/21288	0.00632911392405063	1.51386715972123	0.596305790168543	0.381713090226652	0.585002814534815	0.566111555046714	TCF21/BBS5	2
GO:0048024	regulation of mRNA splicing, via spliceosome	1/89	115/21288	0.00869565217391304	2.07992183683439	0.752392729811193	0.383127267010597	0.585002814534815	0.566111555046714	TRA2B	1
GO:0060079	excitatory postsynaptic potential	1/89	115/21288	0.00869565217391304	2.07992183683439	0.752392729811193	0.383127267010597	0.585002814534815	0.566111555046714	APP	1
GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1/89	115/21288	0.00869565217391304	2.07992183683439	0.752392729811193	0.383127267010597	0.585002814534815	0.566111555046714	BMPR1A	1
GO:1901796	regulation of signal transduction by p53 class mediator	1/89	115/21288	0.00869565217391304	2.07992183683439	0.752392729811193	0.383127267010597	0.585002814534815	0.566111555046714	ATAD5	1
GO:0018210	peptidyl-threonine modification	1/89	116/21288	0.00862068965517241	2.06199147617203	0.743128006355268	0.385720270989063	0.587745247633128	0.56876542786121	APP	1
GO:0070252	actin-mediated cell contraction	1/89	116/21288	0.00862068965517241	2.06199147617203	0.743128006355268	0.385720270989063	0.587745247633128	0.56876542786121	EMP2	1
GO:0072659	protein localization to plasma membrane	2/89	319/21288	0.00626959247648903	1.49963016448875	0.582572094796038	0.386175090982561	0.587831020845488	0.568848431233886	DCHS1/EMP2	2
GO:0006754	ATP biosynthetic process	1/89	117/21288	0.00854700854700855	2.04436761740133	0.733956275251307	0.38830249732016	0.589245044801683	0.570216792685874	NDUFA5	1
GO:0042773	ATP synthesis coupled electron transport	1/89	117/21288	0.00854700854700855	2.04436761740133	0.733956275251307	0.38830249732016	0.589245044801683	0.570216792685874	NDUFA5	1
GO:0042775	mitochondrial ATP synthesis coupled electron transport	1/89	117/21288	0.00854700854700855	2.04436761740133	0.733956275251307	0.38830249732016	0.589245044801683	0.570216792685874	NDUFA5	1
GO:0010632	regulation of epithelial cell migration	2/89	321/21288	0.00623052959501558	1.49028667436732	0.573494165840713	0.389142222539799	0.589912413408225	0.570862610227692	EMP2/RRAS	2
GO:0060840	artery development	1/89	118/21288	0.00847457627118644	2.02704246810131	0.724875669072662	0.390873990293496	0.590716327543962	0.571640563889108	BMPR1A	1
GO:0070167	regulation of biomineral tissue development	1/89	118/21288	0.00847457627118644	2.02704246810131	0.724875669072662	0.390873990293496	0.590716327543962	0.571640563889108	BMPR1A	1
GO:0140747	regulation of ncRNA transcription	1/89	118/21288	0.00847457627118644	2.02704246810131	0.724875669072662	0.390873990293496	0.590716327543962	0.571640563889108	BMPR1A	1
GO:0048661	positive regulation of smooth muscle cell proliferation	1/89	119/21288	0.00840336134453781	2.01000849778113	0.715884374066399	0.393434794018762	0.593977810826688	0.574796725410161	BMPR1A	1
GO:0009165	nucleotide biosynthetic process	2/89	325/21288	0.00615384615384615	1.47194468452895	0.555521162948182	0.395057923983955	0.594963209687392	0.57575030318366	NDUFA5/NME1	2
GO:0006626	protein targeting to mitochondrion	1/89	120/21288	0.00833333333333333	1.99325842696629	0.706980628164896	0.395984952426449	0.594963209687392	0.57575030318366	TIMM9	1
GO:0051261	protein depolymerization	1/89	120/21288	0.00833333333333333	1.99325842696629	0.706980628164896	0.395984952426449	0.594963209687392	0.57575030318366	TRIM54	1
GO:0061640	cytoskeleton-dependent cytokinesis	1/89	120/21288	0.00833333333333333	1.99325842696629	0.706980628164896	0.395984952426449	0.594963209687392	0.57575030318366	EXOC7	1
GO:0006874	intracellular calcium ion homeostasis	2/89	326/21288	0.00613496932515337	1.467429516785	0.55106537129792	0.396532907120519	0.594963209687392	0.57575030318366	SLC35G1/APP	2
GO:0015833	peptide transport	2/89	326/21288	0.00613496932515337	1.467429516785	0.55106537129792	0.396532907120519	0.594963209687392	0.57575030318366	AACS/CCDC186	2
GO:0006302	double-strand break repair	2/89	327/21288	0.00611620795107034	1.4629419647459	0.54662434983266	0.398006288108843	0.594963209687392	0.57575030318366	REV3L/TOP3A	2
GO:1901293	nucleoside phosphate biosynthetic process	2/89	327/21288	0.00611620795107034	1.4629419647459	0.54662434983266	0.398006288108843	0.594963209687392	0.57575030318366	NDUFA5/NME1	2
GO:0002062	chondrocyte differentiation	1/89	121/21288	0.00826446280991736	1.97678521682608	0.698162719087187	0.398524509268572	0.594963209687392	0.57575030318366	BMPR1A	1
GO:0046822	regulation of nucleocytoplasmic transport	1/89	121/21288	0.00826446280991736	1.97678521682608	0.698162719087187	0.398524509268572	0.594963209687392	0.57575030318366	PTPN14	1
GO:1902476	chloride transmembrane transport	1/89	121/21288	0.00826446280991736	1.97678521682608	0.698162719087187	0.398524509268572	0.594963209687392	0.57575030318366	CLCC1	1
GO:0006721	terpenoid metabolic process	1/89	122/21288	0.00819672131147541	1.96058205931111	0.689428982525279	0.401053508119381	0.597529216642513	0.578233447113111	PECR	1
GO:0015908	fatty acid transport	1/89	122/21288	0.00819672131147541	1.96058205931111	0.689428982525279	0.401053508119381	0.597529216642513	0.578233447113111	SLCO3A1	1
GO:0051963	regulation of synapse assembly	1/89	123/21288	0.00813008130081301	1.94464236777199	0.680777800410983	0.403571992376084	0.600674761609207	0.581277414267322	APP	1
GO:0030100	regulation of endocytosis	2/89	332/21288	0.00602409638554217	1.44090970624069	0.524637164953708	0.405348731290329	0.601977897244055	0.582538468269715	ABL2/NEU3	2
GO:0008637	apoptotic mitochondrial changes	1/89	124/21288	0.00806451612903226	1.9289597680319	0.672207599259052	0.406080005259549	0.601977897244055	0.582538468269715	SLC35F6	1
GO:0051224	negative regulation of protein transport	1/89	124/21288	0.00806451612903226	1.9289597680319	0.672207599259052	0.406080005259549	0.601977897244055	0.582538468269715	SERGEF	1
GO:0099565	chemical synaptic transmission, postsynaptic	1/89	124/21288	0.00806451612903226	1.9289597680319	0.672207599259052	0.406080005259549	0.601977897244055	0.582538468269715	APP	1
GO:0007229	integrin-mediated signaling pathway	1/89	125/21288	0.008	1.91352808988764	0.663716848582675	0.408577589815016	0.6050722339128	0.585532880774848	EMP2	1
GO:0001708	cell fate specification	1/89	126/21288	0.00793650793650794	1.89834135901552	0.655304059377617	0.411064788912803	0.606320563646384	0.586740898700801	BMPR1A	1
GO:0007088	regulation of mitotic nuclear division	1/89	126/21288	0.00793650793650794	1.89834135901552	0.655304059377617	0.411064788912803	0.606320563646384	0.586740898700801	DLGAP5	1
GO:0010586	miRNA metabolic process	1/89	126/21288	0.00793650793650794	1.89834135901552	0.655304059377617	0.411064788912803	0.606320563646384	0.586740898700801	BMPR1A	1
GO:0060291	long-term synaptic potentiation	1/89	126/21288	0.00793650793650794	1.89834135901552	0.655304059377617	0.411064788912803	0.606320563646384	0.586740898700801	APP	1
GO:0051146	striated muscle cell differentiation	2/89	337/21288	0.00593471810089021	1.41953122395226	0.503003963392204	0.412649314832788	0.608049689688673	0.588414186774552	CACNA1H/BMPR1A	2
GO:0042274	ribosomal small subunit biogenesis	1/89	127/21288	0.0078740157480315	1.88339378925949	0.646967782671506	0.413541645249007	0.608756413914457	0.589098089040502	TSR2	1
GO:0052548	regulation of endopeptidase activity	2/89	338/21288	0.00591715976331361	1.41533142743169	0.498718727882664	0.414104281701686	0.608976884855421	0.589311440402462	RPS6KA1/SPOCK2	2
GO:0051054	positive regulation of DNA metabolic process	2/89	339/21288	0.00589970501474926	1.41115640847171	0.494447073149903	0.415557505944741	0.6093466702936	0.589669284508918	FAF1/ATAD5	2
GO:0003206	cardiac chamber morphogenesis	1/89	128/21288	0.0078125	1.8686797752809	0.638706608134965	0.416008201346207	0.6093466702936	0.589669284508918	BMPR1A	1
GO:0048259	regulation of receptor-mediated endocytosis	1/89	128/21288	0.0078125	1.8686797752809	0.638706608134965	0.416008201346207	0.6093466702936	0.589669284508918	NEU3	1
GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	1/89	128/21288	0.0078125	1.8686797752809	0.638706608134965	0.416008201346207	0.6093466702936	0.589669284508918	ATAD5	1
GO:0001822	kidney development	2/89	340/21288	0.00588235294117647	1.40700594844679	0.490188906438676	0.417008976655065	0.610206587863315	0.59050143310805	TCF21/DCHS1	2
GO:0006672	ceramide metabolic process	1/89	129/21288	0.00775193798449612	1.85419388555004	0.630519162751508	0.418464499554155	0.610465200122374	0.590751694105933	NEU3	1
GO:0008286	insulin receptor signaling pathway	1/89	129/21288	0.00775193798449612	1.85419388555004	0.630519162751508	0.418464499554155	0.610465200122374	0.590751694105933	FOXO4	1
GO:0003231	cardiac ventricle development	1/89	130/21288	0.00769230769230769	1.83993085566119	0.622404109543256	0.420910582050477	0.610465200122374	0.590751694105933	BMPR1A	1
GO:0006664	glycolipid metabolic process	1/89	130/21288	0.00769230769230769	1.83993085566119	0.622404109543256	0.420910582050477	0.610465200122374	0.590751694105933	NEU3	1
GO:0010469	regulation of signaling receptor activity	1/89	130/21288	0.00769230769230769	1.83993085566119	0.622404109543256	0.420910582050477	0.610465200122374	0.590751694105933	APP	1
GO:0032526	response to retinoic acid	1/89	130/21288	0.00769230769230769	1.83993085566119	0.622404109543256	0.420910582050477	0.610465200122374	0.590751694105933	ABL2	1
GO:0032642	regulation of chemokine production	1/89	130/21288	0.00769230769230769	1.83993085566119	0.622404109543256	0.420910582050477	0.610465200122374	0.590751694105933	APP	1
GO:0036503	ERAD pathway	1/89	130/21288	0.00769230769230769	1.83993085566119	0.622404109543256	0.420910582050477	0.610465200122374	0.590751694105933	FAF1	1
GO:0071774	response to fibroblast growth factor	1/89	130/21288	0.00769230769230769	1.83993085566119	0.622404109543256	0.420910582050477	0.610465200122374	0.590751694105933	KCNC1	1
GO:0009101	glycoprotein biosynthetic process	2/89	343/21288	0.00583090379008746	1.39469977397058	0.477494420608991	0.421352760305022	0.610506209675745	0.590791379354369	BACE2/ITM2C	2
GO:0032602	chemokine production	1/89	131/21288	0.00763358778625954	1.82588558195386	0.614360146349724	0.42334649084136	0.610994201556758	0.591263612710768	APP	1
GO:0090277	positive regulation of peptide hormone secretion	1/89	131/21288	0.00763358778625954	1.82588558195386	0.614360146349724	0.42334649084136	0.610994201556758	0.591263612710768	AACS	1
GO:1903509	liposaccharide metabolic process	1/89	131/21288	0.00763358778625954	1.82588558195386	0.614360146349724	0.42334649084136	0.610994201556758	0.591263612710768	NEU3	1
GO:1904035	regulation of epithelial cell apoptotic process	1/89	131/21288	0.00763358778625954	1.82588558195386	0.614360146349724	0.42334649084136	0.610994201556758	0.591263612710768	PAK4	1
GO:0050000	chromosome localization	1/89	132/21288	0.00757575757575758	1.8120531154239	0.606386004657093	0.425772267762243	0.613894520967066	0.594070273278388	DLGAP5	1
GO:0002793	positive regulation of peptide secretion	1/89	133/21288	0.0075187969924812	1.79842865590944	0.59848044847548	0.428187954478502	0.61430574281846	0.594468215708712	AACS	1
GO:0030326	embryonic limb morphogenesis	1/89	133/21288	0.0075187969924812	1.79842865590944	0.59848044847548	0.428187954478502	0.61430574281846	0.594468215708712	BMPR1A	1
GO:0032755	positive regulation of interleukin-6 production	1/89	133/21288	0.0075187969924812	1.79842865590944	0.59848044847548	0.428187954478502	0.61430574281846	0.594468215708712	APP	1
GO:0035113	embryonic appendage morphogenesis	1/89	133/21288	0.0075187969924812	1.79842865590944	0.59848044847548	0.428187954478502	0.61430574281846	0.594468215708712	BMPR1A	1
GO:0071482	cellular response to light stimulus	1/89	133/21288	0.0075187969924812	1.79842865590944	0.59848044847548	0.428187954478502	0.61430574281846	0.594468215708712	USP28	1
GO:0048638	regulation of developmental growth	2/89	348/21288	0.00574712643678161	1.37466098411468	0.45659830905826	0.428556345328946	0.61430574281846	0.594468215708712	BMPR1A/APP	2
GO:0003014	renal system process	1/89	134/21288	0.00746268656716418	1.78500754653698	0.590642273261928	0.430593592486132	0.615521615222999	0.595644824437029	EMP2	1
GO:0072001	renal system development	2/89	350/21288	0.00571428571428571	1.36680577849117	0.448329317113838	0.43142492421273	0.615521615222999	0.595644824437029	TCF21/DCHS1	2
GO:0000018	regulation of DNA recombination	1/89	135/21288	0.00740740740740741	1.77178526841448	0.582870304886895	0.432989223112431	0.615521615222999	0.595644824437029	ATAD5	1
GO:0007265	Ras protein signal transduction	1/89	135/21288	0.00740740740740741	1.77178526841448	0.582870304886895	0.432989223112431	0.615521615222999	0.595644824437029	RRAS	1
GO:0032760	positive regulation of tumor necrosis factor production	1/89	135/21288	0.00740740740740741	1.77178526841448	0.582870304886895	0.432989223112431	0.615521615222999	0.595644824437029	APP	1
GO:0050864	regulation of B cell activation	1/89	135/21288	0.00740740740740741	1.77178526841448	0.582870304886895	0.432989223112431	0.615521615222999	0.595644824437029	ATAD5	1
GO:0051983	regulation of chromosome segregation	1/89	135/21288	0.00740740740740741	1.77178526841448	0.582870304886895	0.432989223112431	0.615521615222999	0.595644824437029	DLGAP5	1
GO:0030278	regulation of ossification	1/89	136/21288	0.00735294117647059	1.75875743555849	0.575163398642188	0.435374887516676	0.615521615222999	0.595644824437029	BMPR1A	1
GO:0030518	intracellular steroid hormone receptor signaling pathway	1/89	136/21288	0.00735294117647059	1.75875743555849	0.575163398642188	0.435374887516676	0.615521615222999	0.595644824437029	TCF21	1
GO:0033135	regulation of peptidyl-serine phosphorylation	1/89	136/21288	0.00735294117647059	1.75875743555849	0.575163398642188	0.435374887516676	0.615521615222999	0.595644824437029	APP	1
GO:0098659	inorganic cation import across plasma membrane	1/89	136/21288	0.00735294117647059	1.75875743555849	0.575163398642188	0.435374887516676	0.615521615222999	0.595644824437029	CACNA1H	1
GO:0099587	inorganic ion import across plasma membrane	1/89	136/21288	0.00735294117647059	1.75875743555849	0.575163398642188	0.435374887516676	0.615521615222999	0.595644824437029	CACNA1H	1
GO:0055074	calcium ion homeostasis	2/89	353/21288	0.0056657223796034	1.35518986535952	0.436019569321506	0.435713775439467	0.615521615222999	0.595644824437029	SLC35G1/APP	2
GO:0001913	T cell mediated cytotoxicity	1/89	137/21288	0.0072992700729927	1.74591979004347	0.567520438288397	0.437750626690797	0.615521615222999	0.595644824437029	EMP2	1
GO:0006690	icosanoid metabolic process	1/89	137/21288	0.0072992700729927	1.74591979004347	0.567520438288397	0.437750626690797	0.615521615222999	0.595644824437029	FAAH	1
GO:0006821	chloride transport	1/89	137/21288	0.0072992700729927	1.74591979004347	0.567520438288397	0.437750626690797	0.615521615222999	0.595644824437029	CLCC1	1
GO:0010595	positive regulation of endothelial cell migration	1/89	137/21288	0.0072992700729927	1.74591979004347	0.567520438288397	0.437750626690797	0.615521615222999	0.595644824437029	RRAS	1
GO:0042177	negative regulation of protein catabolic process	1/89	137/21288	0.0072992700729927	1.74591979004347	0.567520438288397	0.437750626690797	0.615521615222999	0.595644824437029	BANP	1
GO:0043244	regulation of protein-containing complex disassembly	1/89	137/21288	0.0072992700729927	1.74591979004347	0.567520438288397	0.437750626690797	0.615521615222999	0.595644824437029	TRIM54	1
GO:0072655	establishment of protein localization to mitochondrion	1/89	137/21288	0.0072992700729927	1.74591979004347	0.567520438288397	0.437750626690797	0.615521615222999	0.595644824437029	TIMM9	1
GO:0010948	negative regulation of cell cycle process	2/89	355/21288	0.00563380281690141	1.34755499287862	0.427874611308547	0.438563554993301	0.616077374871542	0.596182637163826	FOXO4/USP28	2
GO:0006334	nucleosome assembly	1/89	138/21288	0.0072463768115942	1.73326819736199	0.559940335139945	0.440116481460053	0.617083469727735	0.597156242605395	ASF1B	1
GO:0072329	monocarboxylic acid catabolic process	1/89	138/21288	0.0072463768115942	1.73326819736199	0.559940335139945	0.440116481460053	0.617083469727735	0.597156242605395	FAAH	1
GO:0070588	calcium ion transmembrane transport	2/89	357/21288	0.00560224089635854	1.34000566518742	0.419778139631641	0.441405685265305	0.617942471905799	0.597987505373248	CACNA1H/SLC35G1	2
GO:0031644	regulation of nervous system process	1/89	139/21288	0.00719424460431655	1.72079864198529	0.552422027186043	0.442472492483696	0.617942471905799	0.597987505373248	APP	1
GO:0050684	regulation of mRNA processing	1/89	139/21288	0.00719424460431655	1.72079864198529	0.552422027186043	0.442472492483696	0.617942471905799	0.597987505373248	TRA2B	1
GO:1903557	positive regulation of tumor necrosis factor superfamily cytokine production	1/89	139/21288	0.00719424460431655	1.72079864198529	0.552422027186043	0.442472492483696	0.617942471905799	0.597987505373248	APP	1
GO:0046879	hormone secretion	2/89	358/21288	0.00558659217877095	1.3362626326031	0.415747890099787	0.442823859528427	0.617942471905799	0.597987505373248	AACS/CCDC186	2
GO:0022904	respiratory electron transport chain	1/89	140/21288	0.00714285714285714	1.70850722311396	0.544964478245871	0.444818700255645	0.618969417808562	0.598981288526966	NDUFA5	1
GO:0042116	macrophage activation	1/89	140/21288	0.00714285714285714	1.70850722311396	0.544964478245871	0.444818700255645	0.618969417808562	0.598981288526966	APP	1
GO:0055007	cardiac muscle cell differentiation	1/89	140/21288	0.00714285714285714	1.70850722311396	0.544964478245871	0.444818700255645	0.618969417808562	0.598981288526966	BMPR1A	1
GO:0070372	regulation of ERK1 and ERK2 cascade	2/89	360/21288	0.00555555555555556	1.32883895131086	0.407722977950315	0.445654382452461	0.619547798414119	0.599540991721352	RRAS/APP	2
GO:0042476	odontogenesis	1/89	141/21288	0.00709219858156028	1.69639015060961	0.537566677156413	0.447155145105146	0.619617758426421	0.599608692543249	BMPR1A	1
GO:1904064	positive regulation of cation transmembrane transport	1/89	141/21288	0.00709219858156028	1.69639015060961	0.537566677156413	0.447155145105146	0.619617758426421	0.599608692543249	KCNC1	1
GO:0006605	protein targeting	2/89	362/21288	0.00552486187845304	1.32149729964616	0.399745009152674	0.448477080653939	0.619617758426421	0.599608692543249	VPS8/TIMM9	2
GO:0001824	blastocyst development	1/89	142/21288	0.00704225352112676	1.68444374109828	0.530227636991479	0.449481867197435	0.619617758426421	0.599608692543249	ASF1B	1
GO:0010927	cellular component assembly involved in morphogenesis	1/89	142/21288	0.00704225352112676	1.68444374109828	0.530227636991479	0.449481867197435	0.619617758426421	0.599608692543249	PHLDB1	1
GO:1904950	negative regulation of establishment of protein localization	1/89	142/21288	0.00704225352112676	1.68444374109828	0.530227636991479	0.449481867197435	0.619617758426421	0.599608692543249	SERGEF	1
GO:0002263	cell activation involved in immune response	2/89	363/21288	0.00550964187327824	1.31785681121738	0.395773441457531	0.449885474402529	0.619617758426421	0.599608692543249	ATAD5/APP	2
GO:0052547	regulation of peptidase activity	2/89	363/21288	0.00550964187327824	1.31785681121738	0.395773441457531	0.449885474402529	0.619617758426421	0.599608692543249	RPS6KA1/SPOCK2	2
GO:0007368	determination of left/right symmetry	1/89	143/21288	0.00699300699300699	1.67266441423745	0.522946394310482	0.451798906534399	0.619617758426421	0.599608692543249	BBS5	1
GO:0030048	actin filament-based movement	1/89	143/21288	0.00699300699300699	1.67266441423745	0.522946394310482	0.451798906534399	0.619617758426421	0.599608692543249	EMP2	1
GO:0030282	bone mineralization	1/89	143/21288	0.00699300699300699	1.67266441423745	0.522946394310482	0.451798906534399	0.619617758426421	0.599608692543249	BMPR1A	1
GO:0043393	regulation of protein binding	1/89	143/21288	0.00699300699300699	1.67266441423745	0.522946394310482	0.451798906534399	0.619617758426421	0.599608692543249	APP	1
GO:0006913	nucleocytoplasmic transport	2/89	365/21288	0.00547945205479452	1.31063567800523	0.387864771424829	0.452696309930142	0.619617758426421	0.599608692543249	NXT1/PTPN14	2
GO:0051169	nuclear transport	2/89	365/21288	0.00547945205479452	1.31063567800523	0.387864771424829	0.452696309930142	0.619617758426421	0.599608692543249	NXT1/PTPN14	2
GO:0097193	intrinsic apoptotic signaling pathway	2/89	366/21288	0.00546448087431694	1.3070547062074	0.383927523903924	0.454098735507318	0.619617758426421	0.599608692543249	ATAD5/USP28	2
GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	1/89	144/21288	0.00694444444444444	1.66104868913858	0.515722008435649	0.454106302955228	0.619617758426421	0.599608692543249	TMED1	1
GO:0014902	myotube differentiation	1/89	144/21288	0.00694444444444444	1.66104868913858	0.515722008435649	0.454106302955228	0.619617758426421	0.599608692543249	CACNA1H	1
GO:0022612	gland morphogenesis	1/89	144/21288	0.00694444444444444	1.66104868913858	0.515722008435649	0.454106302955228	0.619617758426421	0.599608692543249	RPS6KA1	1
GO:0070585	protein localization to mitochondrion	1/89	144/21288	0.00694444444444444	1.66104868913858	0.515722008435649	0.454106302955228	0.619617758426421	0.599608692543249	TIMM9	1
GO:0098661	inorganic anion transmembrane transport	1/89	144/21288	0.00694444444444444	1.66104868913858	0.515722008435649	0.454106302955228	0.619617758426421	0.599608692543249	CLCC1	1
GO:0042886	amide transport	2/89	367/21288	0.00544959128065395	1.30349324924226	0.380001572370155	0.455499155659608	0.620457181384504	0.60042100835496	AACS/CCDC186	2
GO:0010212	response to ionizing radiation	1/89	145/21288	0.00689655172413793	1.64959318093762	0.5085535607564	0.456404096137076	0.620457181384504	0.60042100835496	USP28	1
GO:0021987	cerebral cortex development	1/89	145/21288	0.00689655172413793	1.64959318093762	0.5085535607564	0.456404096137076	0.620457181384504	0.60042100835496	TRA2B	1
GO:0051028	mRNA transport	1/89	145/21288	0.00689655172413793	1.64959318093762	0.5085535607564	0.456404096137076	0.620457181384504	0.60042100835496	NXT1	1
GO:0009914	hormone transport	2/89	369/21288	0.00542005420054201	1.29642824518133	0.372183274172181	0.458293948385178	0.62245264628742	0.60235203451614	AACS/CCDC186	2
GO:0007052	mitotic spindle organization	1/89	147/21288	0.00680272108843537	1.62714973629901	0.494380911885115	0.46097103068614	0.625512668134367	0.605313240314149	DLGAP5	1
GO:0008202	steroid metabolic process	2/89	372/21288	0.00537634408602151	1.28597317868793	0.360538794314318	0.462470903714906	0.626287231567265	0.606062791083112	CACNA1H/APP	2
GO:0035270	endocrine system development	1/89	148/21288	0.00675675675675676	1.61615548132402	0.487374977903905	0.463240250603312	0.626287231567265	0.606062791083112	BMPR1A	1
GO:0046165	alcohol biosynthetic process	1/89	148/21288	0.00675675675675676	1.61615548132402	0.487374977903905	0.463240250603312	0.626287231567265	0.606062791083112	CACNA1H	1
GO:1990266	neutrophil migration	1/89	148/21288	0.00675675675675676	1.61615548132402	0.487374977903905	0.463240250603312	0.626287231567265	0.606062791083112	EMP2	1
GO:0060972	left/right pattern formation	1/89	149/21288	0.00671140939597315	1.60530880024131	0.480421515320423	0.465500024382702	0.628766058575537	0.608461570332509	BBS5	1
GO:0006936	muscle contraction	2/89	375/21288	0.00533333333333333	1.27568539325843	0.348992237674307	0.466629400072431	0.629714881159044	0.60937975297175	CACNA1H/GNAO1	2
GO:0045471	response to ethanol	1/89	150/21288	0.00666666666666667	1.59460674157303	0.473519706295545	0.467750390900983	0.630650664148949	0.610285317099715	USP46	1
GO:0001704	formation of primary germ layer	1/89	151/21288	0.00662251655629139	1.58404643202619	0.466668751390777	0.469991388876658	0.633093423372667	0.612649193286948	BMPR1A	1
GO:0048545	response to steroid hormone	2/89	378/21288	0.00529100529100529	1.26556090601034	0.33754180709168	0.470769243770259	0.633562622774756	0.613103241022351	TCF21/PGRMC2	2
GO:0016042	lipid catabolic process	2/89	379/21288	0.00527704485488127	1.26222169517654	0.333746054536547	0.472145014251775	0.634540948241385	0.614049973820031	NEU3/FAAH	2
GO:0030101	natural killer cell activation	1/89	153/21288	0.0065359477124183	1.56333994271866	0.453116294994105	0.474445433287166	0.634540948241385	0.614049973820031	EMP2	1
GO:0031109	microtubule polymerization or depolymerization	1/89	153/21288	0.0065359477124183	1.56333994271866	0.453116294994105	0.474445433287166	0.634540948241385	0.614049973820031	TRIM54	1
GO:0032006	regulation of TOR signaling	1/89	153/21288	0.0065359477124183	1.56333994271866	0.453116294994105	0.474445433287166	0.634540948241385	0.614049973820031	RPS6KA1	1
GO:0033157	regulation of intracellular protein transport	1/89	153/21288	0.0065359477124183	1.56333994271866	0.453116294994105	0.474445433287166	0.634540948241385	0.614049973820031	PTPN14	1
GO:0062013	positive regulation of small molecule metabolic process	1/89	153/21288	0.0065359477124183	1.56333994271866	0.453116294994105	0.474445433287166	0.634540948241385	0.614049973820031	APP	1
GO:0007041	lysosomal transport	1/89	154/21288	0.00649350649350649	1.55318838464906	0.446413281899359	0.476658556373868	0.634540948241385	0.614049973820031	VPS33A	1
GO:0009799	specification of symmetry	1/89	154/21288	0.00649350649350649	1.55318838464906	0.446413281899359	0.476658556373868	0.634540948241385	0.614049973820031	BBS5	1
GO:0009855	determination of bilateral symmetry	1/89	154/21288	0.00649350649350649	1.55318838464906	0.446413281899359	0.476658556373868	0.634540948241385	0.614049973820031	BBS5	1
GO:0010977	negative regulation of neuron projection development	1/89	154/21288	0.00649350649350649	1.55318838464906	0.446413281899359	0.476658556373868	0.634540948241385	0.614049973820031	ITM2C	1
GO:0030879	mammary gland development	1/89	154/21288	0.00649350649350649	1.55318838464906	0.446413281899359	0.476658556373868	0.634540948241385	0.614049973820031	NME1	1
GO:0035264	multicellular organism growth	1/89	154/21288	0.00649350649350649	1.55318838464906	0.446413281899359	0.476658556373868	0.634540948241385	0.614049973820031	APP	1
GO:1990778	protein localization to cell periphery	2/89	383/21288	0.00522193211488251	1.24903922316426	0.31866663909668	0.477627030796176	0.635181775835312	0.614670107427427	DCHS1/EMP2	2
GO:0008033	tRNA processing	1/89	155/21288	0.00645161290322581	1.54316781442552	0.439758098739343	0.47886246422296	0.635181775835312	0.614670107427427	CLP1	1
GO:0021782	glial cell development	1/89	155/21288	0.00645161290322581	1.54316781442552	0.439758098739343	0.47886246422296	0.635181775835312	0.614670107427427	APP	1
GO:1901222	regulation of non-canonical NF-kappaB signal transduction	1/89	155/21288	0.00645161290322581	1.54316781442552	0.439758098739343	0.47886246422296	0.635181775835312	0.614670107427427	APP	1
GO:0070371	ERK1 and ERK2 cascade	2/89	385/21288	0.0051948051948052	1.24255070771925	0.311188218675951	0.48035530939919	0.636589471126509	0.616032344583441	RRAS/APP	2
GO:0008203	cholesterol metabolic process	1/89	156/21288	0.00641025641025641	1.53327571305099	0.433150030409144	0.481057194771588	0.636947362915702	0.616378679117711	APP	1
GO:0010038	response to metal ion	2/89	387/21288	0.00516795865633075	1.23612925703336	0.303750006914046	0.48307503478274	0.637551975902231	0.616963767581392	CACNA1H/KCNC1	2
GO:0006720	isoprenoid metabolic process	1/89	157/21288	0.00636942675159236	1.52350962570672	0.426588377259447	0.483242785802505	0.637551975902231	0.616963767581392	PECR	1
GO:0007498	mesoderm development	1/89	157/21288	0.00636942675159236	1.52350962570672	0.426588377259447	0.483242785802505	0.637551975902231	0.616963767581392	BMPR1A	1
GO:0043467	regulation of generation of precursor metabolites and energy	1/89	157/21288	0.00636942675159236	1.52350962570672	0.426588377259447	0.483242785802505	0.637551975902231	0.616963767581392	APP	1
GO:0001889	liver development	1/89	158/21288	0.00632911392405063	1.51386715972123	0.420072454663783	0.485419274944693	0.637580125903481	0.616991008546027	RPS6KA1	1
GO:0034767	positive regulation of monoatomic ion transmembrane transport	1/89	158/21288	0.00632911392405063	1.51386715972123	0.420072454663783	0.485419274944693	0.637580125903481	0.616991008546027	KCNC1	1
GO:0051783	regulation of nuclear division	1/89	158/21288	0.00632911392405063	1.51386715972123	0.420072454663783	0.485419274944693	0.637580125903481	0.616991008546027	DLGAP5	1
GO:0046942	carboxylic acid transport	2/89	389/21288	0.0051413881748072	1.22977383668871	0.296351527209275	0.485786158617716	0.637580125903481	0.616991008546027	SLCO3A1/SFXN5	2
GO:0050890	cognition	2/89	389/21288	0.0051413881748072	1.22977383668871	0.296351527209275	0.485786158617716	0.637580125903481	0.616991008546027	JAKMIP1/APP	2
GO:0015849	organic acid transport	2/89	390/21288	0.00512820512820513	1.2266205704408	0.292667040191563	0.487138480228807	0.637580125903481	0.616991008546027	SLCO3A1/SFXN5	2
GO:0032611	interleukin-1 beta production	1/89	159/21288	0.00628930817610063	1.50434598261607	0.413601592600577	0.487586699673984	0.637580125903481	0.616991008546027	APP	1
GO:0032651	regulation of interleukin-1 beta production	1/89	159/21288	0.00628930817610063	1.50434598261607	0.413601592600577	0.487586699673984	0.637580125903481	0.616991008546027	APP	1
GO:0046328	regulation of JNK cascade	1/89	159/21288	0.00628930817610063	1.50434598261607	0.413601592600577	0.487586699673984	0.637580125903481	0.616991008546027	APP	1
GO:0170039	proteinogenic amino acid metabolic process	1/89	159/21288	0.00628930817610063	1.50434598261607	0.413601592600577	0.487586699673984	0.637580125903481	0.616991008546027	SEPHS1	1
GO:0034728	nucleosome organization	1/89	160/21288	0.00625	1.49494382022472	0.407175135249418	0.489745097313674	0.63926904295369	0.618625386080431	ASF1B	1
GO:0050714	positive regulation of protein secretion	1/89	160/21288	0.00625	1.49494382022472	0.407175135249418	0.489745097313674	0.63926904295369	0.618625386080431	AACS	1
GO:0042063	gliogenesis	2/89	393/21288	0.00508905852417303	1.2172570546359	0.281671898453708	0.491182415193512	0.639809872069514	0.619148750420168	RRAS/APP	2
GO:0030010	establishment of cell polarity	1/89	161/21288	0.0062111801242236	1.48565845488171	0.400792440600976	0.491894505035138	0.639809872069514	0.619148750420168	ABL2	1
GO:0061008	hepaticobiliary system development	1/89	161/21288	0.0062111801242236	1.48565845488171	0.400792440600976	0.491894505035138	0.639809872069514	0.619148750420168	RPS6KA1	1
GO:0098656	monoatomic anion transmembrane transport	1/89	161/21288	0.0062111801242236	1.48565845488171	0.400792440600976	0.491894505035138	0.639809872069514	0.619148750420168	CLCC1	1
GO:0035107	appendage morphogenesis	1/89	162/21288	0.00617283950617284	1.47648772367873	0.394452880080022	0.494034959858439	0.641407173981668	0.620694471307149	BMPR1A	1
GO:0035108	limb morphogenesis	1/89	162/21288	0.00617283950617284	1.47648772367873	0.394452880080022	0.494034959858439	0.641407173981668	0.620694471307149	BMPR1A	1
GO:0008584	male gonad development	1/89	163/21288	0.00613496932515337	1.467429516785	0.388155838181027	0.496166498652938	0.641407173981668	0.620694471307149	TCF21	1
GO:0009411	response to UV	1/89	163/21288	0.00613496932515337	1.467429516785	0.388155838181027	0.496166498652938	0.641407173981668	0.620694471307149	USP28	1
GO:0035296	regulation of tube diameter	1/89	163/21288	0.00613496932515337	1.467429516785	0.388155838181027	0.496166498652938	0.641407173981668	0.620694471307149	FAAH	1
GO:0060078	regulation of postsynaptic membrane potential	1/89	163/21288	0.00613496932515337	1.467429516785	0.388155838181027	0.496166498652938	0.641407173981668	0.620694471307149	APP	1
GO:0097746	blood vessel diameter maintenance	1/89	163/21288	0.00613496932515337	1.467429516785	0.388155838181027	0.496166498652938	0.641407173981668	0.620694471307149	FAAH	1
GO:0006639	acylglycerol metabolic process	1/89	164/21288	0.00609756097560976	1.45848177582899	0.38190071211585	0.498289158137903	0.64199895290117	0.621267140149143	FAAH	1
GO:0046546	development of primary male sexual characteristics	1/89	164/21288	0.00609756097560976	1.45848177582899	0.38190071211585	0.498289158137903	0.64199895290117	0.621267140149143	TCF21	1
GO:1904019	epithelial cell apoptotic process	1/89	164/21288	0.00609756097560976	1.45848177582899	0.38190071211585	0.498289158137903	0.64199895290117	0.621267140149143	PAK4	1
GO:0006638	neutral lipid metabolic process	1/89	165/21288	0.00606060606060606	1.44964249233912	0.375686911473053	0.500402974883109	0.64199895290117	0.621267140149143	FAAH	1
GO:0007612	learning	1/89	165/21288	0.00606060606060606	1.44964249233912	0.375686911473053	0.500402974883109	0.64199895290117	0.621267140149143	APP	1
GO:0035150	regulation of tube size	1/89	165/21288	0.00606060606060606	1.44964249233912	0.375686911473053	0.500402974883109	0.64199895290117	0.621267140149143	FAAH	1
GO:0090398	cellular senescence	1/89	165/21288	0.00606060606060606	1.44964249233912	0.375686911473053	0.500402974883109	0.64199895290117	0.621267140149143	BMPR1A	1
GO:0120161	regulation of cold-induced thermogenesis	1/89	165/21288	0.00606060606060606	1.44964249233912	0.375686911473053	0.500402974883109	0.64199895290117	0.621267140149143	SFXN5	1
GO:0046651	lymphocyte proliferation	2/89	400/21288	0.005	1.19595505617978	0.256349565802406	0.500541556499217	0.64199895290117	0.621267140149143	ATAD5/EMP2	2
GO:0046887	positive regulation of hormone secretion	1/89	166/21288	0.00602409638554217	1.44090970624069	0.369513857888361	0.502507985309441	0.643294064729474	0.622520429454535	AACS	1
GO:0106106	cold-induced thermogenesis	1/89	166/21288	0.00602409638554217	1.44090970624069	0.369513857888361	0.502507985309441	0.643294064729474	0.622520429454535	SFXN5	1
GO:0010631	epithelial cell migration	2/89	403/21288	0.00496277915632754	1.1870521649427	0.245636312056765	0.504519406939465	0.643294064729474	0.622520429454535	EMP2/RRAS	2
GO:0045598	regulation of fat cell differentiation	1/89	167/21288	0.00598802395209581	1.43228150440692	0.363380984725871	0.504604225689493	0.643294064729474	0.622520429454535	ADIRF	1
GO:0050768	negative regulation of neurogenesis	1/89	167/21288	0.00598802395209581	1.43228150440692	0.363380984725871	0.504604225689493	0.643294064729474	0.622520429454535	BMPR1A	1
GO:0070555	response to interleukin-1	1/89	167/21288	0.00598802395209581	1.43228150440692	0.363380984725871	0.504604225689493	0.643294064729474	0.622520429454535	APP	1
GO:1902652	secondary alcohol metabolic process	1/89	167/21288	0.00598802395209581	1.43228150440692	0.363380984725871	0.504604225689493	0.643294064729474	0.622520429454535	APP	1
GO:0010639	negative regulation of organelle organization	2/89	404/21288	0.00495049504950495	1.18411391700968	0.242083396469044	0.505840893240017	0.644313745707275	0.623507182286577	TRIM54/SLC35F6	2
GO:0090132	epithelium migration	2/89	406/21288	0.00492610837438424	1.17828084352687	0.235004510195092	0.508477142274949	0.646928058170957	0.626037071814321	EMP2/RRAS	2
GO:0098781	ncRNA transcription	1/89	169/21288	0.00591715976331361	1.41533142743169	0.351233569924802	0.508770540663261	0.646928058170957	0.626037071814321	BMPR1A	1
GO:0032943	mononuclear cell proliferation	2/89	407/21288	0.00491400491400491	1.17538580459929	0.231478438133054	0.509791896010906	0.647346584761908	0.626442083095199	ATAD5/EMP2	2
GO:0006367	transcription initiation at RNA polymerase II promoter	1/89	170/21288	0.00588235294117647	1.40700594844679	0.345217950929235	0.510840687066073	0.647346584761908	0.626442083095199	MED4	1
GO:0007605	sensory perception of sound	1/89	170/21288	0.00588235294117647	1.40700594844679	0.345217950929235	0.510840687066073	0.647346584761908	0.626442083095199	TIMM9	1
GO:0009100	glycoprotein metabolic process	2/89	408/21288	0.00490196078431373	1.172504957039	0.227961213233191	0.51110439668603	0.647346584761908	0.626442083095199	BACE2/ITM2C	2
GO:0006119	oxidative phosphorylation	1/89	171/21288	0.00584795321637427	1.39877784348512	0.33924035707308	0.512902207041975	0.647346584761908	0.626442083095199	NDUFA5	1
GO:0007093	mitotic cell cycle checkpoint signaling	1/89	171/21288	0.00584795321637427	1.39877784348512	0.33924035707308	0.512902207041975	0.647346584761908	0.626442083095199	FOXO4	1
GO:0021915	neural tube development	1/89	171/21288	0.00584795321637427	1.39877784348512	0.33924035707308	0.512902207041975	0.647346584761908	0.626442083095199	DCHS1	1
GO:0051092	positive regulation of NF-kappaB transcription factor activity	1/89	171/21288	0.00584795321637427	1.39877784348512	0.33924035707308	0.512902207041975	0.647346584761908	0.626442083095199	SLCO3A1	1
GO:0003205	cardiac chamber development	1/89	172/21288	0.00581395348837209	1.39064541416253	0.333300275928113	0.514955136131016	0.647346584761908	0.626442083095199	BMPR1A	1
GO:0007204	positive regulation of cytosolic calcium ion concentration	1/89	172/21288	0.00581395348837209	1.39064541416253	0.333300275928113	0.514955136131016	0.647346584761908	0.626442083095199	ABL2	1
GO:0016525	negative regulation of angiogenesis	1/89	172/21288	0.00581395348837209	1.39064541416253	0.333300275928113	0.514955136131016	0.647346584761908	0.626442083095199	FOXO4	1
GO:0090130	tissue migration	2/89	411/21288	0.0048661800486618	1.16394652669565	0.217462127032022	0.515028337603438	0.647346584761908	0.626442083095199	EMP2/RRAS	2
GO:0007030	Golgi organization	1/89	173/21288	0.00578034682080925	1.3826070013639	0.327397205085225	0.516999509728494	0.647346584761908	0.626442083095199	TMED1	1
GO:0010821	regulation of mitochondrion organization	1/89	173/21288	0.00578034682080925	1.3826070013639	0.327397205085225	0.516999509728494	0.647346584761908	0.626442083095199	SLC35F6	1
GO:0030509	BMP signaling pathway	1/89	173/21288	0.00578034682080925	1.3826070013639	0.327397205085225	0.516999509728494	0.647346584761908	0.626442083095199	BMPR1A	1
GO:0031929	TOR signaling	1/89	173/21288	0.00578034682080925	1.3826070013639	0.327397205085225	0.516999509728494	0.647346584761908	0.626442083095199	RPS6KA1	1
GO:0051494	negative regulation of cytoskeleton organization	1/89	173/21288	0.00578034682080925	1.3826070013639	0.327397205085225	0.516999509728494	0.647346584761908	0.626442083095199	TRIM54	1
GO:0051961	negative regulation of nervous system development	1/89	173/21288	0.00578034682080925	1.3826070013639	0.327397205085225	0.516999509728494	0.647346584761908	0.626442083095199	BMPR1A	1
GO:0010976	positive regulation of neuron projection development	1/89	174/21288	0.00574712643678161	1.37466098411468	0.32153065190017	0.519035363085546	0.647696413325872	0.626780614786714	ABL2	1
GO:0043433	negative regulation of DNA-binding transcription factor activity	1/89	174/21288	0.00574712643678161	1.37466098411468	0.32153065190017	0.519035363085546	0.647696413325872	0.626780614786714	FAF1	1
GO:0097530	granulocyte migration	1/89	174/21288	0.00574712643678161	1.37466098411468	0.32153065190017	0.519035363085546	0.647696413325872	0.626780614786714	EMP2	1
GO:2000181	negative regulation of blood vessel morphogenesis	1/89	174/21288	0.00574712643678161	1.37466098411468	0.32153065190017	0.519035363085546	0.647696413325872	0.626780614786714	FOXO4	1
GO:0016125	sterol metabolic process	1/89	175/21288	0.00571428571428571	1.36680577849117	0.315700133247211	0.521062731309728	0.648902803039737	0.627948047045055	APP	1
GO:1903531	negative regulation of secretion by cell	1/89	175/21288	0.00571428571428571	1.36680577849117	0.315700133247211	0.521062731309728	0.648902803039737	0.627948047045055	SERGEF	1
GO:0030336	negative regulation of cell migration	2/89	416/21288	0.00480769230769231	1.14995678478825	0.200136038187796	0.521522789982095	0.648902803039737	0.627948047045055	BMPR1A/RRAS	2
GO:1901653	cellular response to peptide	2/89	417/21288	0.00479616306954436	1.14719909465686	0.196696251409676	0.522814827890834	0.648902803039737	0.627948047045055	FOXO4/APP	2
GO:0035051	cardiocyte differentiation	1/89	176/21288	0.00568181818181818	1.35903983656793	0.309905175280373	0.523081649365592	0.648902803039737	0.627948047045055	BMPR1A	1
GO:0170033	L-amino acid metabolic process	1/89	176/21288	0.00568181818181818	1.35903983656793	0.309905175280373	0.523081649365592	0.648902803039737	0.627948047045055	SEPHS1	1
GO:1901343	negative regulation of vasculature development	1/89	176/21288	0.00568181818181818	1.35903983656793	0.309905175280373	0.523081649365592	0.648902803039737	0.627948047045055	FOXO4	1
GO:1902600	proton transmembrane transport	1/89	177/21288	0.00564971751412429	1.35136164540088	0.304145313202031	0.525092152075257	0.650849516227734	0.629831895810746	ATP6V0A1	1
GO:0006865	amino acid transport	1/89	178/21288	0.00561797752808989	1.34376972604469	0.298420091038551	0.527094274118993	0.652782581297661	0.631702537191528	SFXN5	1
GO:0042176	regulation of protein catabolic process	2/89	421/21288	0.00475059382422803	1.13629934078839	0.18302033301742	0.52796001494909	0.653306226551936	0.632209272581214	FAF1/BANP	2
GO:0010970	transport along microtubule	1/89	179/21288	0.00558659217877095	1.3362626326031	0.292729061422757	0.529088050035782	0.654153289021608	0.633028981204853	APP	1
GO:0045667	regulation of osteoblast differentiation	1/89	181/21288	0.00552486187845304	1.32149729964616	0.281447832138293	0.533050700941443	0.657399484856712	0.636170348949654	BMPR1A	1
GO:1902850	microtubule cytoskeleton organization involved in mitosis	1/89	181/21288	0.00552486187845304	1.32149729964616	0.281447832138293	0.533050700941443	0.657399484856712	0.636170348949654	DLGAP5	1
GO:1902904	negative regulation of supramolecular fiber organization	1/89	181/21288	0.00552486187845304	1.32149729964616	0.281447832138293	0.533050700941443	0.657399484856712	0.636170348949654	TRIM54	1
GO:0007519	skeletal muscle tissue development	1/89	182/21288	0.0054945054945055	1.31423632547228	0.275856778900222	0.535019644306971	0.657628312793986	0.636391787438819	TCF21	1
GO:0030307	positive regulation of cell growth	1/89	182/21288	0.0054945054945055	1.31423632547228	0.275856778900222	0.535019644306971	0.657628312793986	0.636391787438819	RPS6KA1	1
GO:0050657	nucleic acid transport	1/89	182/21288	0.0054945054945055	1.31423632547228	0.275856778900222	0.535019644306971	0.657628312793986	0.636391787438819	NXT1	1
GO:0050658	RNA transport	1/89	182/21288	0.0054945054945055	1.31423632547228	0.275856778900222	0.535019644306971	0.657628312793986	0.636391787438819	NXT1	1
GO:0032612	interleukin-1 production	1/89	183/21288	0.00546448087431694	1.3070547062074	0.270298210679867	0.536980378299991	0.658392400658759	0.637131200922946	APP	1
GO:0032652	regulation of interleukin-1 production	1/89	183/21288	0.00546448087431694	1.3070547062074	0.270298210679867	0.536980378299991	0.658392400658759	0.637131200922946	APP	1
GO:0048639	positive regulation of developmental growth	1/89	183/21288	0.00546448087431694	1.3070547062074	0.270298210679867	0.536980378299991	0.658392400658759	0.637131200922946	BMPR1A	1
GO:1990845	adaptive thermogenesis	1/89	184/21288	0.00543478260869565	1.29995114802149	0.264771720101067	0.538932936761555	0.659514127762929	0.638216704547035	SFXN5	1
GO:0010634	positive regulation of epithelial cell migration	1/89	185/21288	0.00540540540540541	1.29292438505922	0.259276907218912	0.54087735339481	0.659514127762929	0.638216704547035	RRAS	1
GO:0015698	inorganic anion transport	1/89	185/21288	0.00540540540540541	1.29292438505922	0.259276907218912	0.54087735339481	0.659514127762929	0.638216704547035	CLCC1	1
GO:0050905	neuromuscular process	1/89	185/21288	0.00540540540540541	1.29292438505922	0.259276907218912	0.54087735339481	0.659514127762929	0.638216704547035	APP	1
GO:0051236	establishment of RNA localization	1/89	185/21288	0.00540540540540541	1.29292438505922	0.259276907218912	0.54087735339481	0.659514127762929	0.638216704547035	NXT1	1
GO:0050678	regulation of epithelial cell proliferation	2/89	432/21288	0.00462962962962963	1.10736579275905	0.146078683240858	0.541918359939034	0.659514127762929	0.638216704547035	NME1/BMPR1A	2
GO:2000146	negative regulation of cell motility	2/89	432/21288	0.00462962962962963	1.10736579275905	0.146078683240858	0.541918359939034	0.659514127762929	0.638216704547035	BMPR1A/RRAS	2
GO:0006665	sphingolipid metabolic process	1/89	186/21288	0.00537634408602151	1.28597317868793	0.253813379343578	0.542813661765557	0.659514127762929	0.638216704547035	NEU3	1
GO:0007584	response to nutrient	1/89	186/21288	0.00537634408602151	1.28597317868793	0.253813379343578	0.542813661765557	0.659514127762929	0.638216704547035	F5	1
GO:0071772	response to BMP	1/89	186/21288	0.00537634408602151	1.28597317868793	0.253813379343578	0.542813661765557	0.659514127762929	0.638216704547035	BMPR1A	1
GO:0071773	cellular response to BMP stimulus	1/89	186/21288	0.00537634408602151	1.28597317868793	0.253813379343578	0.542813661765557	0.659514127762929	0.638216704547035	BMPR1A	1
GO:0008037	cell recognition	1/89	187/21288	0.0053475935828877	1.27909631676981	0.248380750869277	0.544741895302798	0.661312177425207	0.639956690518167	APP	1
GO:0006820	monoatomic anion transport	1/89	188/21288	0.00531914893617021	1.27229261295721	0.242978643108148	0.546662087299294	0.66200868535834	0.640630706402076	CLCC1	1
GO:0038061	non-canonical NF-kappaB signal transduction	1/89	188/21288	0.00531914893617021	1.27229261295721	0.242978643108148	0.546662087299294	0.66200868535834	0.640630706402076	APP	1
GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1/89	188/21288	0.00531914893617021	1.27229261295721	0.242978643108148	0.546662087299294	0.66200868535834	0.640630706402076	RPS6KA1	1
GO:0007338	single fertilization	1/89	189/21288	0.00529100529100529	1.26556090601034	0.237606684128918	0.548574270912107	0.663779368002754	0.642344209107393	CACNA1H	1
GO:0001701	in utero embryonic development	2/89	441/21288	0.00453514739229025	1.08476649086601	0.116551069285462	0.553128450684615	0.668741364557219	0.647145969912285	BMPR1A/ASF1B	2
GO:0035265	organ growth	1/89	192/21288	0.00520833333333333	1.24578651685393	0.221668078658469	0.554263100995123	0.669136092510528	0.647527951075308	BMPR1A	1
GO:0006979	response to oxidative stress	2/89	442/21288	0.00452488687782805	1.082312268036	0.113307558679736	0.554362240710417	0.669136092510528	0.647527951075308	FOXO4/APP	2
GO:0050796	regulation of insulin secretion	1/89	193/21288	0.00518134715025907	1.239331664435	0.216413125232912	0.556143579949021	0.669768474161528	0.6481399114812	AACS	1
GO:0022900	electron transport chain	1/89	194/21288	0.00515463917525773	1.23294335688637	0.21118655694906	0.558016214288179	0.669768474161528	0.6481399114812	NDUFA5	1
GO:0050729	positive regulation of inflammatory response	1/89	194/21288	0.00515463917525773	1.23294335688637	0.21118655694906	0.558016214288179	0.669768474161528	0.6481399114812	APP	1
GO:0071478	cellular response to radiation	1/89	194/21288	0.00515463917525773	1.23294335688637	0.21118655694906	0.558016214288179	0.669768474161528	0.6481399114812	USP28	1
GO:1902903	regulation of supramolecular fiber organization	2/89	445/21288	0.00449438202247191	1.07501578083575	0.103620831127571	0.558049423940356	0.669768474161528	0.6481399114812	TRIM54/APP	2
GO:0006109	regulation of carbohydrate metabolic process	1/89	195/21288	0.00512820512820513	1.2266205704408	0.20598803927469	0.559881036366891	0.669768474161528	0.6481399114812	APP	1
GO:0007009	plasma membrane organization	1/89	195/21288	0.00512820512820513	1.2266205704408	0.20598803927469	0.559881036366891	0.669768474161528	0.6481399114812	EMP2	1
GO:0007565	female pregnancy	1/89	195/21288	0.00512820512820513	1.2266205704408	0.20598803927469	0.559881036366891	0.669768474161528	0.6481399114812	EMP2	1
GO:0015718	monocarboxylic acid transport	1/89	195/21288	0.00512820512820513	1.2266205704408	0.20598803927469	0.559881036366891	0.669768474161528	0.6481399114812	SLCO3A1	1
GO:0048660	regulation of smooth muscle cell proliferation	1/89	195/21288	0.00512820512820513	1.2266205704408	0.20598803927469	0.559881036366891	0.669768474161528	0.6481399114812	BMPR1A	1
GO:0060538	skeletal muscle organ development	1/89	195/21288	0.00512820512820513	1.2266205704408	0.20598803927469	0.559881036366891	0.669768474161528	0.6481399114812	TCF21	1
GO:0007018	microtubule-based movement	2/89	449/21288	0.0044543429844098	1.06543880283276	0.0908060165709496	0.562932494206363	0.672022129700197	0.650320790632269	DLGAP5/APP	2
GO:0070661	leukocyte proliferation	2/89	449/21288	0.0044543429844098	1.06543880283276	0.0908060165709496	0.562932494206363	0.672022129700197	0.650320790632269	ATAD5/EMP2	2
GO:0000910	cytokinesis	1/89	197/21288	0.0050761421319797	1.21416756972566	0.195673846237035	0.563587372501114	0.672022129700197	0.650320790632269	EXOC7	1
GO:0097553	calcium ion transmembrane import into cytosol	1/89	197/21288	0.0050761421319797	1.21416756972566	0.195673846237035	0.563587372501114	0.672022129700197	0.650320790632269	CACNA1H	1
GO:0050671	positive regulation of lymphocyte proliferation	1/89	198/21288	0.00505050505050505	1.2080354102826	0.190557530038888	0.565428950607766	0.673673426612646	0.651918762880819	ATAD5	1
GO:0043484	regulation of RNA splicing	1/89	199/21288	0.0050251256281407	1.20196488058269	0.185467982533964	0.567262844557311	0.673681719582958	0.651926788049593	TRA2B	1
GO:0048659	smooth muscle cell proliferation	1/89	199/21288	0.0050251256281407	1.20196488058269	0.185467982533964	0.567262844557311	0.673681719582958	0.651926788049593	BMPR1A	1
GO:0048736	appendage development	1/89	199/21288	0.0050251256281407	1.20196488058269	0.185467982533964	0.567262844557311	0.673681719582958	0.651926788049593	BMPR1A	1
GO:0060173	limb development	1/89	199/21288	0.0050251256281407	1.20196488058269	0.185467982533964	0.567262844557311	0.673681719582958	0.651926788049593	BMPR1A	1
GO:0007219	Notch signaling pathway	1/89	200/21288	0.005	1.19595505617978	0.180404896679799	0.569089086049767	0.674222009577034	0.652449630677222	APP	1
GO:0007254	JNK cascade	1/89	200/21288	0.005	1.19595505617978	0.180404896679799	0.569089086049767	0.674222009577034	0.652449630677222	APP	1
GO:0031214	biomineral tissue development	1/89	200/21288	0.005	1.19595505617978	0.180404896679799	0.569089086049767	0.674222009577034	0.652449630677222	BMPR1A	1
GO:0032946	positive regulation of mononuclear cell proliferation	1/89	201/21288	0.00497512437810945	1.19000503102465	0.175367970573572	0.570907706655874	0.675291794159915	0.653484869138872	ATAD5	1
GO:0050954	sensory perception of mechanical stimulus	1/89	201/21288	0.00497512437810945	1.19000503102465	0.175367970573572	0.570907706655874	0.675291794159915	0.653484869138872	TIMM9	1
GO:0043534	blood vessel endothelial cell migration	1/89	203/21288	0.00492610837438424	1.17828084352687	0.165371415022927	0.574522210848736	0.678468895377588	0.6565593735108	EMP2	1
GO:0045664	regulation of neuron differentiation	1/89	203/21288	0.00492610837438424	1.17828084352687	0.165371415022927	0.574522210848736	0.678468895377588	0.6565593735108	APP	1
GO:0045786	negative regulation of cell cycle	2/89	459/21288	0.00435729847494553	1.04222662847911	0.0592588318305922	0.574973640150498	0.678468895377588	0.6565593735108	FOXO4/USP28	2
GO:0051048	negative regulation of secretion	1/89	204/21288	0.00490196078431373	1.172504957039	0.160411206478074	0.576318156935265	0.679511815731028	0.657568615258714	SERGEF	1
GO:0008217	regulation of blood pressure	1/89	205/21288	0.0048780487804878	1.1667854206632	0.155475999270903	0.578106607136022	0.680456800926909	0.658483084429537	EMP2	1
GO:0019827	stem cell population maintenance	1/89	205/21288	0.0048780487804878	1.1667854206632	0.155475999270903	0.578106607136022	0.680456800926909	0.658483084429537	BMPR1A	1
GO:0060537	muscle tissue development	2/89	462/21288	0.00432900432900433	1.03545892309937	0.0499273072271124	0.578539439483096	0.680456800926909	0.658483084429537	TCF21/BMPR1A	2
GO:0001659	temperature homeostasis	1/89	206/21288	0.00485436893203883	1.16112141376677	0.150565515575469	0.579887592383135	0.680456800926909	0.658483084429537	SFXN5	1
GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules	1/89	206/21288	0.00485436893203883	1.16112141376677	0.150565515575469	0.579887592383135	0.680456800926909	0.658483084429537	DCHS1	1
GO:2001242	regulation of intrinsic apoptotic signaling pathway	1/89	206/21288	0.00485436893203883	1.16112141376677	0.150565515575469	0.579887592383135	0.680456800926909	0.658483084429537	ATAD5	1
GO:0000070	mitotic sister chromatid segregation	1/89	207/21288	0.00483091787439614	1.15551213157466	0.145679482076606	0.581661143482552	0.680867137902335	0.658880170558834	DLGAP5	1
GO:0002377	immunoglobulin production	1/89	207/21288	0.00483091787439614	1.15551213157466	0.145679482076606	0.581661143482552	0.680867137902335	0.658880170558834	ATAD5	1
GO:0048839	inner ear development	1/89	207/21288	0.00483091787439614	1.15551213157466	0.145679482076606	0.581661143482552	0.680867137902335	0.658880170558834	DCHS1	1
GO:0001558	regulation of cell growth	2/89	465/21288	0.0043010752688172	1.02877854295034	0.0406553940509953	0.582083702301589	0.680867137902335	0.658880170558834	RPS6KA1/PAK4	2
GO:0071897	DNA biosynthetic process	1/89	208/21288	0.00480769230769231	1.14995678478825	0.140817629874538	0.583427291114545	0.68189798287952	0.659877726875739	REV3L	1
GO:0051251	positive regulation of lymphocyte activation	2/89	467/21288	0.00428265524625268	1.02437263912615	0.034506805213504	0.584434567329713	0.682216556072692	0.66018601251352	ABL2/ATAD5	2
GO:0031345	negative regulation of cell projection organization	1/89	209/21288	0.00478468899521531	1.1444545992151	0.135979694391971	0.585186065834223	0.682216556072692	0.66018601251352	ITM2C	1
GO:0098727	maintenance of cell number	1/89	209/21288	0.00478468899521531	1.1444545992151	0.135979694391971	0.585186065834223	0.682216556072692	0.66018601251352	BMPR1A	1
GO:0006006	glucose metabolic process	1/89	210/21288	0.00476190476190476	1.13900481540931	0.131165415283585	0.586937498072031	0.682216556072692	0.66018601251352	HKDC1	1
GO:0044409	symbiont entry into host	1/89	210/21288	0.00476190476190476	1.13900481540931	0.131165415283585	0.586937498072031	0.682216556072692	0.66018601251352	EXOC7	1
GO:0071466	cellular response to xenobiotic stimulus	1/89	210/21288	0.00476190476190476	1.13900481540931	0.131165415283585	0.586937498072031	0.682216556072692	0.66018601251352	KCNC1	1
GO:1902905	positive regulation of supramolecular fiber organization	1/89	210/21288	0.00476190476190476	1.13900481540931	0.131165415283585	0.586937498072031	0.682216556072692	0.66018601251352	APP	1
GO:0002702	positive regulation of production of molecular mediator of immune response	1/89	211/21288	0.004739336492891	1.13360668832206	0.126374536347848	0.588681618134257	0.682587274181112	0.660544759171873	ATAD5	1
GO:0050806	positive regulation of synaptic transmission	1/89	211/21288	0.004739336492891	1.13360668832206	0.126374536347848	0.588681618134257	0.682587274181112	0.660544759171873	APP	1
GO:1901991	negative regulation of mitotic cell cycle phase transition	1/89	211/21288	0.004739336492891	1.13360668832206	0.126374536347848	0.588681618134257	0.682587274181112	0.660544759171873	FOXO4	1
GO:0040013	negative regulation of locomotion	2/89	471/21288	0.00424628450106157	1.01567308380448	0.0222869369383334	0.5891075254458	0.682587274181112	0.660544759171873	BMPR1A/RRAS	2
GO:0006352	DNA-templated transcription initiation	1/89	212/21288	0.00471698113207547	1.12825948696205	0.121606805441083	0.590418456203529	0.683033116000161	0.660976203601226	MED4	1
GO:0006694	steroid biosynthetic process	1/89	212/21288	0.00471698113207547	1.12825948696205	0.121606805441083	0.590418456203529	0.683033116000161	0.660976203601226	CACNA1H	1
GO:0071248	cellular response to metal ion	1/89	213/21288	0.00469483568075117	1.12296249406552	0.116861974393725	0.592148042339318	0.684497149255873	0.662392959422633	CACNA1H	1
GO:0006816	calcium ion transport	2/89	475/21288	0.00421052631578947	1.00712004730928	0.0101684998836694	0.593742088418266	0.685802333920864	0.663655996286666	CACNA1H/SLC35G1	2
GO:0051260	protein homooligomerization	1/89	216/21288	0.00462962962962963	1.10736579275905	0.102762456624355	0.59729358790351	0.6893646652251	0.667103290665645	KCNC1	1
GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1/89	217/21288	0.00460829493087558	1.10226272458965	0.0981068199871453	0.598994464454221	0.690247527398419	0.667957642927569	ATAD5	1
GO:0032869	cellular response to insulin stimulus	1/89	217/21288	0.00460829493087558	1.10226272458965	0.0981068199871453	0.598994464454221	0.690247527398419	0.667957642927569	FOXO4	1
GO:0099504	synaptic vesicle cycle	1/89	218/21288	0.00458715596330275	1.09720647355943	0.0934728991870829	0.600688237538725	0.690904378942183	0.668593283029867	ATP6V0A1	1
GO:0003012	muscle system process	2/89	482/21288	0.004149377593361	0.99249382255583	-0.0108004685053898	0.601760105201733	0.690904378942183	0.668593283029867	CACNA1H/GNAO1	2
GO:0002456	T cell mediated immunity	1/89	219/21288	0.0045662100456621	1.09219639833769	0.0888604682550694	0.602374936487897	0.690904378942183	0.668593283029867	EMP2	1
GO:0021543	pallium development	1/89	219/21288	0.0045662100456621	1.09219639833769	0.0888604682550694	0.602374936487897	0.690904378942183	0.668593283029867	TRA2B	1
GO:0034764	positive regulation of transmembrane transport	1/89	219/21288	0.0045662100456621	1.09219639833769	0.0888604682550694	0.602374936487897	0.690904378942183	0.668593283029867	KCNC1	1
GO:0055001	muscle cell development	1/89	219/21288	0.0045662100456621	1.09219639833769	0.0888604682550694	0.602374936487897	0.690904378942183	0.668593283029867	BMPR1A	1
GO:0048469	cell maturation	1/89	220/21288	0.00454545454545455	1.08723186925434	0.0842693046658777	0.60405459051289	0.692292557114618	0.669936633325546	APP	1
GO:0070665	positive regulation of leukocyte proliferation	1/89	221/21288	0.00452488687782805	1.082312268036	0.0796991892697122	0.605727228705616	0.692637679813941	0.670270611117006	ATAD5	1
GO:0099111	microtubule-based transport	1/89	221/21288	0.00452488687782805	1.082312268036	0.0796991892697122	0.605727228705616	0.692637679813941	0.670270611117006	APP	1
GO:0007059	chromosome segregation	2/89	486/21288	0.00411522633744856	0.984325149119157	-0.0226497572888572	0.606288967305765	0.692637679813941	0.670270611117006	DLGAP5/TOP3A	2
GO:0044703	multi-organism reproductive process	1/89	222/21288	0.0045045045045045	1.07743698754935	0.0751499062254382	0.607392880039228	0.692637679813941	0.670270611117006	EMP2	1
GO:0051216	cartilage development	1/89	222/21288	0.0045045045045045	1.07743698754935	0.0751499062254382	0.607392880039228	0.692637679813941	0.670270611117006	BMPR1A	1
GO:0098739	import across plasma membrane	1/89	222/21288	0.0045045045045045	1.07743698754935	0.0751499062254382	0.607392880039228	0.692637679813941	0.670270611117006	CACNA1H	1
GO:0002821	positive regulation of adaptive immune response	1/89	223/21288	0.00448430493273543	1.07260543155137	0.0706212429354337	0.609051573368598	0.692637679813941	0.670270611117006	ATAD5	1
GO:0008016	regulation of heart contraction	1/89	223/21288	0.00448430493273543	1.07260543155137	0.0706212429354337	0.609051573368598	0.692637679813941	0.670270611117006	CACNA1H	1
GO:0032635	interleukin-6 production	1/89	223/21288	0.00448430493273543	1.07260543155137	0.0706212429354337	0.609051573368598	0.692637679813941	0.670270611117006	APP	1
GO:0032675	regulation of interleukin-6 production	1/89	223/21288	0.00448430493273543	1.07260543155137	0.0706212429354337	0.609051573368598	0.692637679813941	0.670270611117006	APP	1
GO:0072594	establishment of protein localization to organelle	2/89	489/21288	0.00408997955010225	0.978286344523334	-0.031474634156709	0.609660383706296	0.692795890575337	0.670423712842217	VPS8/TIMM9	2
GO:0009060	aerobic respiration	1/89	224/21288	0.00446428571428571	1.06781701444623	0.0661129899820149	0.610703337430796	0.693446822717801	0.671053624696049	NDUFA5	1
GO:0010975	regulation of neuron projection development	2/89	491/21288	0.00407331975560081	0.974301471429552	-0.0373287290572054	0.611895982533845	0.693712439513983	0.671310664036368	ABL2/ITM2C	2
GO:0044706	multi-multicellular organism process	1/89	225/21288	0.00444444444444444	1.06307116104869	0.0616249410653925	0.612348200845563	0.693712439513983	0.671310664036368	EMP2	1
GO:2000116	regulation of cysteine-type endopeptidase activity	1/89	225/21288	0.00444444444444444	1.06307116104869	0.0616249410653925	0.612348200845563	0.693712439513983	0.671310664036368	RPS6KA1	1
GO:0007051	spindle organization	1/89	226/21288	0.00442477876106195	1.05836730635378	0.0571568929431137	0.613986192115788	0.694501252584959	0.672074004285605	DLGAP5	1
GO:2000241	regulation of reproductive process	1/89	226/21288	0.00442477876106195	1.05836730635378	0.0571568929431137	0.613986192115788	0.694501252584959	0.672074004285605	CACNA1H	1
GO:0042060	wound healing	2/89	494/21288	0.00404858299595142	0.968384660874312	-0.0460666727111038	0.615231368035145	0.694747954056055	0.672312739125788	FGFR1OP2/F5	2
GO:0006403	RNA localization	1/89	227/21288	0.00440528634361234	1.05370489531258	0.0527086453709489	0.615617339627975	0.694747954056055	0.672312739125788	NXT1	1
GO:0031334	positive regulation of protein-containing complex assembly	1/89	227/21288	0.00440528634361234	1.05370489531258	0.0527086453709489	0.615617339627975	0.694747954056055	0.672312739125788	FAF1	1
GO:0043270	positive regulation of monoatomic ion transport	1/89	228/21288	0.0043859649122807	1.04908338261384	0.048280001045182	0.617241671652718	0.695212486573575	0.672762270682439	KCNC1	1
GO:1901654	response to ketone	1/89	228/21288	0.0043859649122807	1.04908338261384	0.048280001045182	0.617241671652718	0.695212486573575	0.672762270682439	F5	1
GO:0015711	organic anion transport	2/89	496/21288	0.00403225806451613	0.964479884015948	-0.0518634766496972	0.617442954177209	0.695212486573575	0.672762270682439	SLCO3A1/SFXN5	2
GO:0071805	potassium ion transmembrane transport	1/89	229/21288	0.00436681222707424	1.04450223247142	0.0438707655462641	0.618859216345164	0.69627562479719	0.673791077413017	KCNC1	1
GO:0001503	ossification	2/89	499/21288	0.00400801603206413	0.958681407759339	-0.0605164627991534	0.620742336387932	0.69786200165564	0.675326226044637	DCHS1/BMPR1A	2
GO:0060348	bone development	1/89	231/21288	0.00432900432900433	1.03545892309937	0.0351097574427862	0.622074055779324	0.698294697316973	0.675744948839832	DCHS1	1
GO:0090276	regulation of peptide hormone secretion	1/89	231/21288	0.00432900432900433	1.03545892309937	0.0351097574427862	0.622074055779324	0.698294697316973	0.675744948839832	AACS	1
GO:0009952	anterior/posterior pattern specification	1/89	233/21288	0.00429184549356223	1.02657086367363	0.0264241213286599	0.625262080880395	0.701339596424778	0.678691520251204	BMPR1A	1
GO:0002791	regulation of peptide secretion	1/89	234/21288	0.00427350427350427	1.02218380870066	0.0221091108364191	0.626846107230509	0.702048601492028	0.679377629704329	AACS	1
GO:1901605	alpha-amino acid metabolic process	1/89	234/21288	0.00427350427350427	1.02218380870066	0.0221091108364191	0.626846107230509	0.702048601492028	0.679377629704329	SEPHS1	1
GO:0016064	immunoglobulin mediated immune response	1/89	236/21288	0.00423728813559322	1.01352123405066	0.0135338138034296	0.629994324891338	0.703970931223276	0.681237882418385	ATAD5	1
GO:0042180	cellular ketone metabolic process	1/89	236/21288	0.00423728813559322	1.01352123405066	0.0135338138034296	0.629994324891338	0.703970931223276	0.681237882418385	CACNA1H	1
GO:0090087	regulation of peptide transport	1/89	236/21288	0.00423728813559322	1.01352123405066	0.0135338138034296	0.629994324891338	0.703970931223276	0.681237882418385	AACS	1
GO:0007163	establishment or maintenance of cell polarity	1/89	237/21288	0.00421940928270042	1.00924477314749	0.00927317833849466	0.631558570810238	0.705184626756322	0.682412384572041	ABL2	1
GO:0006399	tRNA metabolic process	1/89	238/21288	0.00420168067226891	1.00500424889057	0.00503032304312817	0.63311627767442	0.705855260445782	0.683061361758773	CLP1	1
GO:0007601	visual perception	1/89	238/21288	0.00420168067226891	1.00500424889057	0.00503032304312817	0.63311627767442	0.705855260445782	0.683061361758773	BBS5	1
GO:0009612	response to mechanical stimulus	1/89	239/21288	0.00418410041841004	1.00079921019228	0.00080507951478018	0.634667472509906	0.705983802377158	0.683185752737503	KCNC1	1
GO:0032412	regulation of monoatomic ion transmembrane transporter activity	1/89	239/21288	0.00418410041841004	1.00079921019228	0.00080507951478018	0.634667472509906	0.705983802377158	0.683185752737503	APP	1
GO:1903828	negative regulation of protein localization	1/89	239/21288	0.00418410041841004	1.00079921019228	0.00080507951478018	0.634667472509906	0.705983802377158	0.683185752737503	SERGEF	1
GO:0006470	protein dephosphorylation	1/89	240/21288	0.00416666666666667	0.996629213483146	-0.00340271830478782	0.636212182232297	0.706636271681203	0.683817152113978	PTPN14	1
GO:0048167	regulation of synaptic plasticity	1/89	240/21288	0.00416666666666667	0.996629213483146	-0.00340271830478782	0.636212182232297	0.706636271681203	0.683817152113978	APP	1
GO:0043583	ear development	1/89	241/21288	0.004149377593361	0.99249382255583	-0.00759323417213134	0.637750433647221	0.707382838589567	0.684539610438861	DCHS1	1
GO:0009566	fertilization	1/89	242/21288	0.00413223140495868	0.988392608413038	-0.0117666295838005	0.639282253450775	0.707382838589567	0.684539610438861	CACNA1H	1
GO:0032640	tumor necrosis factor production	1/89	242/21288	0.00413223140495868	0.988392608413038	-0.0117666295838005	0.639282253450775	0.707382838589567	0.684539610438861	APP	1
GO:0032680	regulation of tumor necrosis factor production	1/89	242/21288	0.00413223140495868	0.988392608413038	-0.0117666295838005	0.639282253450775	0.707382838589567	0.684539610438861	APP	1
GO:0050953	sensory perception of light stimulus	1/89	242/21288	0.00413223140495868	0.988392608413038	-0.0117666295838005	0.639282253450775	0.707382838589567	0.684539610438861	BBS5	1
GO:0099003	vesicle-mediated transport in synapse	1/89	243/21288	0.00411522633744856	0.984325149119157	-0.0159230638170888	0.640807668229967	0.708539213372715	0.685658642878431	ATP6V0A1	1
GO:0071241	cellular response to inorganic substance	1/89	244/21288	0.0040983606557377	0.980291029655554	-0.02006269396988	0.64232670446316	0.709686808301993	0.686769178988405	CACNA1H	1
GO:0045732	positive regulation of protein catabolic process	1/89	245/21288	0.00408163265306122	0.976289841779408	-0.0241856749996149	0.643839388520505	0.710825672206396	0.687871266020962	FAF1	1
GO:0006643	membrane lipid metabolic process	1/89	246/21288	0.0040650406504065	0.972321183885996	-0.0282921597614016	0.645345746664386	0.711482149476901	0.688506543936255	NEU3	1
GO:0019724	B cell mediated immunity	1/89	247/21288	0.00404858299595142	0.968384660874312	-0.032382299045293	0.646845805049847	0.711482149476901	0.688506543936255	ATAD5	1
GO:0022898	regulation of transmembrane transporter activity	1/89	247/21288	0.00404858299595142	0.968384660874312	-0.032382299045293	0.646845805049847	0.711482149476901	0.688506543936255	APP	1
GO:0071706	tumor necrosis factor superfamily cytokine production	1/89	247/21288	0.00404858299595142	0.968384660874312	-0.032382299045293	0.646845805049847	0.711482149476901	0.688506543936255	APP	1
GO:1903555	regulation of tumor necrosis factor superfamily cytokine production	1/89	247/21288	0.00404858299595142	0.968384660874312	-0.032382299045293	0.646845805049847	0.711482149476901	0.688506543936255	APP	1
GO:1901888	regulation of cell junction assembly	1/89	248/21288	0.00403225806451613	0.964479884015948	-0.0364562416127507	0.648339589725031	0.71259381135948	0.689582307370886	APP	1
GO:0006364	rRNA processing	1/89	249/21288	0.00401606425702811	0.960606470827129	-0.0405141342323173	0.649827126631613	0.713696955905904	0.690649828516258	TSR2	1
GO:0000819	sister chromatid segregation	1/89	250/21288	0.004	0.95676404494382	-0.0445561217145182	0.651308441605223	0.713729532962633	0.690681353575258	DLGAP5	1
GO:0006457	protein folding	1/89	250/21288	0.004	0.95676404494382	-0.0445561217145182	0.651308441605223	0.713729532962633	0.690681353575258	PPIL3	1
GO:0051701	biological process involved in interaction with host	1/89	250/21288	0.004	0.95676404494382	-0.0445561217145182	0.651308441605223	0.713729532962633	0.690681353575258	EXOC7	1
GO:0019318	hexose metabolic process	1/89	251/21288	0.00398406374501992	0.952952235999821	-0.048582346946011	0.652783560375882	0.714814960322514	0.691731729668032	HKDC1	1
GO:0008406	gonad development	1/89	252/21288	0.00396825396825397	0.949170679507758	-0.0525929509230041	0.654252508568427	0.715892025325244	0.692774013445874	TCF21	1
GO:0002285	lymphocyte activation involved in immune response	1/89	253/21288	0.00395256916996047	0.945419016742905	-0.05658807278396	0.65571531170293	0.716960774471328	0.693808249907669	ATAD5	1
GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1/89	254/21288	0.00393700787401575	0.941696894629744	-0.0605678498416038	0.65717199519513	0.718021254009494	0.694834483808653	APP	1
GO:0006813	potassium ion transport	1/89	255/21288	0.00392156862745098	0.938003965631196	-0.0645324176142537	0.658622584356851	0.718541650833103	0.695338075667931	KCNC1	1
GO:0019722	calcium-mediated signaling	1/89	255/21288	0.00392156862745098	0.938003965631196	-0.0645324176142537	0.658622584356851	0.718541650833103	0.695338075667931	APP	1
GO:0002708	positive regulation of lymphocyte mediated immunity	1/89	257/21288	0.00389105058365759	0.930704323875312	-0.0724164585891752	0.661505580419086	0.72062092401636	0.697350203722522	ATAD5	1
GO:0045137	development of primary sexual characteristics	1/89	257/21288	0.00389105058365759	0.930704323875312	-0.0724164585891752	0.661505580419086	0.72062092401636	0.697350203722522	TCF21	1
GO:0015931	nucleobase-containing compound transport	1/89	258/21288	0.00387596899224806	0.92709694277502	-0.0763361941288603	0.66293803742744	0.721116228027636	0.697829513081516	NXT1	1
GO:0048738	cardiac muscle tissue development	1/89	258/21288	0.00387596899224806	0.92709694277502	-0.0763361941288603	0.66293803742744	0.721116228027636	0.697829513081516	BMPR1A	1
GO:0048588	developmental cell growth	1/89	259/21288	0.00386100386100386	0.92351741789944	-0.0802412451165565	0.664364500321827	0.722135326436768	0.698815702157544	APP	1
GO:0007179	transforming growth factor beta receptor signaling pathway	1/89	260/21288	0.00384615384615385	0.919965427830596	-0.0841317385459255	0.665784993900759	0.723146440356126	0.699794164583698	BMPR1A	1
GO:0007596	blood coagulation	1/89	261/21288	0.00383141762452107	0.916440656076456	-0.0880077997908807	0.667199542861328	0.724149614216673	0.700764943356152	F5	1
GO:0060560	developmental growth involved in morphogenesis	1/89	263/21288	0.00380228136882129	0.909471525611996	-0.0957171192860987	0.670010905211096	0.726666239107623	0.703200299896476	APP	1
GO:1903313	positive regulation of mRNA metabolic process	1/89	264/21288	0.00378787878787879	0.906026557711951	-0.0995506204259781	0.671407767491059	0.72764618445945	0.704148600269056	TRA2B	1
GO:0060047	heart contraction	1/89	265/21288	0.00377358490566038	0.902607589569642	-0.10337017521202	0.672798782934994	0.728513819937756	0.704988217545475	CACNA1H	1
GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	1/89	266/21288	0.0037593984962406	0.899214327954718	-0.107175901313988	0.674183975739008	0.728513819937756	0.704988217545475	GNAO1	1
GO:0050817	coagulation	1/89	266/21288	0.0037593984962406	0.899214327954718	-0.107175901313988	0.674183975739008	0.728513819937756	0.704988217545475	F5	1
GO:0070374	positive regulation of ERK1 and ERK2 cascade	1/89	266/21288	0.0037593984962406	0.899214327954718	-0.107175901313988	0.674183975739008	0.728513819937756	0.704988217545475	APP	1
GO:0016054	organic acid catabolic process	1/89	267/21288	0.00374531835205993	0.895846484029794	-0.110967914936029	0.675563370000221	0.72893633558912	0.705397089069649	FAAH	1
GO:0046395	carboxylic acid catabolic process	1/89	267/21288	0.00374531835205993	0.895846484029794	-0.110967914936029	0.675563370000221	0.72893633558912	0.705397089069649	FAAH	1
GO:0007599	hemostasis	1/89	269/21288	0.00371747211895911	0.889185915375298	-0.118511262371777	0.678304858790204	0.730825176563587	0.707224934465816	F5	1
GO:1901617	organic hydroxy compound biosynthetic process	1/89	269/21288	0.00371747211895911	0.889185915375298	-0.118511262371777	0.678304858790204	0.730825176563587	0.707224934465816	CACNA1H	1
GO:0005996	monosaccharide metabolic process	1/89	271/21288	0.003690036900369	0.882623657697251	-0.126001118736431	0.681023440117376	0.733218667279656	0.709541133153409	HKDC1	1
GO:0033002	muscle cell proliferation	1/89	273/21288	0.00366300366300366	0.876157550314854	-0.133438363277939	0.683719303235858	0.735584224852583	0.711830300731563	BMPR1A	1
GO:0045333	cellular respiration	1/89	274/21288	0.00364963503649635	0.872959895021734	-0.137137525045299	0.685058774185752	0.735951705698459	0.712185914666983	NDUFA5	1
GO:0051222	positive regulation of protein transport	1/89	274/21288	0.00364963503649635	0.872959895021734	-0.137137525045299	0.685058774185752	0.735951705698459	0.712185914666983	AACS	1
GO:0002700	regulation of production of molecular mediator of immune response	1/89	276/21288	0.0036231884057971	0.866634098680997	-0.14449745409705	0.687720911464807	0.737736977753157	0.713913535652653	ATAD5	1
GO:0003015	heart process	1/89	276/21288	0.0036231884057971	0.866634098680997	-0.14449745409705	0.687720911464807	0.737736977753157	0.713913535652653	CACNA1H	1
GO:0014706	striated muscle tissue development	1/89	277/21288	0.0036101083032491	0.86350545572547	-0.148158428202165	0.689043624147066	0.738618710477415	0.714766794938358	BMPR1A	1
GO:0045444	fat cell differentiation	1/89	278/21288	0.00359712230215827	0.860399320992644	-0.151806877848658	0.690360796935173	0.739493228380087	0.715613072387796	ADIRF	1
GO:0032409	regulation of transporter activity	1/89	279/21288	0.003584229390681	0.85731545245862	-0.155442903387985	0.691672452769194	0.73961176293817	0.715727779157295	APP	1
GO:0050807	regulation of synapse organization	1/89	279/21288	0.003584229390681	0.85731545245862	-0.155442903387985	0.691672452769194	0.73961176293817	0.715727779157295	APP	1
GO:0002705	positive regulation of leukocyte mediated immunity	1/89	280/21288	0.00357142857142857	0.854253611556982	-0.159066603982307	0.692978614495289	0.73961176293817	0.715727779157295	ATAD5	1
GO:0051896	regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	1/89	280/21288	0.00357142857142857	0.854253611556982	-0.159066603982307	0.692978614495289	0.73961176293817	0.715727779157295	RRAS	1
GO:0097529	myeloid leukocyte migration	1/89	280/21288	0.00357142857142857	0.854253611556982	-0.159066603982307	0.692978614495289	0.73961176293817	0.715727779157295	EMP2	1
GO:0032386	regulation of intracellular transport	1/89	281/21288	0.00355871886120996	0.851213563117278	-0.162678077622964	0.694279304866096	0.739929172454835	0.716034938696704	PTPN14	1
GO:0033044	regulation of chromosome organization	1/89	281/21288	0.00355871886120996	0.851213563117278	-0.162678077622964	0.694279304866096	0.739929172454835	0.716034938696704	DLGAP5	1
GO:0032868	response to insulin	1/89	284/21288	0.00352112676056338	0.842221870549138	-0.17344009955203	0.698148773978218	0.743515842323373	0.719505785684563	FOXO4	1
GO:0010001	glial cell differentiation	1/89	285/21288	0.00350877192982456	0.83926670609107	-0.177003622501851	0.699427804596954	0.744340556840193	0.720303868028761	APP	1
GO:0045860	positive regulation of protein kinase activity	1/89	286/21288	0.0034965034965035	0.836332207118724	-0.180555391514531	0.700701476233905	0.744621525536751	0.720575763516741	EMP2	1
GO:0050803	regulation of synapse structure or activity	1/89	286/21288	0.0034965034965035	0.836332207118724	-0.180555391514531	0.700701476233905	0.744621525536751	0.720575763516741	APP	1
GO:0045930	negative regulation of mitotic cell cycle	1/89	287/21288	0.00348432055749129	0.833418157616568	-0.184095497925116	0.701969811088451	0.745432304791552	0.721360360604706	FOXO4	1
GO:0002573	myeloid leukocyte differentiation	1/89	291/21288	0.00343642611683849	0.821962237924244	-0.198141087793871	0.706990223496187	0.749684097524713	0.7254748519133	APP	1
GO:0051259	protein complex oligomerization	1/89	291/21288	0.00343642611683849	0.821962237924244	-0.198141087793871	0.706990223496187	0.749684097524713	0.7254748519133	KCNC1	1
GO:0002274	myeloid leukocyte activation	1/89	292/21288	0.00342465753424658	0.819147298753271	-0.201624214984031	0.708232204260527	0.750461567014567	0.726227214895096	APP	1
GO:0042113	B cell activation	1/89	293/21288	0.00341296928327645	0.816351574184147	-0.205096206056501	0.709468979542524	0.751232408345458	0.726973163758388	ATAD5	1
GO:0016072	rRNA metabolic process	1/89	294/21288	0.00340136054421769	0.813574868149507	-0.208557145312343	0.710700570912884	0.751996658605814	0.727712734393922	TSR2	1
GO:0009636	response to toxic substance	1/89	295/21288	0.00338983050847458	0.810816987240526	-0.212007116106669	0.711926999853951	0.752754354684285	0.728445962499119	KCNC1	1
GO:0097305	response to alcohol	1/89	296/21288	0.00337837837837838	0.80807774066201	-0.215446200862567	0.713148287760063	0.75350553327084	0.729172883579132	USP46	1
GO:0001649	osteoblast differentiation	1/89	297/21288	0.00336700336700337	0.805356940188401	-0.218874481084774	0.714364455937909	0.753710709948795	0.729371434569539	BMPR1A	1
GO:0046883	regulation of hormone secretion	1/89	297/21288	0.00336700336700337	0.805356940188401	-0.218874481084774	0.714364455937909	0.753710709948795	0.729371434569539	AACS	1
GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1/89	299/21288	0.00334448160535117	0.799969937243997	-0.225698949435616	0.716781517899455	0.755720328021226	0.731316156857651	ATAD5	1
GO:0090150	establishment of protein localization to membrane	1/89	305/21288	0.00327868852459016	0.784232823724443	-0.245921247575668	0.723912019301818	0.762693020335845	0.738063682837042	TIMM9	1
GO:0034976	response to endoplasmic reticulum stress	1/89	308/21288	0.00324675324675325	0.776594192324529	-0.255894894529684	0.727410410864938	0.765285560646065	0.74057250329068	FAF1	1
GO:0140014	mitotic nuclear division	1/89	308/21288	0.00324675324675325	0.776594192324529	-0.255894894529684	0.727410410864938	0.765285560646065	0.74057250329068	DLGAP5	1
GO:0016197	endosomal transport	1/89	318/21288	0.00314465408805031	0.752172991308035	-0.28850777778447	0.738758151849008	0.776117004257326	0.751054171470426	EMP2	1
GO:0071560	cellular response to transforming growth factor beta stimulus	1/89	318/21288	0.00314465408805031	0.752172991308035	-0.28850777778447	0.738758151849008	0.776117004257326	0.751054171470426	BMPR1A	1
GO:1903532	positive regulation of secretion by cell	1/89	319/21288	0.00313479623824451	0.749815082244373	-0.291717278063888	0.739866903612739	0.776728599878142	0.751646017081007	AACS	1
GO:0002819	regulation of adaptive immune response	1/89	322/21288	0.0031055900621118	0.742829227440854	-0.30129109833838	0.743165317650303	0.778529008191902	0.753388285536641	ATAD5	1
GO:0051402	neuron apoptotic process	1/89	322/21288	0.0031055900621118	0.742829227440854	-0.30129109833838	0.743165317650303	0.778529008191902	0.753388285536641	APP	1
GO:1904062	regulation of monoatomic cation transmembrane transport	1/89	322/21288	0.0031055900621118	0.742829227440854	-0.30129109833838	0.743165317650303	0.778529008191902	0.753388285536641	KCNC1	1
GO:0001909	leukocyte mediated cytotoxicity	1/89	323/21288	0.00309597523219814	0.740529446550944	-0.304464352750987	0.74425557266934	0.779117792538876	0.753958056508629	EMP2	1
GO:0071559	response to transforming growth factor beta	1/89	325/21288	0.00307692307692308	0.735972342264477	-0.310784200530017	0.746422372754318	0.779761478253225	0.75458095594032	BMPR1A	1
GO:0098742	cell-cell adhesion via plasma-membrane adhesion molecules	1/89	325/21288	0.00307692307692308	0.735972342264477	-0.310784200530017	0.746422372754318	0.779761478253225	0.75458095594032	DCHS1	1
GO:0006520	amino acid metabolic process	1/89	327/21288	0.00305810397553517	0.731470982372951	-0.31706890031487	0.748571019123096	0.779761478253225	0.75458095594032	SEPHS1	1
GO:0007611	learning or memory	1/89	327/21288	0.00305810397553517	0.731470982372951	-0.31706890031487	0.748571019123096	0.779761478253225	0.75458095594032	APP	1
GO:0043491	phosphatidylinositol 3-kinase/protein kinase B signal transduction	1/89	327/21288	0.00305810397553517	0.731470982372951	-0.31706890031487	0.748571019123096	0.779761478253225	0.75458095594032	RRAS	1
GO:0048193	Golgi vesicle transport	1/89	327/21288	0.00305810397553517	0.731470982372951	-0.31706890031487	0.748571019123096	0.779761478253225	0.75458095594032	TMED1	1
GO:0051321	meiotic cell cycle	1/89	327/21288	0.00305810397553517	0.731470982372951	-0.31706890031487	0.748571019123096	0.779761478253225	0.75458095594032	TOP3A	1
GO:0050670	regulation of lymphocyte proliferation	1/89	328/21288	0.00304878048780488	0.729240887914497	-0.320198217473914	0.749638581705895	0.780322447435565	0.755123809971544	ATAD5	1
GO:0010721	negative regulation of cell development	1/89	329/21288	0.00303951367781155	0.727024350261262	-0.32331892376825	0.750701662155713	0.780877963102734	0.755661386595759	BMPR1A	1
GO:0048608	reproductive structure development	1/89	331/21288	0.00302114803625378	0.72263145388506	-0.329534733159548	0.752814451000703	0.782523830321379	0.757254104489413	TCF21	1
GO:0032944	regulation of mononuclear cell proliferation	1/89	332/21288	0.00301204819277108	0.720454853120347	-0.332629949533131	0.753864196377471	0.78306316173012	0.757776019486917	ATAD5	1
GO:0061458	reproductive system development	1/89	335/21288	0.00298507462686567	0.714003018614791	-0.341865513330456	0.756987056624166	0.785753630204536	0.760379605750116	TCF21	1
GO:0071375	cellular response to peptide hormone stimulus	1/89	337/21288	0.0029673590504451	0.709765611976128	-0.347981363850365	0.759047165631517	0.787337953098796	0.761912766745383	FOXO4	1
GO:0045165	cell fate commitment	1/89	338/21288	0.0029585798816568	0.707665713715843	-0.351027092444385	0.760070735020033	0.787845631872487	0.76240405125359	BMPR1A	1
GO:0034504	protein localization to nucleus	1/89	342/21288	0.00292397660818713	0.699388921742559	-0.363129917319467	0.764122195962731	0.790933501084231	0.765392205152697	BANP	1
GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1/89	342/21288	0.00292397660818713	0.699388921742559	-0.363129917319467	0.764122195962731	0.790933501084231	0.765392205152697	BMPR1A	1
GO:0051047	positive regulation of secretion	1/89	344/21288	0.00290697674418605	0.695322707081265	-0.369133993241799	0.766122484653854	0.792447871573937	0.766857672688142	AACS	1
GO:0033674	positive regulation of kinase activity	1/89	346/21288	0.00289017341040462	0.691303500681951	-0.37510704622509	0.768105999510472	0.793942781554272	0.76830430814458	EMP2	1
GO:0002706	regulation of lymphocyte mediated immunity	1/89	347/21288	0.00288184438040346	0.689311271573357	-0.378082061772641	0.769091510256512	0.794404746238344	0.76875135478979	ATAD5	1
GO:0016311	dephosphorylation	1/89	351/21288	0.00284900284900285	0.681455872467108	-0.389906505015374	0.77299231100465	0.797754714919835	0.771993144286384	PTPN14	1
GO:0071214	cellular response to abiotic stimulus	1/89	352/21288	0.00284090909090909	0.679519918283963	-0.392843946752249	0.773957286135785	0.797754714919835	0.771993144286384	USP28	1
GO:0104004	cellular response to environmental stimulus	1/89	352/21288	0.00284090909090909	0.679519918283963	-0.392843946752249	0.773957286135785	0.797754714919835	0.771993144286384	USP28	1
GO:0062012	regulation of small molecule metabolic process	1/89	356/21288	0.00280898876404494	0.671884863022346	-0.404520418747034	0.777776794206579	0.801131823641553	0.775261197400854	APP	1
GO:0030111	regulation of Wnt signaling pathway	1/89	357/21288	0.00280112044817927	0.670002832593712	-0.407421437937402	0.778721656872144	0.801545320227783	0.77566134110892	APP	1
GO:0051235	maintenance of location	1/89	358/21288	0.00279329608938547	0.66813131630155	-0.410315306133577	0.779662547060782	0.801799606473039	0.775907415791216	FAF1	1
GO:0002366	leukocyte activation involved in immune response	1/89	359/21288	0.00278551532033426	0.666270226283997	-0.41320206689266	0.780599481284939	0.801799606473039	0.775907415791216	ATAD5	1
GO:0042254	ribosome biogenesis	1/89	359/21288	0.00278551532033426	0.666270226283997	-0.41320206689266	0.780599481284939	0.801799606473039	0.775907415791216	TSR2	1
GO:0070663	regulation of leukocyte proliferation	1/89	362/21288	0.00276243093922652	0.66074864982308	-0.421820134199529	0.783386712278852	0.803543394027334	0.777594891918691	ATAD5	1
GO:1904951	positive regulation of establishment of protein localization	1/89	362/21288	0.00276243093922652	0.66074864982308	-0.421820134199529	0.783386712278852	0.803543394027334	0.777594891918691	AACS	1
GO:0034765	regulation of monoatomic ion transmembrane transport	1/89	364/21288	0.00274725274725275	0.65711816273614	-0.427530756140538	0.785225386139878	0.804869662652064	0.778878331886672	KCNC1	1
GO:0098813	nuclear chromosome segregation	1/89	365/21288	0.00273972602739726	0.655317839002617	-0.430375765101953	0.786138927558036	0.805246470936183	0.779242972053141	DLGAP5	1
GO:0015980	energy derivation by oxidation of organic compounds	1/89	370/21288	0.0027027027027027	0.646462192529608	-0.444499414156391	0.790649319283156	0.809304473242647	0.783169930930976	NDUFA5	1
GO:0032956	regulation of actin cytoskeleton organization	1/89	373/21288	0.00268096514745308	0.641262764707654	-0.452893913544995	0.793310271326677	0.811465083361199	0.785260769340079	ABL2	1
GO:0006887	exocytosis	1/89	379/21288	0.00263852242744063	0.631110847588272	-0.469508440542482	0.79853225072841	0.815675256111083	0.789334984682697	EXOC7	1
GO:0031647	regulation of protein stability	1/89	379/21288	0.00263852242744063	0.631110847588272	-0.469508440542482	0.79853225072841	0.815675256111083	0.789334984682697	USP28	1
GO:0044403	biological process involved in symbiotic interaction	1/89	381/21288	0.0026246719160105	0.627797929753163	-0.474996006797047	0.800243752515662	0.816857809661316	0.790479350509006	EXOC7	1
GO:0050870	positive regulation of T cell activation	1/89	390/21288	0.00256410256410256	0.613310285220398	-0.499386856528243	0.807769304278845	0.823665234585524	0.79706694601104	ABL2	1
GO:0031346	positive regulation of cell projection organization	1/89	391/21288	0.00255754475703325	0.611741716715998	-0.502067007365389	0.808587972664297	0.823665234585524	0.79706694601104	ABL2	1
GO:0045862	positive regulation of proteolysis	1/89	391/21288	0.00255754475703325	0.611741716715998	-0.502067007365389	0.808587972664297	0.823665234585524	0.79706694601104	PLGRKT	1
GO:0044282	small molecule catabolic process	1/89	394/21288	0.00253807106598985	0.60708378486283	-0.510072387244375	0.811023350058401	0.825575873937986	0.798915885858989	FAAH	1
GO:0002440	production of molecular mediator of immune response	1/89	398/21288	0.00251256281407035	0.600982440291344	-0.520665582231611	0.814222920495884	0.82826124671133	0.801514540974532	ATAD5	1
GO:0060271	cilium assembly	1/89	401/21288	0.00249376558603491	0.596486312309115	-0.528551086655544	0.816587391908692	0.830094006247637	0.803288115947758	BBS5	1
GO:0002703	regulation of leukocyte mediated immunity	1/89	410/21288	0.0024390243902439	0.583392710331598	-0.551910799939577	0.823503723896329	0.83654820437127	0.809533891259549	ATAD5	1
GO:0002699	positive regulation of immune effector process	1/89	411/21288	0.0024330900243309	0.581973263347823	-0.554479470476347	0.824256102887287	0.836736236585512	0.80971585142548	ATAD5	1
GO:0009895	negative regulation of catabolic process	1/89	415/21288	0.00240963855421687	0.576363882496277	-0.564701754384023	0.827234036730146	0.839181708512355	0.812082352715614	BANP	1
GO:0032970	regulation of actin filament-based process	1/89	416/21288	0.00240384615384615	0.574978392394123	-0.567244361837745	0.827970690336768	0.839351730753768	0.812246884497491	ABL2	1
GO:0141091	transforming growth factor beta receptor superfamily signaling pathway	1/89	417/21288	0.00239808153477218	0.573599547328429	-0.569781837554114	0.828704238083032	0.839518373058016	0.812408145489149	BMPR1A	1
GO:1903039	positive regulation of leukocyte cell-cell adhesion	1/89	423/21288	0.00236406619385343	0.565463383536537	-0.584900393476111	0.833041022784013	0.843332538508181	0.816099141635749	ABL2	1
GO:0001906	cell killing	1/89	425/21288	0.00235294117647059	0.562802379378718	-0.589900034643826	0.834462351531196	0.844192022296649	0.816930870461557	EMP2	1
GO:0044782	cilium organization	1/89	428/21288	0.00233644859813084	0.558857502887745	-0.597362802286744	0.83657194138757	0.845746136769476	0.818434798543736	BBS5	1
GO:0051347	positive regulation of transferase activity	1/89	429/21288	0.00233100233100233	0.557554804745816	-0.599840704633562	0.8372692135456	0.845871294506685	0.818555914612713	EMP2	1
GO:0050767	regulation of neurogenesis	1/89	430/21288	0.00232558139534884	0.556258165665012	-0.602313803934311	0.837963544050152	0.845993311070482	0.818673990944923	BMPR1A	1
GO:1903311	regulation of mRNA metabolic process	1/89	434/21288	0.00230414746543779	0.551131362294827	-0.612158647168301	0.840711694172274	0.848187242752465	0.820797074877676	TRA2B	1
GO:0010959	regulation of metal ion transport	1/89	435/21288	0.00229885057471264	0.549864393645874	-0.614608087052132	0.841391499447937	0.848292865130353	0.820899286434797	KCNC1	1
GO:0030522	intracellular receptor signaling pathway	1/89	444/21288	0.00225225225225225	0.538718493774674	-0.636445971571253	0.847382077412405	0.853749019250886	0.826179247175167	TCF21	1
GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	1/89	448/21288	0.00223214285714286	0.533908507223114	-0.646034739028966	0.84997221602419	0.855774074154047	0.828138907798671	BMPR1A	1
GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	1/89	456/21288	0.00219298245614035	0.524541691306919	-0.66500349074312	0.855022796797115	0.860271913557807	0.832491500292158	FAF1	1
GO:0046486	glycerolipid metabolic process	1/89	460/21288	0.00217391304347826	0.519980459208598	-0.674386075356597	0.857484670094115	0.86216079644773	0.834319386250221	FAAH	1
GO:0140694	non-membrane-bounded organelle assembly	1/89	465/21288	0.0021505376344086	0.514389271475172	-0.686021372160247	0.860503953110487	0.864607173595346	0.836686763529199	DLGAP5	1
GO:0043434	response to peptide hormone	1/89	470/21288	0.00212765957446809	0.508917045182883	-0.697555605699053	0.863459974216745	0.866986699775153	0.838989448631656	FOXO4	1
GO:0031331	positive regulation of cellular catabolic process	1/89	481/21288	0.00207900207900208	0.49727860963816	-0.722586286394765	0.869746958452786	0.872705281440721	0.844523362450396	APP	1
GO:0009410	response to xenobiotic stimulus	1/89	486/21288	0.00205761316872428	0.492162574559578	-0.733812048092978	0.872509218183648	0.874881778940096	0.846629575195554	KCNC1	1
GO:0016055	Wnt signaling pathway	1/89	492/21288	0.00203252032520325	0.486160591942998	-0.747161700177763	0.875747562456183	0.877403680769116	0.849070038267919	APP	1
GO:0022409	positive regulation of cell-cell adhesion	1/89	494/21288	0.00202429149797571	0.484192330437156	-0.751582736505333	0.876808830816052	0.877403680769116	0.849070038267919	ABL2	1
GO:0198738	cell-cell signaling by wnt	1/89	494/21288	0.00202429149797571	0.484192330437156	-0.751582736505333	0.876808830816052	0.877403680769116	0.849070038267919	APP	1
GO:0006869	lipid transport	1/89	500/21288	0.002	0.47838202247191	-0.76476102212943	0.879939153412105	0.879939153412105	0.851523633917441	SLCO3A1	1
